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xv Abstract 
Abstract 
The Sec pathway is the major route for secretion of proteins by bacteria. Its major 
components are: (i) the translocation channel comprising the SecYEG proteins; (ii) 
SecA: a chaperone/targeting/molecular motor that drives the movement of proteins 
across the membrane with participation of SecB or SRP (signal recognition particle) 
chaperones. Following translocation, proteins are folded to their mature conformation 
by folding factors such as PrsA. When compared with B. subtilis, the secretory 
translocase of B. anthracis contains homologues of several Sec pathway components: 
(i) two homologues of SecA (SecA1 and SecA2), (ii) two homologues of SecY (SecY1 
and SecY2), (iii) three homologues of the PrsA foldase (PrsAA, PrsAB and PrsAC). In 
previous studies, SecA2 was shown to be specific for secretion of S-layer proteins: Sap 
and EA1, while SecY2 has not been shown to have any substrate specificity. Instead, it 
seems to ensure high levels of protein secretion in later phases of the growth cycle.  
A combination of approaches was used to continue the analysis of functioning of the 
SecA2 secretion pathway. They involved analysis of deletion mutants of B. anthracis, 
complementation studies, gene expression analysis, protein interaction investigation.  
We found that a novel protein BA0881 facilitates secretion of Sap and EA1, but is 
not essential for the processes, and was renamed SecH. Moreover, protein interaction 
and complementation studies revealed putative interactions between (i) SecA2 and EA1, 
(ii) SecA2 and SecH, (iii) EA1 and SecH, (iv) SecA1 and SecA2, raising the possibility 
that SecA2 and SecA1 form a dimer, which might be a functional entity for the 
secretion of Sap and EA1, with SecH having a role in enhancing interaction between 
SecA1/SecA2 dimer and its substrates.  
The role of PrsA-like foldases on secretion was also investigated. PrsAB was found 
to show substrate specificity for Sap and EA1, while PrsAA showed substrate 
specificity for penicillin binding proteins.  
Analysis of cell morphology suggests that PrsAB and SecA2 may also have 
substrates other than those of Sap and EA1 as their null-mutants show changes in cell 
length and shape.   
Lastly, analysis of gene expression showed that the deletion of genes encoding 
elements of the translocation sytem: SecA2, SecH, PrsAA, PrsAB, PrsAC, SecY2 leads 
to changes in the level of expression of sap and eag. 
 
1 Chapter 1: General introduction  
Chapter 1: General introduction 
1.1 Genus Bacillus  
Bacillus is a bacterial genus which comprises spore-forming, Gram-positive rods which 
are aerobic or facultatively anaerobic. The members of this genus are widely distributed 
in the environment. Although most members of the genus are non-pathogenic, a few 
species are responsible for well-known diseases. The best known disease-causing 
member of the genus is Bacillus anthracis, the causative agent of anthrax. On the other 
hand, B. subtilis is generally recognised as safe (GRAS), and is used for the production 
of a wide range of bioproducts. Taxonomically, based on 16S rRNA/DNA sequence 
similarities, the genus Bacillus can be divided into six RNA groups (Ash et al., 1991; 
Nielsen, et al., 1994, Fritze, 2004). The species included in this research are B. subtilis 
and B. anthracis. They belong to the RNA group 1 and within it, they are categorised to 
the Bacillus subtilis and Bacillus cereus groups, respectively.   
1.2 Bacillus cereus group 
The B. cereus group comprises six members: B. anthracis, B. cereus, B. mycoides,       
B. pseudomycoides, B. thuringiensis, B. weihenstephanensis. B. mycoides,                    
B. pseudomycoides, B. weihenstephanensis are non-pathogenic, while B. thuringiensis 
may cause disease in insects, and B. anthracis as well as B. cereus in mammals. B. 
anthracis, B. cereus and B. thuringiensis are phylogenetically closely related and have 
very similar genomes. In the study by Ash et al. (1991), the 16S rRNA sequences of B. 
thuringiensis, B. cereus and B. anthracis differed less than 1%. Other studies confirmed 
very close relationship between those species. MLST (multilocus sequence typing) 
studies, which compare the sequences of specific housekeeping genes, showed that 
some of the strains of B. cereus and B. thuringiensis analysed in that study were more 
closely related to some strains of B. anthracis than to other strains within their own 
species (Halgeson, 2004). Comparison of the genomic sequences of B. anthracis, B. 
cereus and B. thuringiensis showed a high degree of similarity, with conserved gene 
order and only a small subset of genes that were unique to any of those species (Rasko 
et al., 2005). Thus, as B. thuringiensis and B. cereus sensu stricto and B. anthracis are 
genetically very closely related, they might be re-classified as a single species: B. cereus 
sensu lato (Helgason et al., 2000, Bavykin et al., 2004). The most striking difference 
between the chromosome of B. anthracis as compared with those of B. thuringiensis 
and B. cereus is a point mutation in the plcR gene of the former (Agaisse et al., 1991). 
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The product of the plcR gene is a pleiotropic regulator controlling most of the secreted 
virulence factors in B. cereus and B. thuringiensis. The plcR gene is non-functional in 
B. anthracis. The lack of PlcR in B. anthracis renders this bacterium non-haemolytic 
and sensitive to γ phage. These features distinguish B. anthracis from B. cereus and B. 
thuringiensis on the phenotypic level (Drobniewski, 1993). The other distinguishing 
features of B. anthracis are the presence of plasmids and the products of genes encoded 
by them. B. anthracis carries plasmids pXO1 and pXO2 encoding key virulence factors 
and their regulators (Koehler, 2009), while the distinguishable feature of B. 
thuringiensis is the possession of crystals formed by Cry proteins, which are usually 
plasmid encoded (Konstad et al., 1983, Gonzales et al., 1984).  
1.3 B. anthracis is the causative agent of anthrax 
B. anthracis is the etiological agent of anthrax (Spencer, 2003). Anthrax is a disease that 
affects mainly herbivores, but humans can also be infected. The infection occurs via 
spores, which enter the host through skin lesions, consumption of contaminated food or 
inhalation of contaminated air. Depending on the point of entry, cutaneous, 
gastrointestinal and pulmonary anthrax can develop (Spencer, 2003). Spores are 
ingested by macrophages local to the point entry. Spores germinate inside macrophages 
to the vegetative bacillus and produce capsule and toxins. The vegetative cells get 
released from macrophages and continue multiply and produce the edema and lethal 
toxins at the site of entry. Their action impairs functioning of the immune system and 
triggers development of anthrax-related pathological changes: edema, vascular damage, 
hemorrhage, tissue necrosis (Tournier et al., 2007). Bacteria may also get into the 
bloodstream, disseminate to other parts of the body and cause septicaemia, which if 
untreated promptly leads ultimately to death. The cutaneous form is most common, 
accounting for about 95% of cases (Tutrone et al., 2002). The characteristic symptom of 
cutaneous anthrax is a raised bump that develops into a black necrotic ulceration, which 
may be surrounded by edema (Meade, 2004). If untreated, approximately 20% of 
patients will develop septic shock and die. However with the appropriate antibiotic 
treatment the mortality is below 1% (Carucci et al., 2002). In gastrointestinal anthrax 
the necrotic ulcerations, edema and hemorrhages are formed in the intestines leading to 
the development of symptoms which include nausea, loss of appetite, fever, abdominal 
cramps, vomiting of blood and severe diarrhoea. The gastrointestinal form of anthrax is 
often undiagnosed which leads to high mortality due to septicaemia (Sirisanthanta and 
Brown, 2002). Pulmonary anthrax is the most severe form (Shafazand et al., 1999). 
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Anthrax toxins cause development of edema, hemorrhages and necrosis in the 
pulmonary tracts. Cells of B. anthracis disseminate to other parts of the body causing 
similar pathological changes as in the pulmonary tract. At first symptoms resemble 
those of flu but the patient’s condition rapidly deteriorates usually leading to death 
(>95% of untreated cases), which is the result of respiratory failure due to pulmonary 
edema and of septicaemia. When appropriate treatment is applied, the mortality can 
drop to 45% (Jernigan et al., 2002).  
Treatment of anthrax 
In vitro B. anthracis exhibits sensitivity to penicillins, fluoroquinolones, tetracycline, 
chloramphenicol, aminoglycosides, macrolides, imipenem/meropenem, rifampicin, and 
vancomycin. According to the recommendations of the Health Protection Agency 
(2010) the use of penicillins alone is not recommended due to the occurrence of β-
lactamase encoding strains. Instead, ciprofloxacin or doxycycline are used in 
combination with one of the following antibiotics: rifampin, vancomycin, imipenem, 
chloramphenicol, penicillin, ampicillin, clindamycin and clarithromycin. The use of the 
combination of antibiotics gives firstly synergistic effect against B. anthracis and 
secondly it is effective against B. anthracis strains being resistant to one of the 
antibiotics used. 
Prevention of anthrax 
The veterinary anthrax vaccine employs the toxigenic, non-encapsulated, attenuated B. 
anthracis strain, Sterne 34F2 strain (Turnbull et al., 1989). Human vaccines usually are 
also based on B. anthracis Sterne 34F2
 
and can use either live spores (of attenuated non 
capsulated strain) or cell-free culture filtrates. In the USA the non-encapsulated, non-
proteolytic derivative of bovine isolate V770-NP1-R is used (Turnbull et al., 1989).  
The pathogenicity factors of B. anthracis  
Pathogenicity of B. anthracis is due to its two toxins: lethal toxin and edema toxin as 
well as its capsule. Each of the toxins is formed by two proteins: lethal toxin by 
protective antigen and lethal factor, and edema toxin by protective antigen and edema 
factor. The protective antigen, lethal and edema factors are encoded by the pagA, lef and 
cya genes, respectively (Bhatnagar and Batra, 2001). Those genes, together with genes 
encoding regulatory elements AtxA and PagR, are located on the pXO1 virulence 
plasmid. B. anthracis also harbours a second pathogenicity plasmid, pXO2, encoding 
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the cap operon responsible for the production of the poly-γ-D-glutamate capsule, which 
inhibits the phagocytosis of vegetative cells of B. anthracis by the immune system 
(Makins et al., 1989).  
While the role of the capsule is to protect, against host’s immune system, lethal 
and edema toxins are involved in both: modulation of the immune responses and the 
development of the specific symptoms of anthrax. Individually, none of the toxin 
components: protective antigen, lethal factor, edema factor is toxic. The protective 
antigen is necessary to deliver the toxic components: lethal and edema factor to the 
interior of the cell, where those factors exert their toxic action. And only when lethal or 
edema factors are in the presence of the protective antigen, then their toxicity can be 
observed. Initial research in regard to the effects exhibited by the those toxins showed 
that a combination of the protective antigen and the lethal toxin induces lethal shock in 
experimental animals, while a combination of the protective antigen and edema factor 
induces edema at the site of infection (Smith and Stoner, 1967).  
Protective antigen, a component of both B. anthracis toxins, is a receptor 
binding protein responsible for delivering the enzymatic components of the toxins 
(lethal and edema factors) into the interior of the host cell, where they perform their 
toxic action. Upon binding to the cell surface, protective antigen (PA 83; 83 kDa) 
undergoes cleavage by a furin-like protease at an RKKR site, leading to removal of its 
20 kDa N-terminal fragment (PA20). The 63 kDa fragment (PA63) remains bound to 
the receptor and undergoes a structural rearrangement to form a pre-pore, which binds 
lethal and edema factors. The complexes of the protective antigen with lethal and edema 
factor are internalised by endocytosis, followed by the release of lethal and edema factor 
from the resulting endosome into the cytosol via a channel formed by protective antigen 
(Young and Collier, 2007). Once in the cytosol, the enzymatic sub-units (lethal and 
edema factors) of the toxins exhibit their cytotoxic effects. The lethal factor inhibits 
mitogen-activated protein kinase kinases (MAPKK) (Duesbery et al., 1999; Vitale et 
al., 1998) (model of action of the anthrax toxins is presented on the Figure 1.1).  
 
 
 
 
 
 
 
 
5 Chapter 1: General introduction  
 
Figure 1.1: Action of anthrax toxin at the molecular level. (1) The protective antigen 
(PA) binds to a receptor, ATR or CMG2; (2) cleavage by a furin protease removes 20 
kDa fragment (PA20); (3) 63 kDa (PA63) self-associates to form the heptameric 
prepore; (4) up to three molecules of EF and/or LF bind to the prepore; (5) the complex 
is endocytosed and trafficked to an acidic intracellular compartment; (6) under the 
influence of low pH the prepore converts to a pore, and EF and LF are translocated to 
the cytosol. There, EF catalyzes the formation of cAMP, and LF proteolytically 
inactivates MAPKKs (Collier and Young, 2003). 
 
The main effect associated with the lethal toxin is cell death and resulting 
necrosis, vascular damage and haemorrhages, which belong to the main symptoms of 
anthrax. The effects of the action of the lethal toxin are mediated by the disruption of 
cell’s signalling pathways due to cleavage of MAPKKs, but it is not completely clear 
how the lethal toxin-induced cell death is achieved. However, the research that has been 
done offers some clues to how that death occurs. The detrimental effect of the lethal 
toxin, that have been observed, include: (1) changes in the membrane permeability, 
triggering colloid-osmotic lysis (Hanna et al., 1992); (2) toxic effects exerted by 
reactive oxygen intermediates (Hanna et al., 1994); (3) inhibition of certain NF-B target 
gens leads to the apoptosis of activated macrophages (Park et al., 2002). Lethal toxin is 
also implicated in development of toxic shock, but the mechanism in not yet known. It 
was postulated that the septic shock could develop due to macrophage lysis and 
cytokine (TNF-α/IL-1β) induction by lethal toxin (Hanna et al., 1993). However, it was 
shown that the septic shock induced by the lethal toxin does to require cytokine shock 
or macrophage sensitivity to toxin (Moayeri et al., 2003). Additionally, the lethal toxin 
is able to supress functioning of the immune system by a number of means which 
include:  (1) inhibition of neutrophil’s mobility (During et al., 2005); (2) inhibition of 
proliferation and differentiation of monocytes (Kassam et al., 2005), (3) suppression of 
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cytokine production of macrophages (Erwin et al., 2005); (4) activation of cell death of 
macrophages (Kassam et al., 2005); (5) cell death of immature dendritic cells (Alileche 
et al., 2005), (6) Inhibition of activation, proliferation, surface-molecule expression and 
cytokine expression in T cells (Paccani et al., 2005; Comer et al., 2005).  
The effect of the increased concentrations of edema toxin-induced levels of 
cAMP in the cell is the disruption of water homeostasis and cellular signalling pathways 
leading to edema, one of the symptoms of anthrax (Leppla, 1982, Dixon et al., 1999). 
Other major effect of the edema toxin is impairment of function of the immune system 
as edema toxin-induced levels of cAMP cause: (1) inhibition of phagocytosis (O’Brien 
et al., 1985); (2) cell death of macrophages (Voth et al., 2005); (3) suppression of 
cytokine production in the dendritic cells (Tournier et al., 2005); (4) Inhibition of  
activation, proliferation, surface-molecule expression and cytokine expression in T cells 
(Paccani et al., 2005; Comer et al., 2005). 
Regulation of pathogenicity of B. anthracis 
AtxA is the master regulator of the expression of the genes involved in the 
pathogenicity of B. anthracis. It was shown to mediate activation or repression of genes 
located on pXO1 and pXO2 plasmids, as well as on the chromosome (Mignot et al., 
2003; Bourgogne et al., 2003). It can directly induce the expression of pathogenicity 
factors genes such as pagA, lef and cya (Uchida et al., 1993; Koehler et al., 1994), as 
well as regulators (e.g. pagR, acpA, acpB) whose products in turn affect the expression 
of genes further down the regulatory cascade. pagR is part of the pag operon which also 
contains the pagA gene. PagR autogenously controls the pag operon by inhibition 
(Hoffmaster and Koehler, 1999) and also regulates two chromosomal genes, sap and 
eag, that are key elements of this project. PagR up-regulates eag and down-regulates 
sap. As the expression of sap and eag is part of the regulation mediated by toxigenicity 
regulatory factors and as it is highly energy-consuming process it has been postulated 
that products of those genes, namely Sap and EA1 are pathogenicity factors, but this 
hypothesis has not been proved. 
AtxA and CO2 both induce acpA and acpB. Their products, AcpA and AcpB are 
required for the activation of the capsule-encoding cap operons (Drysdale et al., 2004; 
Vietri et al., 1995). The AtxA-mediated regulation is depicted on the Figure 1.2.  
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1.4 Bacterial protein secretion 
 
The analysis of completed genome sequencing projects reveals that 15-25% of the 
genome encodes proteins that are destined for secretion in most bacteria (identified by 
the presence of the N-terminal signal peptide) (Liu and Rost, 2001). Their secretion is 
mediated primarily via the Sec-dependent secretion (Sec) pathway (Tjalsma et al., 2000; 
Bendtsen et al., 2005). The Sec pathway is described in detail in the Section 1.5.1. 
Gram-negative bacteria additionally possess specialized secretion pathways for the 
secretion of a sub-set of proteins across the outer membrane. In both Gram-negative and 
Gram-positive bacteria a small subset of proteins are translocated across the 
cytoplasmic membrane via the twin-arginine translocation (Tat) pathway. The Tat 
pathway serves to secrete fully-folded proteins (Figure 1.3c) that mostly contain metal 
cofactors, which must be bound to the folded protein in the cytoplasm. Thus folding 
Figure 1.2: AtxA-mediated regulation of genes encoding virulence factors and sap and 
eag (modified from Mignot et al., 2004). Plasmids pXO1 and pXO2 are shown as two 
grey ovals, while the chromosome is showed as a big, closed, entangled circle at the 
bottom of the diagram. pXO1 plasmid harbours genes of the regulatory molecules (atxA 
and pagR) and of toxin components (cya, lef, pagA). pXO2 harbours capBCAD operon 
responsible for the capsule production, as well as acpA and acpB genes encoding 
regulators of capBCAD operon. ‘+’ means stimulatory effect, while ‘-‘ means inhibitory 
effect on the gene expression. AtxA is the master regulator and induces expression of 
genes of the regulators pagR, acpA, acpB as well as of the toxin components: lef, cya 
and pagA. pagR and pagA constitute a single operon. When PagR is produced it 
autoinhibit its own operon, as well in up-regulates eag and down-regulates sap 
expression. Induction of acpA and acpB leads to the production of AcpA and AcpB, 
which in turn induce expression of capBCAD operon.  
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must occur before the translocation of these proteins to trans side of the cytoplasmic 
membrane.  
The secreted proteins can be integrated into the cytoplasmic membrane 
(membrane proteins) or secreted across it (extracellular proteins). Subsets of 
extracellular proteins become bound to the cell wall. The subsequent fates of the rest of 
remaining extracellular proteins depend on the type of bacterium. In Gram-negative 
bacteria these proteins are either compartmentalised in the periplasm or are integrated 
into the outer membrane. Gram-positive bacteria lack an outer membrane and, as a 
result, a conventional periplasm. In consequence, in Gram-positive bacteria, the proteins 
that fulfil the variety of functions in the periplasm of Gram-negative bacteria, are 
usually tethered to the cell membrane by virtue of an acyl modification at their N-
terminus (i.e. lipoproteins) or attached to the cell wall or they are secreted to the 
surrounding medium. In case of cell surface proteins, they can be attached to the cell 
wall via covalent or non-covalent (ionic) interactions. Covalent linkage is carried out by 
enzymes, called sortases, which link the C-terminus of their target proteins to the 
peptidoglycan. Sortases recognise their substrates by the virtue of the presence of a 
sortase recognition sequence (typically LPXTG), a stretch of hydrophobic amino acids 
and a positively charged C-terminal tail (Fischetti et al., 1990; Mazmanian et al., 1999). 
Non-covalent linkage of surface proteins includes predominately interactions with 
anionic wall polymers (reviewed in Navarre and Schneewind, 1999). Some proteins are 
attached to the cell wall by electrostatic interaction between their SLH (S-layer 
homology) domains and negatively-charged polymers attached to the cell wall (more 
extensively described in the Section 1.8). 
 
1.5 Sec pathway  
The main components of the bacterial Sec translocation system are: (1) the cytoplasmic 
chaperones: SecB and SRP; (2) the SecA ATPase, which serves as a piloting protein 
and the molecular motor driving movement of preproteins through the translocation 
channel; (3) a membrane-spanning translocation channel formed by a heterotrimeric 
SecYEG complex; (4) accessory proteins (Section 1.5.4).  
The secretion of proteins by the Sec pathway takes place while they are in an 
unfolded conformation (secretion competent state) as they must pass through the narrow 
channel of the SecYEG translocase on their way to the trans side of the cytoplasmic 
membrane or to be integrated into the membrane itself. The competent state of the 
secretory proteins is maintained by the cellular chaperones SecB (found only in Gram-
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negative bacteria) (Section 1.5.3a) and Signal Recognition Particle (SRP) (found in 
both Gram-positive and negative bacteria) (Section 1.5.3b). The SecB chaperone 
mediates translocation post-translationally by recognising the signal peptide and binding 
along the full length of the preprotein. The resulting binary complex then interacts with 
SecA, which drives the translocation of the preprotein through SecYEG translocation 
channel (Randall and Hardy, 2002; Zhou and Xu, 2005). In Gram-positive bacteria the 
CsaA chaperone is a putative functional (but not structural) homologue of SecB 
(Section 1.5.3a). In contrast, SRP drives co-translational protein translocation (Luirnik 
and Sinning, 2004; Shan and Walter, 2005). SRP binds the signal peptide of the nascent 
protein during its synthesis on the ribosome, arrests translation and delivers the 
preprotein-ribosome complex to the membrane-bound docking protein FtsY. The 
preprotein is then passed to SecA which drives translocation through the translocation 
channel (Figure 1.3).   
1.5.1 Signal peptides and targeting cytosolic factors 
The common feature of all secretory proteins targeted to the Sec or Tat pathways is their 
N-terminal signal peptide (Tjalsma et al., 2004; Harwood and Cranenburgh, 2008). The 
structure features of the signal peptides of both the Sec and Tat pathways substrates 
exhibit the same pattern: (i) an N-terminus consisting of positively charged amino acids 
(N region); (ii) a hydrophobic core (H region); (iii) a C-terminal cleavage region (C-
region) (Figure 1.3). Signal peptides are recognized by membrane targeting cytosolic 
factors, e.g. SRP or SecB that compete with each other and other cytosolic factors for 
binding to polypeptides emerging from the ribosome. In the case of polypeptides 
lacking signal sequences, the competition is won by factors other than SRP or SecB and 
the polypeptides are generally folded and are retained in the cytoplasm. If the N-
terminal end of the protein is strongly hydrophobic and helical, then SRP binds and 
targets it for the secretion in a co-translational way (Bruch et al., 1989; Valent et al., 
1998). In contrast, SecB binds the mature regions of the preprotein after it has been 
synthesized (post-translational mode of secretion). The SecB binding sites are located in 
the unfolded parts of the preprotein, thus proteins with a lower rates of folding are 
preferential targets for SecB (Topping and Randall, 1997). The signal peptides of the 
SecB-mediated secretory pathway may serve to delay protein folding so that SecB 
binding can maintain their substrates in a secretion competent state (Beena et al., 2004). 
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Figure 1.3: Schematic overview of the Escherichia coli Sec and Tat translocases. (a) 
Co-translational and (b) post-translational targeting routes, of translocation of unfolded 
proteins by the Sec translocase. (c) Translocation of folded precursor proteins by the Tat 
translocase (Natale et al., 2008).  Proteins are secreted by the means of the N-terminal 
signal peptide (helical structure). Co-translational mode of translocation (a) is mediated 
by the Signal Recognition Particle (SRP), which binds to the signal peptide of the 
nascent protein and delivers the ribosome with the protein being synthesized to the 
docking protein FtsY which provides energy (from GTP hydrolysis) for passing the 
ribosome/nascent protein to the SecA molecular motor. The SecA drives protein 
translocation through the translocation channel (SecYEG) with energy for the processes 
obtained through the hydrolysis of ATP. The auxiliary complex (SecDFYajC) facilitates 
the process. While the protein has been translocated the signal peptidase (Lep) cleaves 
the signal peptide. The co-translational mode of translocation (b) is mediated by the 
SecB chaperone. SecB binds fully synthesised protein and delivers it to the SecA, which 
drives its translocation. Substrates of the Tat pathway (c) are secreted by the TatABC 
transporter. N-terminal and C-terminal ends of proteins are annotated as ‘N’ and ‘C’, 
respectively. 
 
The fate of proteins piloted by SRP is predominately membrane integration, while the 
fate of those piloted by SecB is secretion across the cytoplasmic membrane. In the 
above model the main function of the signal peptide is targeting. However, recently a 
new model was proposed by Gouridis et al. (2009), in which the signal peptide is not 
indispensable for targeting, but has other important functions. The model assumes that 
the signal peptides of the Sec pathway drive three successive states: first, “triggering” 
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that drives the translocase to a lower activation energy state; then “trapping” that 
engages the mature part of the preprotein with translocase and, finally, “secretion” 
during which the preprotein is secreted by the action of SecA. This model is based on 
studies in E.coli on the secretion of proPhoA (periplasmic alkaline phosphatase), which 
is SecB independent. It was observed that proPhoA binds with high affinity to SecYEG-
bound SecA but not to SecYEG alone. When the signal peptide becomes impaired, the 
binding affinity is reduced only slightly (Gouridis et al., 2009 and references within). In 
contrast, truncation of the carboxy terminal part of proPhoA reduced the SecA binding 
affinity seven-fold (Gouridis et al., 2009), indicating that the mature part of the protein 
is also important to binding with SecA, and hence important for targeting. The study 
also indicated that the signal peptide is not necessary for targeting, but is necessary for 
translocation since it drastically lowers the ATPase activation energy. The initiation of 
protein secretion induced by lowering the activation energy by the signal peptide was 
termed “triggering”. The next step, which is also signal peptide-dependent is called 
“trapping” where the mature part of the protein becomes bound in the translocase. 
Lastly, the preprotein is translocated by SecA driven by rounds of ATP hydrolysis. The 
findings based on experiments with proPhoA which gave rise to the above model were 
validated using other combinations of signal peptides and PhoA as well the signal 
peptide of PhoA and mature domains of other proteins (Gouridis et al., 2009).  
Types of signal peptides 
Within the Sec pathway substrates, two classes of protein can be differentiated on the 
basis of their signal peptides: types I and II (Figure 1.3) (Tjalsma et al., 2004; Harwood 
and Cranenburgh, 2008). Proteins with Type I signal peptides are targeted to the 
periplasm (Gram-negative bacteria), cell wall or to the external medium, while proteins 
with type II peptides are acyl modified and directed to the cytoplasmic membrane and, 
in the case of Gram-negative bacteria, also to the outer membrane.  
In spite of their common overall structural patterns, there are differences in the 
signal peptides of Gram-positive and Gram-negative bacteria. Type I signal peptides of 
Gram-negative bacteria are on average less hydrophobic and shorter (ca. 25 amino 
acids) than those of those Gram-positive bacteria (ca. 30 amino acids). After the protein 
has been translocated, the signal peptide is removed by cleavage by a signal peptidase at 
a target site in the C-terminal region. In Gram-negative bacteria, signal peptides are 
usually cleaved 3-7 residues downstream of the C-terminal part of the H region. In 
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Gram-positive bacteria, the signal peptides are preferentially cleaved 7-9 residues 
downstream of the C-terminal part of the H region (Dalbey et al., 1997).   
Gram-negative bacteria encode only a single type I signal peptidase (Lep), while 
Gram-positive bacteria can encode more that one of those proteins. Bacillus subtilis for 
example encodes 5 type I signal peptidases: SipS, SipT, SipU, SipV and SipW. SipS 
and SipT are the major signal peptidases and at least one of those proteins must be 
present for B. subtilis to maintain viability (Tjalsma et al., 1997). Some Bacillus strains 
contain additional plasmid-encoded signal peptidases (e.g. SipP), which in some cases 
can complement the lethality of the SipS and SipT double deletion (Tjalsma et al., 
1999). 
Type II signal peptides are found at the N-terminus of lipoproteins and are 
cleaved by a type II signal peptidase (LspA) (Tjalsma et al., 2001). In comparison to the 
type I signal peptides, the type II signal peptides possess shorter N and H regions as 
well rather different signal peptidase recognition site (consensus LAG-Cys), called the 
Lipobox (Figure 1.4).   
Figure 1.4: General features of the signal peptides and propeptides of Bacillus secretory 
proteins. The N-terminal (N), hydrophobic (H) and cleavage (C) regions are identified 
by contrasting shading and their lengths (amino acyl residues) are indicated in brackets. 
Cleavage sites are indicated by arrows. (a) Sec-dependent signal peptide cleaved by a 
type I signal peptidase (SP) at the AXA cleavage site. (b) Tat-dependent signal peptide 
with twin arginine motif (SRRxFLK), also cleaved by a type I SP. (c) Lipoprotein 
signal peptide cleaved by the type II SP. (d) The signal peptide and propeptide 
(prepropeptide) at the N-terminal end of a secretory protein requiring the propeptide for 
folding on the trans side of the cytoplasmic membrane (Harwood and Cranenburgh, 
2008). 
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The signal peptides of proteins secreted by the Tat pathway include the so-called 
twin arginine motif (SRRxFLK) at the junction between the N and H regions. Overall, 
they are longer (ca. 37 amino acids) and exhibit lower hydrophobicity in comparison to 
the signal peptides of the Sec pathway substrates (Figure 1.3). Moreover, they have 
basic residues in the C-region. This latter characteristic is likely to play a role in 
preventing Tat substrates from being secreted via the Sec pathway (Cristobal et al., 
1999).  
 
1.5.2  Structure and mode of action of SecA   
SecA has been found to exist in a monomer-dimer equilibrium, but with the balance 
shifted towards the dimeric form (Woodbury et al., 2002; Vassylyev et al., 2006; 
Papanikolau et al., 2007). Based on crystallographic studies (Hunt et al., 2002; Sharma 
et al., 2003; Osborne et al., 2004; Mitra et al., 2006; Vassylyev et al., 2006; Zimmer et 
al., 2006; Papanikolau et al., 2007), SecA can be divided into the following 
regions/domains (Figure 1.5): (1) the DEAD motor domain; (2) helical scaffold domain 
(HSD); (3) substrate specificity domain (SSD); (4) C- terminal domain. The C- terminal 
domain can be further divided into additional sub-structures: (i) the helical Wing 
domain (HWD); (ii) IRA1 (intermolecular motor of ATPase activity) and (iii) the C-
terminal region (CTD) containing a SecB-binding site. The DEAD domain is composed 
of nucleotide-binding domains (NBD1 and NBD2). The cleft formed at their 
interference is the site of ATP binding and its entrance is covered by ATP flap, which 
has a role in regulating ATP binding (Karamanou et al., 1999). The SSD is the site of 
the preprotein binding (Musial-Siwek et al., 2007; Papanikou et al., 2005). The helical 
scaffolding domain (HSD) spans the SecA molecule serving as a scaffold for the other 
domains. The C-terminal domain is thought to have a role in the translocation process 
itself. 
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Figure 1.5: Structure of SecA. SecA consist of four main domains: (1) DEAD domain; 
(2) C domain and (3) substrate specificity domain (SSD), which can be divided into N-
terminal subdomain (SSD(N)) (orange ribbons) and C-terminal subdomain (SSD(C)) 
(pink ribbons); (4) helical scaffolding domain (HSD) (green ribbons). C-domain can be 
further divided into: (i) intermolecular motor of ATPase activity (IRA1) (yellow 
ribbons); (ii) wing domain (HSD) (purple ribbons) and the C-terminal region (CTD) 
(not shown). DEAD domain is composed of: (i) nucleotide binding domain 1 (NBD1) 
(dark blue ribbons), its N-terminal part is shown in light blue (NPN1); (ii) nucleotide 
binding domain 2 (NBD2) (violet ribbons). The cleft between NBD1 and NBD2 is 
covered by ATP flap (brown ribbon) (from Mitra et al., 2006).  
 
SecA drives translocation by pushing the secretory protein through the translocation 
channel by repeated cycles of insertion and deinsertion. ATP and preprotein-bound 
SecA interacts with the SecYEG translocon and, as it inserts, pushes 20-30 amino acids 
of the preprotein through the channel (Schiebel et al., 1991; Joly et al., 1993; 
Economou et al., 1994; Wolk et al., 1997). ATP hydrolysis triggers the release of the 
preprotein from SecA results in the deinsertion of the latter. Repeated cycles of insertion 
and deinsertion lead to preprotein integration into the membrane or secretion (the model 
is presented on the Figure 1.6). When the translocation is well advanced, the proton 
motive force can continue to drive translocation (Schiebel et al., 1991; Driessen, 1992).  
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Figure 1.6: Model for ATP-driven preprotein translocation. At the start of 
translocation: ADP-bound SecA – preprotein complex is docked onto the SecYEG 
channel. The three steps of translocation can be distinguished: (Step 1): ADP dissociates 
and is replaced by ATP, which triggers insertion of SecA into the translocation channel 
pushing around 30 amino acids of the pre-protein into it, (Step 2): Hydrolysis of ATP 
causes dissociation of SecA from the pre-protein and de-insertion from the translocation 
channel; (Step 3): De-inserted SecA binds to the exposed portion of the partially-
translocated preprotein. The cycles of the insertion and de-insertion continue pushing 
the whole preprotein is pushed through the channel (Figure modified from Wolk at al., 
1997).   
Interaction between signal peptide and SecA 
The signal peptide binds to a groove in SecA located at the interface of the substrate 
specificity domain and IRA1. The groove is mostly hydrophobic, but is surrounded by a 
number of polar and charged residues (Gelis et al., 2007). Firstly, the positively charged 
amino acids located at the N-terminus of the signal peptide form electrostatic 
interactions with acidic residues of SecA found around this hydrophobic groove. Next, 
hydrophobic interactions are formed between the signal peptide and the groove. 
However, part of the signal peptide binding grove is occluded by the C-terminal domain 
of SecA, preventing the binding of the signal peptides of SecB-dependent proteins. This 
auto-inhibition can be overcome by the action of SecB in displacing the C-terminal 
domain of SecA. In the case of SecB-independent substrates such as PhoA, the 
inhibition of signal peptide binding by the C-terminal domain is low, and consequently 
the signal peptide binds without the need for additional factors (Gelis et al., 2007).   
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1.5.3 Intracellular pathways 
1.5.3a Post-translational mode of translocation 
The key component of the post-translational mode of translocation is SecB, which is a 
molecular chaperone responsible for keeping a subset of secretory proteins of the Sec 
pathway in a secretion competent state, i.e. in an essentially unfolded conformation. 
This chaperone has been found only in the Gram-negative bacteria (Fekkes et al., 1999; 
Muren et al., 1999). Unlike SecA, SecB is not essential for viability (Kumamoto et al., 
1983). When the secB gene is disrupted, leading to the lack of a functional SecB 
protein, the secretion of SecB-dependent proteins is prevented. Such a mutant is unable 
to grow in rich media, but is viable in minimal media. The first protein to be shown to 
be SecB dependent was the maltose binding protein, MBP (Gannon et al., 1993). It was 
observed that in the absence of a functional SecB, the preMBP folds in the cytoplasm 
and is retained within this compartment. Subsequently, SecB was shown to be involved 
in the secretion of a variety of proteins including: GBP, PhoE, LamB, OmpF, OmpA, 
DegP, FhuA, FkpA, OmpT, OmpX, OppA, TolB, TolC, YbgF, YgiW and YncE (Baars 
et al., 1996). The predominant model for the chaperoning action of SecB is called the 
‘’kinetic partitioning model’’ (Hardy and Randall, 1991). It assumes that the signal 
peptides of SecB targeted proteins, slow down their folding. In the environment of the 
cytoplasm, there is competition between chaperones. If a molecular chaperone, such as 
DnaK or the trigger factor outcompete SecB, the protein will be retained in the 
cytoplasm. If SecB wins, the protein is destined for secretion. The resulting 
SecB/preprotein binary complex interacts with SecA, to form a ternary complex (Hartl 
et al., 1990). The affinity of the SecB/preprotein complex to SecA depends on the 
association of the later with the SecYEG translocation channel. When SecA is bound to 
the translocation channel, then its affinity for SecB increases greatly. The interaction 
becomes even stronger when SecB is present as a binary complex with preprotein 
substrate (Fekkes et al., 1998; Hartl et al., 1990). So the model that emerges from these 
data is that SecB binds to its preprotein substrate and the binary complex binds dimeric 
SecA already docked on the SecYEG channel. The preprotein is transferred to the SecA 
molecular motor, triggering the displacement of ADP and its replacement by ATP. This 
in turn induces the dissociation of SecB. Finally SecA drives protein translocation 
(Fekkes et al., 1997).  
Although a SecB homologue has not been found in Gram-positive bacteria, the 
CsaA protein of Bacillus subtilis has been proposed to possess chaperone-like activity. 
Moreover, CsaA stimulates the secretion of SecB-dependent proteins in SecB-negative 
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mutants of E. coli (Müller et al., 2000). Bioinformatic analysis revealed that CsaA is 
also present in other bacteria (both Gram-positive and Gram-negative) including: 
Bacillus anthracis, Bordetella bronchiseptica; Bacillus haloduran, Legionella 
pneumophila; Pseudomonas aeruginosa; Rhodobacter sphaeroides; Thermus 
thermophile (Kawaguchi et al., 2001).  
The structure of SecB has been shown to be tetrameric, consisting of a dimer of 
dimers (Muren et al., 1991; Topping et al., 2001, Dekker et al., 2003). Each monomer is 
comprised of four stranded β-sheets in an anti-parallel arrangement. The cores of each 
monomer, built by β-sheets, are linked by -helices and the subunits of each dimer are 
rotated with respect to each other at 180
o
 (Figure 1.7) (Dekker et al., 2003).  
 
Figure 1.7: View of SecB, showing its tetrameric structure (subunits A-D). Each 
subunit consists of four β-sheets strands linked by -helices (Dekker et al., 2003).  
Each side of the tetramer possesses two channels (called also grooves), harbouring two 
putative substrate binding sites with leucine at the position 42 being crucial for substrate 
binding (Figure 1.8) (Bechtluft et al., 2010). Preprotein substrates are probably wrapped 
around the tetramer in such a way to access these binding sites and in such a way as to 
be maintained in an essentially unfolded state (Peltier et al., 2002; Mogk et al., 2003).  
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Figure 1.8: Solvent-accessible surface of the SecB tetramer (Protein Data Bank entry 
1QYN) with the hydrophobic surface colored green and the position of leucine 42 
colored dark red. The proposed peptide binding groove is encircled (Bechtluft et al., 
2010). 
1.5.3b Co-translational mode of translocation 
The signal recognition particle (SRP) is involved in the co-translational mode of 
translocation (Figure 1.3). It has been found in both Prokaryotes and Eukaryotes 
(Keenan et al., 2001). The SRP of E. coli is a ribonucleoprotein comprising the Ffh 
(fifty-four kDa protein homologue) protein and 4.5S RNA. In B. subtilis the SRP is 
additionally comprised of the histone-like HBsu protein (Nakamura et al., 1999). Ffh 
has a flexible, hydrophobic groove which can accommodate a wide range of peptides 
(Luirink et al., 2004). The 4.5S RNA probably aids the processes by interacting with the 
positively-charged amino acids of the N-terminus of the signal peptide (Luirink et al., 
2004). The current model assumes that SRP binds to the signal peptide of the nascent 
protein, which in Eukaryotes halts translocation (Walter and Blobel, 1981). This 
translation arrest has not been shown to occur in bacteria. Consistent with this 
observation, the SRP of Gram-negative bacteria lacks the domains (5’ and 3’ RNA 
domains) responsible for translational arrest (Nakamura et al., 1999; Siegel and Walter, 
1988). Gram-positive bacteria do, however, contain those domains, although it remains 
to be established whether SRP-mediated translational arrest occurs in these bacteria 
(Siegel and Walter, 1988). Next, the ribosome/nascent protein complex is delivered to 
the docking protein FtsY and then passed to the SecA/SecYEG translocase, where SecA 
drives translocation of the preprotein through the channel. The intracellular process 
leading to transferring the preprotein to SecA is driven by the energy released from the 
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hydrolysis of GTP, as SRP and FtsY have GTPase activity (Shan and Walter, 2005). 
Both key components specific to this pathway, SRP and FtsY, are essential for viability 
in E. coli (Phillips et al., 1992; Luirnik et al., 1994) and in B. subtilis (Kobayashi et al., 
2003). However, in streptococci, the SRP pathway was shown not to be essential under 
non-stressfull growth conditions (Crowley et al., 2004).  
1.5.4  SecYEG translocation channel 
The SecYEG translocation channel is composed of three proteins, SecY, SecE and 
SecG (Brundage et al., 1990; Akimaru et al., 1991), which form a pore in the 
cytoplasmic membrane through which secretory proteins pass across or into the 
membrane (Figure 1.9). SecY and SecE are closely associated and form the core of the 
translocation channel. The largest subunit of the translocation channel is SecY. In E. 
coli SecY is 443 amino acid long (Cerretti et al., 1983), while In Bacillus subtilis SecY 
is 423 amino acids in length. In B. subtilis, like in E. coli, SecY and possesses ten 
transmembrane domains (TMDs) with the N- and C-termini residing in the cytoplasm 
(Akiyama and Ito, 1987). SecY is essential for protein translocation and therefore 
viability (Ito et al., 1984; Kobayashi et al., 2003). The transmembrane segments are 
organized into two domains: N-terminal (with TMD 1-5) and C-terminal (with TMD 6-
10). This dimeric-like arrangement is referred to as a clamshell-like structure, in which 
the domains are joined by a hinge-like loop. SecY is the main component of the 
translocation pore and is opened and closed by a structure called the plug, which was 
studied in E. coli. The equilibrium between the open and closed states moves towards 
the open state when a signal peptide becomes bound to the side of the translocation 
channel (between TMD 2 and 7) (Plath et al., 1998). This triggers a shift of the 
equilibrium towards the open state by the formation of a disulphide bond between the 
plug and the SecE protein, while the closed state is triggered by the reduction of that 
bond (Harris and Silhavy, 1999). At its narrowest point, a ring of hydrophobic amino 
acids lines the pore, forming a gasket-like structure around the protein being 
translocated. This presumably prevents the passage of small molecules during 
translocation (Berg et al., 2004). After the movement of the plug out of the channel, the 
ring of hydrophobic amino acids opens slightly, allowing for the insertion of the mature 
region of the secretory substrate into the pore of the channel in the form of the loop. 
Membrane proteins move to the membrane via a lateral gate formed by the open face of 
the clamshell.  
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SecY may exist in dimeric (Sluis et al., 2002; Duong et al., 2003; Tziatzios et 
al., 2004) and oligomeric (Beckmann et al., 1996; Beckman et al., 2001; Menetret et 
al., 2005; Mitra et al., 2005; Scheuring et al., 2005) arrangements, with the dimer 
probably being the minimal functional entity. Observations suggest that the dimeric 
arrangement of SecY may exist in two forms: (i) back-to-back (Veenendaal et al., 2002) 
and (ii) “front-to-front” (Mitra et al., 2006). In case of the “front-to-front” arrangement, 
SecYEG might fuse to form a single large channel.  
SecE is the second component of the translocation channel and, like SecY, is 
essential for viability and protein secretion. E. coli SecE is 127 amino acids in length 
and encompasses three transmembrane domains. In Gram-positive bacteria, SecE is 
smaller consisting of approximately 60 amino acids and encompasses only one 
transmembrane domain, which corresponds to cytoplasmic loop 2 and the third TMD of 
E. coli SecE (Murphy et al., 1994). In E. coli the first two transmembrane domains are 
not necessary for viability and protein secretion (Schatz et al., 1991; Nishiyama et al., 
1992). SecE is closely associated with and forms a clamp across SecY, probably 
holding two SecY subunits together. It participates in the opening of the translocation 
channel upon its bind the signal peptide of the the substrate protein, by binding the plug 
by means of the disulphide bond (Harris and Silhavy, 1999). 
SecG is loosely associated with the translocation channel and consists of 110 
amino acids and forms two transmembrane domains in E. coli (Kontinen et al., 1996). 
B. subtilis was found to possess yvl gene encoding functional homologue of SecG of      
E. coli (van Wely et al., 1999). In both, E. coli and B. subtilis, they are predicted two 
posses two transmembrane domains linked through a glycin-rich loop, but B. subtilis 
SecG is shorter as its lacks carboxy-terminal extension.  It is not essential for viability 
or protein translocation, but its deletion leads to a cold-sensitive phenotype (Flower et 
al., 2000). However, SecG has an enhancing effect on translocation at least in an in 
vitro translocation assay (Douville et al., 1994; Nishiyama et al., 1993). In the secG-
negative strain of B. subtilis, the cold-sensitive phenotype was only observed under 
conditions of -amylase overproduction (van Wely et al., 1999). 
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Figure 1.9: Structure of the SecYEG translocation complex from Methanococcus 
jannaschii. (a) The SecY structure as seen from the plane of the membrane. SecY is 
coloured blue, SecE is green and SecG is brown. The cytoplasm is to the top and the 
periplasm to the bottom. (b) The complex viewed from the periplasmic side. The three 
chains are the same colours as in part (a) but the plug is highlighted in pink. The 
complex forms a channel with the plug blocking translocation in the inactive state. SecE 
and SecG are located on three sides of the complex, leaving the fourth side open to 
accept signal sequence binding and to enable lateral exit of membrane domains. (c) The 
diagrams illustrate the export pathway: (i) The SecY complex is in the inactive state. 
The plug prevents passage of molecules and the ring is closed. (ii) Binding of a signal 
sequence (SS) to SecY TM7 and TM2 triggers movement of the plug out of the channel 
and opening of the hydrophobic ring. (iii) The fully active state is depicted. The plug 
has moved to interact with the periplasmic portion of SecE and the ring has widened to 
enable movement of the mature secretory protein (M) through the channel (Flower et 
al., 2007). 
 
 
The SecD, SecF proteins form an auxiliary translocation complex, which associates 
with SecYEG to facilitate protein translocation. In E. coli SecD and SecF are two 
separate proteins to form a complex with YajC protein (Duong and Wickner, 1997). In 
contrast, B. subtilis SecD and SecF are fused into a single membrane protein of 571 
amino acids that is predicted to span the membrane 12 times and form complex with 
YrbF, which is a homologue of E. coli YajC (Bolhius et al., 1998). However, in            
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B. halodurans, SecD and SecF are two seprate proteins (Takami et al., 2000). In other 
Gram-positive bacterium Lactococcus lactis a homolog of SecDF has not been found 
(Bolotin et al., 1999). When the SecD and SecF proteins are depleted, cell viability and 
protein secretion were observed to be severely compromised in E. coli (Duong et al., 
1997). In B. subtilis, depletion of SecDF results in a weak cold sensitivity of growth and 
a reduced efciency of the secretion of neutral protease (Bolhuis et al., 1998). It is has 
been proposed that the SecD, SecF, YajC complex participates in the release of 
translocated proteins from the membrane or the regulation of SecA cycling (Economou 
et al., 1995).  
YidC, that has been found in E. coli, participates in the insertion of proteins into 
the cytoplasmic membrane and is essential for viability (Dalbey and Kuhn, 2004). It 
accomplishes its action on its own or in co-operation with the SecYEG complex. YidC 
is also required for the correct folding of transmembrane proteins and depletion of YidC 
leads to the induction of membrane stress (Shimohata et al., 2007).  In B. subtilis two 
homologs of YidC are found: SpoIIIJ and YqjG. Both: SpoIIIJ and YqjG are able to 
complement E. coli YidC-deficiency in the respect to SecYEG-dependent membrane 
proteins, but not to SecYEG-independent proteins (Saller et al., 2009). Either SpoIIIJ or 
YqjG must be present in B. subtilis so that bacterium remains viable (Murakami et al., 
2002, Tjalsma et al., 2003).  
Summery comparison of the components of the translocation channel and the 
associated proteins in Gram-negative and Gram-positive bacteria is presented in the 
Table 1.1. 
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Table 1.1: Summery comparison of the components of the translocation channel and 
the associated proteins in Gram-negative and Gram-positive bacteria.  
Component Gram-negative (E. coli) Gram-positive (B. subtilis if not 
mentioned otherwise) 
SecY Common features 
 Essential for protein secretion and viability  
 10 transmembrane segments are organized into two domains with dimeric-like 
arrangement which is referred to as a clamshell-like structure. 
 Main component the of the translocation channel, where the pore is located. 
Differences 
 Size: 443-amino acid polypeptide  Size: 423-amino acid polypeptide 
SecE Common features 
 Essential for protein secretion and viability. 
 forms a clamp across SecY probably stabilising it. 
Differences 
 Size: 127 amino acids in length  
 Three transmembrane domains 
 Size: approximately 60 amino acids  
 One transmembrane domain 
SecG Common features 
 Not essential for protein secretion and viability, but cold-sensitive phenotype 
observed. 
 Composed of two transmembrane domains. 
Differences 
 B. subtilis SecG is shorter then SecG of E. coli as in comparison, it lacks 
carboxy-terminal extension. 
SecDF/ 
YajC/YrbF 
Common features 
 Not essential for protein secretion and viability, but enhance secretion 
Differences 
 SecD and SecF are two separate 
proteins to form a complex with 
YajC.  
 
 
 
 Deletion of SecDF has strong 
negative effect on cell viability and 
protein secretion. 
 
 
 SecD and SecF are fused into a single 
membrane protein that forms a 
complex with YrbF. In B. halodurans 
SecD and SecF are two separate 
proteins. 
 Lactococcus lactis lacks a clear 
SecDF homolog. 
 In B. subtilis, depletion of SecDF 
results in a weak cold sensitivity of 
growth and a reduced efficiency of 
the secretion of neutral protease. 
YidC /its 
homologs 
Common features 
 Involved in the biogenesis of membrane proteins. 
Differences 
 YidC has been found in E. coli 
 
 involved in the insertion of 
hydrophobic sequences into the 
membrane in the SecYEG-
dependent and in the SecYEG-
independent manner. 
 essential for viability. 
 
 In B. subtilis two homologs of YidC 
are found: SpoIIIJ and YqjG. 
 SpoIIIJ and YqjG are able to 
complement E. coli YidC-deficiency   
in the respect to SecYEG-dependent 
membrane proteins, but not to 
SecYEG-independent proteins. 
 Either SpoIIIJ or YqjG must be 
present in B. subtilis so that bacterium 
remains viable. 
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1.5.5 Extracellular pathways  
After their translocation across the cytoplasmic membrane in an essentially unfolded 
state, proteins must be properly folded so that they are functional; misfolded proteins 
are removed by 'quality control' extracellular proteases (Miot and Betton, 2004). The 
rapid folding of secreted proteins is critical since it avoids the formation of protein 
aggregates and inappropriate interactions with the cell wall, potentially blocking cell 
wall growth sites. A number of factors (called foldases) are employed to ensure the 
correct and rapid folding of secretory substrate proteins. Those include: (i) peptidyl-
prolyl cis-trans isomerases; (ii) thiol-disulphide oxidoreductases; (iii) propetides; (iv) 
certain metal cations. 
Peptidyl-prolyl cis/trans isomerases (PPIases) are important folding factors of a 
subset of secretory proteins containing proline residues, which can exist in either the cis 
or the trans isomeric form. Since peptide bonds require the trans isomer of proline, cis-
trans isomerisation is required to ensure the cis isomers are converted to the trans form 
(Schmid, 2001). In Gram-negative bacteria, the PPIases involved in secretion are found 
in the periplasm. However, in Gram-positive bacteria the PPIases involved in secretion 
are lipoproteins attached to the outer interface of the cytoplasmic membrane so that they 
are active at the membrane-cell wall interface. In terms of structure and function, 
PPIases can be grouped into three families: cyclophilins, FK506-binding proteins 
(FKBP) and parvulins (Gothel et al., 1999). B. subtilis PrsA belongs to the a parvulin 
family with parvulin-like domain surrounded by N- and C-terminal regions that share 
homology only to PrsA-like proteins encoded by species related to B. subtilis (Rahfeld 
et al., 1994). Its PrsA is essential for both protein secretion and cell viability (Kontinen 
and Sarvas, 1993; Kontinen et al., 1991). Interestingly, one of B. subtilis PrsA 
substrates, AmyQ does not possess proline residues, suggesting that the PPIase activity 
of PrsA may not be involved in processing this protein. This was confirmed by the 
ability of a derivative of PrsA with mutations in the putative active centre of its PPIase 
domain to be active for the folding of AmyQ. This suggests that in addition to its PPIase 
activity, PrsA, has a second, but as yet unknown, chaperone-like activity (Vitikainen et 
al., 2001). In comparison, B. anthracis encodes three PrsA-like proteins, PrsAA, PrsAB, 
PrsAC, all three are able to complement a prsA-null mutant of B. subtilis (Williams et 
al., 2003).  
Some secretory proteins contain disulphide bonds that are necessary for their 
stability and activity. Formation of these bonds takes place following translocation. The 
reaction is catalysed by thiol-disulphide oxidoreductases. Four of these enzymes have 
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been described in B. subtilis: BdbA, BdbB, BdbC, BdbD (Bolhuis et al., 1999; Meima 
et al., 2001).   
Propeptides are a common feature of Bacillus secretory proteins, particularly 
proteases and are located between the signal peptide and the mature protein (Figure 
1.4d). When present in proteases, they inhibit their proteolytic activity prior to 
translocation (Wanderman, 1989) but, once translocated, the propepides catalyse their 
folding (Gallagher et al., 1995; Wang et al., 1998) and activation (Yabuta et al., 2001). 
Finally, most Bacillus secretary proteins are metalloproteins and metal cations 
are important for their folding, stability and activity. Metal ions are adsorbed to the 
anionic cell wall and are readily available for proteins as they emerge from the 
translocation channel.  
1.6 Additional SecA and SecY systems (secondary translocases)  
Multiply homologues of SecY (SecY1 and SecY2) and SecA (SecA1 and SecA2) have 
been found in some Gram-positive bacteria such as: Streptococcus gordonii,                  
S. parasanguinis, S. pneumoniae, Staphylococcus aureus, Mycobacterium tuberculosis, 
Listeria monocytogenes, Bacillus anthracis Mycobacterium smegmatis, Listeria 
innocua, and Corynebacterium glutamicum (Rigel and Braunstein, 2008). SecA1 and 
SecY1 are so named because their sequences are more similar to the canonical SecA 
and SecY, respectively, and they have ‘house-keeping’ roles. SecA2 and SecY2 share 
less homology with canonical SecA and SecY, respectively, and are always (in the case 
of SecA2), or in many cases (in the case of SecY2), involved in export of a subset of 
proteins, especially virulence factors (Bensing and Sullam, 2002; Bessing et al., 2005; 
Braunstain et al., 2003; Chen et al., 2004; Lenz and Portnoy, 2002, Lenz et al., 2003; 
Machata et al., 2005). The last observation may indicate that secondary translocases 
have evolved to facilitate pathogenesis of certain pathogenic bacteria. Secretion 
pathways comprising additional types of SecA-like and SecY-like proteins can be split 
into two categories: (i) those containing both SecA2 and SecY2, and (ii) those 
containing SecA2 only.  
SecA2 only systems have been found in Mycobacterium tuberculosis, M. 
smegmatis and Listeria monocytogenes. In these bacteria, SecA2 drives the secretion of 
a subset of proteins some of which possess clearly identifiable signal peptides, (e.g. p60 
autolysin of L. monocytogenes, Lenz et al., 2003), and others that do not (e.g. 
superoxide dismutase of L. monocytogenes, Archambaud et al., 2006). The failure to 
delete SecA1, while overexpressing SecA2 in mycobacteria showed the SecA1 is 
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essential for viability in this group of bacteria and SecA2 cannot complement its 
function. Similarly, SecA1 cannot replace SecA2 in the secretion of SecA2-dependant 
proteins (Braunstain et al., 2001).   
Systems comprising both SecA2 and SecY2 have been found in many species of 
the Streptococcus group as well in S. aureus and B. anthracis. Here, two types of 
systems are postulated to exist (Rigel and Braunstein, 2008): (i) SecA2 and SecY2 co-
operate with SecA1 and SecY1 to form a canonical translocon; (2) SecA2 and SecY2 
form a novel translocon without the participation of SecA1 and SecY1 (Figure 1.10).  
 
Figure 1.10: Models for SecA2-dependent export. In the various accessory Sec 
systems, a SecA2-exported protein (shown in blue) might be exported either through a 
novel translocon or the canonical SecA1/SecYEG translocon with the assistance of 
SecA2. The example of a novel translocon is modelled on the SecA2/SecY2 system of 
S. gordonii, which is a candidate for this type of pathway (Rigel and Braunstein, 2008).  
 
An example of a species encoding a novel translocon is Streptococcus gordonii (Figure 
1.10). This accessory translocon is thought to consist of SecA2, SecY2 and five 
accessory proteins, Asp1 to Asp5 (Bensing and Sullam, 2002; Takamatsu et al., 2004; 
Takamatsu et al., 2005). The secretory preprotein substrate of this system, GspB, is a 
virulence factor responsible for the binding of S. gordonii to platelets (Bensing and 
Sullam, 2002). SecA2 and SecY2 are thought to act together in the secretion of this 
protein as the deletion of either prevents GspB secretion (Bensing and Sullam, 2002). 
Asp1-3 are predicted to be intracellular proteins, while Asp4 and Asp5 are homologues 
of SecE and SecG, respectively. They appear to interact with SecY2 to form a 
translocation channel, which interacts specifically with SecA2 to transport GspB 
(Takamatsu et al., 2005). GspB and all of the other components of this accessory 
translocon are encoded in a common locus. Similar loci are found in related pathogenic 
bacteria e.g. S. parasanguinis (Rigel and Braunstein, 2008) (Figure 1.11), suggesting 
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that the putative substrate proteins encoded within those loci are also pathogenicity 
factors. 
 
Figure 1.11: Organization of accessory sec loci. Genes with similar colouring encoded 
proteins with homology or similar properties. Genes encoding SecA2-dependent 
substrates are in blue, glycosyl transferases in green, accessory Sec proteins in red, 
accessory SecA2-dependent secretion factors in orange. Genes encoding proteins with 
predicted transmembrane domains are hatched (Rigel and Braunstein, 2008). 
 
1.7 Secondary translocase of B. anthracis 
B. anthracis contains homologues of many elements of the B. subtilis secretion 
pathway. Apart from two homologues of SecA (SecA1 and SecA2) and two 
homologues of SecY (SecY1 and SecY2) mentioned before, it also contains: three 
homologues of the PrsA foldase (PrsAA, PrsAB and PrsAC), and 7 homologues of 
signal peptidase, called Sip; in comparison five homologues of Sips are found in B. 
subtilis (Figure 1.12).  
The role of SecA2 and SecY2 in B. anthracis was investigated by Pohl and 
colleagues (unpublished). The supernatant fractions of the extracellular proteins isolated 
from the wild type and ΔsecA2 and ΔsecY2 mutants of B. anthracis were analysed by 
two-dimensional gel electrophoresis (Figure 1.13). Comparison of the protein profiles 
of the wild type and the mutants showed that SecA2 is necessary for the secretion of 
two prominent proteins, identified by mass spectrometry as Sap and EA1. In contrast, 
the pattern of proteins secreted by the ΔsecY2 was identical to that of the wild type, 
indicating that under these conditions SecY2 is not required for the exclusive secretion 
of any protein, including Sap and EA1. 
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Figure 1.12: Sec translocation systems of B. anthracis and B. subtilis. The translocase 
of B. subtilis encompasses one type type of SecY and SecA molecular motor. SecY 
together with SecE and SecG forms the translocation channel. SecDF is an auxiliary 
translocation complex which facilitates secretion, but is not essential for the processes. 
Five homologues of the Sip signal peptidase are present in B. subtilis with the role of 
removing the signal peptide after a secretory protein has been translocated. PrsA foldase 
(also only one type of PrsA is present in B. subtilis) folds its substrate proteins into the 
mature conformation on the outer surface of cytoplasmic membrane. In comparison, in 
B. anthracis, there are two homologues of SecA (SecA1 and SecA2) and two 
homologues of SecY (SecY1 and SecY2) as well as three homologues of PrsA (PrsAA, 
PrsAB, PrsAC) and seven homologues of signal peptidase Sip.  
 
 
 
 
 
 
 
 
 
 
 
 
29 Chapter 1: General introduction  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of the intracellular proteins of ΔsecA2 and ΔsecY2 mutants by 2D PAGE gels 
(Figure 1.14) (Pohl et al., unpublished) showed that when secA2 was not expressed, the 
precursors of Sap and EA1 (preSap and preEA1) were no longer found in the 
cytoplasm. One interpretation of this observation is that SecA2 not only functions in the 
secretion of Sap and EA1 but also as a cytoplasmic chaperone preventing the 
degradation of these proteins.  
 
 
 
 
 
Extracellular proteins 
Figure 1.13: False-coloured 2D gel overlays of B. anthracis extracellular proteins 
isolated from the wild-type, ΔsecA2 and ΔsecY2. Extracellular proteome of the 
ΔsecA2 mutant showed a dramatic reduction in the secretion of two of the major 
surface-associated antigens, namely Sap and EA1 (red spots). In contrast, the 
extracellular proteome of the ΔsecY2 mutant gave an identical profile to that of the 
wild-type (yellow spots) (Pohl et al., unpublished). 
 Mutant                       Wild-type    
Both 
Proteins present in: 
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To investigate the role of SecY2, the expression profiles of the B. anthracis secY1 and 
secY2 genes were analysed in the wild-type strain (Figure 1.15) (Pohl et al., 
unpublished). RNA purified from cultures harvested at different phases of growth cycle 
(exponential, transitional, early stationary and late stationary phases) was analysed by 
Northern blotting. Hybridization with a secY1-specific probe showed that secY1 
expression was highest during the exponential phase and decreased progressively 
towards late stationary phase. secY1 is located within the extensively processed 13.5 kb 
S10-spc-α ribosomal operon that gives rise to transcripts of various sizes. Hybridization 
with a secY2-specific probe showed that secY2 expression peaked in the transitional 
Wild-type/ 
secA2 
Wild-type/ 
secY2 
 
Intracellular proteins 
Figure 1.14: False-coloured 2D gel overlays of B. anthracis intracellular proteins 
isolated from the wild-type, ΔsecA2, ΔsecY2. Intracellular proteome of the ΔsecA2 
mutant showed an absence of the major surface-associated antigens, namely Sap and 
EA1 (red spots). In contrast, the extracellular proteome of the ΔsecY2 mutant gave an 
identical profile to that of the wild-type (yellow spots) (Pohl et al., unpublished). 
  Mutant                       Wild-type  
Both 
Proteins present in: 
Sap EA1 
Sap EA1 
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phase but remained high throughout stationary phase. These results suggest that SecY2 
serves to maintain high levels of protein secretion throughout the entire growth cycle.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.15: Expression profiles of secY1 and secY2 in B. anthracis wild type strain at 
various stages of the growth cycle (Pohl et al., unpublished).   
The above experimental data suggest that SecA2 and SecY2 do not form a novel 
translocon in B. anthracis, but instead interact with or form components of the 
canonical translocase.  This is consistent with the observation that B. anthracis secA2 
and secY2 genes are located at well-separated chromosomal locations (Read et al., 
2003). Additionally, there is a question of the roles of the multiply homologues of PrsA 
foldase and Sip signal peptidase. The B. anthracis PrsA-like foldases PrsAA, PrsAB 
and PrsAC are all able to complement the B. subtilis native PrsA foldase although, the 
PrsAC complementation mutant exhibits a different colony morphology (Williams et 
al., 2003). The last observation suggests that the PrsA-like proteins show at least some 
substrate specificity. This leads to the question as to whether one or more of the PrsA 
and Sip homologues are specifically involved in secretion of SecA2-dependent 
substrates.  
kb 
kb 
secY1 
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1.8 S-layer proteins as markers for the analysis of secretory machinery of                    
B. anthracis 
1.8.1 General features of S-layers 
As S-layer proteins were found to be substrates for SecA2, they were subsequently used 
as marker proteins allowing evaluation of participation of other components in the 
formation of secondary translocase. This section gives an overview of S-layer proteins, 
with a focus on the S-layer proteins of B. anthracis.  
S-layers can be found in some species of bacteria and archea on their surfaces 
and are defined as crystalline arrays (lattices) of proteins. They can be aligned in 
oblique (p2), trimeric (p3), tetragonal (p4), hexagonal (p6) symmetries (images and 
schematic illustrations of oblique, tetragonal and hexagonal arrangements are shown on 
the Figure 1.16).   
                
Figure 1.16: (a-c) Freeze-etching images of S-layers on intact cells showing the three 
different lattice types schematically illustrated in (d-f). (a,d) oblique (~2) lattice; (b,e) 
square (~4) lattice; (c,f) hexagonal (~6)  lattice. The bars represent 50 nm (Holt and 
Leadbetter). 
With few exceptions S-layers consist of a single type of protein or glycoprotein. 
However, S-layers of Clostridium difficile, Bacillus anthracis, Brevibacterium brevis 
and Aquaspirillum serpens consist of two types of proteins. In the case of Clostridium 
difficile both constituent subunits of the S-layer combine to form a single lattice 
(Takeoka et al., 1991). In B. anthracis each protein-type forms separate lattices, each 
existing at different phases of the cell growth cycle (Mignot et al., 2002). 
Brevibacterium brevis and Aquaspirillum serpens possesses superimposed S-layer 
lattices, each composed of distinct proteins (Yamada et al., 1981, Kist et al., 1984). S-
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layer proteins are very abundant, covering the entire surface of the bacterium. Pores 
occupy up to 70% of the S-layer surface. Bacteria exhibiting a generation time of 20 
minutes must synthesize and extend the existing S-layer at the rate of at least 500 S-
layer proteins per second in order to maintain the complete coverage of the cell surface 
(Sletyr et al., 1983). S-layer proteins are attached to the cell wall (Gram-positive 
bacteria, cell wall possessing archea) or outer membrane (Gram-negative bacteria and 
cell wall – deprived archea) and to each other via non-covalent bonds.  
Functions of S-layers 
Many functions have been identified or proposed for S-layers. S-layers are often the 
outermost component of the cell-envelope and are thought to be involved in the 
regulation of macromolecule exchange with the environment, by acting as a molecular 
sieve (Sára and Sleytr, 1987; Sára et al., 1992). They may also have a role in cell 
integrity and shape maintenance in archaea, in which it is often the only cell-envelope 
component (Baumeister et al., 1992; Hovmöller et al., 1998; Peters et al., 1995; 
Mescher and Strominger, 1976; Wildhaber and Baumeister, 1987). They may also serve 
as an attachment site for cell-associated exoenzymes (Egelseer et al., 1995; Matuschek 
et al., 1996).  
The S-layers of some bacteria (e.g. A. salmonicida, C. fetus, A. serpens, C. 
crescentus) protect them from attack by the bacterial parasite Bdellovibrio 
bacteriovorus (Koval 1997).  
S-layers are also implicated in the interaction with host by mediating binding 
and adhesion with various cell types and tissues. S-layer-mediated interaction with host 
includes both normal human microflora, e.g. lactobacilli as well as pathogens. S-layers 
can mediate adhesion of microbial flora to the walls of the intestine by interaction with 
various components of the intestinal tissue, like laminin and collagens. It was shown 
that S-layer protein CbsA of Lactobacillus crispatus is involved in adherence to the 
collagen and laminin, while SlpA of Lactobacillus brevis has the affinity towards 
epithelial cells and fibronectin (Sillanpää et al., 2000, Antikainen et al., 2002, Hynönen 
et al., 2002). In the case of S-layer mediated interactions between host and pathogen, S-
layers are classified as the virulence factors. For example S-layers of Bacillus cereus 
strains, isolated from periodontal and endodontic infections, were shown to mediate 
interaction with laminin, as well as they are the site of attachment of protease which 
mediates interaction with fibronectin (Kotiranta et al., 1998). S-layer protein of 
Bacteroides forsythus, BspA, another periodontal pathogen was shown to adhere to KB 
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cells (subline of the keratin-forming tumor cell line HeLa), which implies the ability to 
adhere to the epithelium. After, the stage of adherence, Bacteroides forsythus invades 
the cells, which is also thought to be mediated by BspA. That S-layer protein also 
mediates haemagglutination. The role of BspA as a virulence factor was confirmed by 
the ability of B. forsythus S-layer to cause the formation of abscesses in mice which 
were not immunised against BspA, but not in the immunised mice (Sabet et al., 2003).   
In some pathogenic bacteria, S-layers endow them with protection against the 
immune system through various mechanisms. In Campylobacter fetus, Campylobacter 
rectus, S-layer protects them against complement-mediated cell lysis by preventing 
binding complement factors (Blaser et al., 1988; Okuda et al., 1997). Additionally, S-
layer of C. fetus was observed to provide protection against antibody opsonisation by 
the antigenic variance of S-layer proteins (Garcia et al., 1995, Grogono-Thomas et al., 
2000), while in C. rectus S-layer was shown to down-regulate proinflammatory 
cytokines (IL-6, IL-8, and TNFα ) which may favour C. rectus survival (Wang et al., 
2000).  
In Aeromonas salmonicida S-layer is called A-layer and is a virulence factor 
with both adhesive and immune-protective functions, mediated by various mechanisms. 
Those mechanisms include: (1) protection against the complement-mediated killing 
(Munn et al., 1982); (2) adhesion to the extracellular matrix through the interaction with 
fibronectin, laminin and collagen (Doig et al., 1992; Trust et al., 1993); (3) adhesion to 
macrophages (Garduño and Kay 1992a; Garduño et al., 1992a; Trust et al., 1983) and 
survival inside them (Garduño et al., 1993a; Graham et al., 1988; Olivier et al., 1986).  
The role of S-layer in the virulence of B. anthracis hasn’t till now been 
elucidated. As the expression of eag and sap genes, encoding, Sap and EA1 S-layer 
proteins are subject to the regulation mediated by AtxA and PagR pathogenicity 
regulatory molecules, it might indicate that S-layer in B. anthracis is also involved in 
virulence. Consistently with that assumption, the S-layer was shown to protect against 
binding of C3 component of the complement system, in the strain deprived of the 
capsule (Ray et al., 1998). However, during infection the capsule but not the S-layer is 
the outermost surface layer. In accordance with this, no difference in virulence was 
observed in the mouse model upon infection with the S-layer-deprived mutant in the 
pXO1
+
 pXO2
-
 or pXO1
-
pXO2
+
 backgrounds (Mesnage et al.,1998, Fuet, 2009). Other 
potential role of Sap and EA1 proteins lies in the cell wall metabolism, as they both 
were found to possess some murein hyrolytic activity (Ahn et al., 2006). When strains 
lacking Sap only or both Sap and EA1 were grown in the liquid medium, then they 
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flocculated and sedimented abnormally upon stopping of shaking (Bahl et al., 1997). 
This could be caused by alterations in cell surface properties, and implying that             
B. anthracis S-layer might be involved in adhesion within the host.  
Applications of S-layers in biotechnology and medicine  
S-layers can be extracted from cell surfaces using various methods using agents that 
disrupt hydrogen bonds, by metal-chelating agents or by cation substitution (Sletyr et 
al., 1986; Sletyr et al., 1988; Beveridge et al., 1976; Beveridge 1994; Koval et al., 
1984). As, they re-assemble spontaneously in the liquid suspension or on the solid 
surfaces or interfaces (e.g. lipid films, liposomes), the S-layer containing structures are 
easy to produce. S-layers exhibit uniform physico-chemical properties as they are 
composed of identical protein or glycoprotein species. That’s why S-layers have been 
found to be suitable for production of isoporous filtration membranes (Sára and Sleytr, 
1987).  
They also found application as matrices for immobilisation of molecules (e.g. 
enzymes, antibodies). The immobilization can be directly to the S-layer due to the high 
density and defined position of carboxyl groups. For example Staphylococcus protein A, 
and some enzymes (glucose oxidases, galactosidases, invertases) were experimentally 
immobilized on such matrices forming an approximation of a monolayer on the S-layer 
matrices (Küpcü et al., 1995). Alternatively, hybrid molecules of a protein of interest 
and a S-layer protein can be generated. A typical chimeric protein comprises (1) an 
accessible N-terminal SCWP (secondary cell wall polymer)-binding domain, which 
could be exploited for oriented binding and recrystallization on artificial solid supports 
precoated with SCWP, (2) the self-assembly domain and (3) a functional sequence 
fused to the C-terminal end of the S-layer protein (Sára et al., 2005). Various ligands 
were can be part of such chimeric proteins, for example biotin, antigens, antibodies and 
specific affinity domains. Affinity matrices composed of S-layer proteins (rSbsB or 
rSbpA) with the streptavidin fused to them was demonstrated to effective in capturing 
any biotinylated molecules (Moll et al., 2002; Huber et al., 2006a, b). Chimeric protein 
of the ZZ domain (a synthetic analogue of the B-domain of Protein A, capable of 
binding the Fc-part of IgGs) and rSbpA S-layer protein were coated on microbeads; and 
they can find application detoxification of the extracorporeal blood (Völlenkle et al., 
2004). The camel antibody against the prostate specific antigen was coated on gold 
chips precoated with thiolated cell wall secondary polymers, containing S-layer proteins 
and those chips were used in the surface plasmon resonance technique for sensing 
 
36 Chapter 1: General introduction  
prostate specific antigen (Pleschberger et al., 2003, 2004). S-layers can also be used as 
surfaces for assembly of inorganic superlatices. This process has been observed in 
Cynaobacteria, on which S-layers calcium sulfate and calcium carbonate get crystallised 
(Schultze-Lam et al., 1992). Under laboratory conditions other compounds like for 
example can be crystallised on the S-layer surfaces and such nano-technological 
constructs could be used in electronic and non-linear optics (Pum and Sleytr, 1999; 
Bohr, 2002).  
S-layer can also be used for stabilization of liposomes, which are used for 
targeted drug delivery or immunodiagnostic assays. The drawback of liposomes is their 
instability. S-layers re-crystallise readily between two phases, including lipid bi-layers. 
When they crystallise in the liposomal bi-layer, they stabilise liposomes (Mader et al., 
1999). When S-layers have recrystallized on the liposomal surface, functional molecules 
for specific therapeutic or diagnostic applications can be covalently attached (Küpcü et 
al., 1995, Mader et al., 2000).  
S-layer can also be used as vaccines. S-layer protein of Campylobacter fetus was 
employed to construct vaccine against abortion in chickens, caused by this pathogen 
(Grogono-Thomas et al., 1997). S-layers can also serve as carriers for haptens and as 
adjuvants (Smith et al., 1993). The experiments of have also been done with the 
chimeric S-layer proteins as a part of live vaccines. Epitopes of oncoprotein c-Myc and 
poliovirus were expressed in Lactobacillus brevis as chimeric proteins of SlpA S-layer 
protein (Avall-Jaaskelainen et al., 2002). S-layer proteins are also tested as a component 
in the vaccines for immunotherapy of type 1 allergy as S-layer proteins 
immunomodulating properties (Breitwieser et al., 2002; Ilk et al., 2002; Bohle et al., 
2004).  
1.8.2 S-layer of B. anthracis 
Molecular structure 
In B. anthracis there are two S-layer proteins: Sap (surface array protein) and EA1 
(extractable antigen1), encoded by the sap and eag genes, respectively (Mesnage et al., 
1997, Mesnage et al., 1998, Fouet et al., 1999). The molecular size of Sap and EA1 
determined by mass spectroscopy is 86.6 kDa and 91.3 kDa, respectively (Walz et al., 
2007). The S-layer formed by them has the hexagonal arrangement (Gerhardt, 1967). In 
B. anthracis, as is the case with the S-layer proteins of other Gram-positive bacteria, 
Sap and EA1 proteins consist of N-terminal domains that facilitate interaction with the 
cell wall and C-terminal crystallisation domains that are responsible for interacting with 
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other S-layer proteins to form a crystalline array (Mesnage et al., 1999). The N-terminus 
of pre-S-layer proteins typically consists of a cleavable signal peptide that is responsible 
for targeting the protein for secretion. The signal peptide is followed by three positively 
charged SLH (S-layer homology) domains (Mesnage et al., 2000) that interact 
electrostatically with the negatively charged polymers of the cell wall. In B. anthracis 
both Sap and EA1 were shown to interact with pyruvate substituents of the cell wall 
(Chauvaux et al., 1999, Mesnage et al., 2000). Sap was also demonstrated to interact 
with acetyl groups (Laaberki et al., 2010).  
Genomic context of sap and eag genes  
It is noteworthy to see that sap and eag genes are located in the proximity of secA2 
(Figure 1.17). Located between secA2 and sap are two genes, csaA (BA0883) and csaB, 
which encode the proteins (CsaA and CsaB) responsible for the pyruvyl modification of 
the cell wall.  
 
 
The nomenclature of CsaA is somewhat confusing since, in B. anthracis, two different 
proteins have been ascribed this name. One CsaA is a molecular chaperone described in 
the Section 1.5.3a and it is encoded by the csaA gene (BA2064). The other CsaA is an 
oligosaccharide transporter encoded by BA0883 gene that, together with CsaB 
(polysaccharide pyruvyl transferase) is involved in the attachment of Sap and EA1 to 
the cell wall (Mesnage et al., 2000). However, only CsaB was shown to be essential for 
the attachment of Sap and EA1 as well as all other SLH domain-containing proteins 
(Mesnage et al., 2000; Kern et al., 2010). CsaB is responsible for adding pyruvate 
groups to the secondary cell wall polymer (SCWP), called neutral polysaccharide of B. 
anthracis and pyruvylation is necessary for the interaction between SLH domains and 
SCWP to take place. Thus, in a csaB-null mutant, the attachment of SLH domain-
containing proteins is abolished (Mesnage et al., 2000; Kern et al., 2010).  
Regulation of eag and sap expression 
In rich media, Sap and EA1 are synthesized sequentially in a growth phase-dependent 
manner (Mignot et al., 2002) (Figure 1.18). Sap is predominantly synthesized in the 
Figure 1.17: Genomic context of sap and eag genes.  
 
38 Chapter 1: General introduction  
exponential phase and EA1 in the stationary phase, during which Sap production is 
inhibited. When EA1 emerges onto the cell surface, it displaces Sap releasing it to the 
growing medium. This leads to the sequential occurrence of two (Sap and EA1) S-
layers in the exponential and stationary phases, respectively. The growth phase-
dependent expression of sap and eag partly relies on their transcription being driven by 
different sigma factors – sap expression is driven by σA (the predominant σ factor of the 
exponential phase) and while that of eag is predominately by σ
H 
(the predominant σ 
factor of the stationary phase). Moreover, Sap and EA1 were shown to possess DNA-
binding activity and to repress eag expression (Mignot et al., 2002). In the synthetic 
medium, which is thought to best resemble the conditions encountered by B. anthracis 
during infection, the expression of sap and eag is dependent on the presence or absence 
of the pXO1 plasmid. The plasmidless strain grown in the synthetic medium losses its 
growth phase-dependent manner of sap and eag expression, with high level of sap and 
low level of eag expression regardless of the growth phase. However, when sap is 
disrupted eag transcription increases indicating that eag is constantly suppressed by Sap 
when the plasmidless strain is grown in synthetic medium (Mignot et al., 2002). When 
the pXO1
+
 strain is grown in synthetic medium, the expression pattern of sap and eag 
becomes altered – eag is expressed at the expense of sap irrespective of the growth 
phase (Mignot et al., 2003). This is due to regulation mediated by the regulatory 
molecules encoded on the pXO1 plasmid, namely AtxA and PagR. AtxA induces 
expression of PagR, which in turn induces the expression of eag and the repression of 
sap. In vivo, the EA1 S-layer predominates when the toxins and capsule are produced, 
while the Sap S-layer predominates in non-capsulated bacteria (Mignot et al., 2004). 
This may indicate that Sap and EA1 play distinct roles in vivo. Sap, as the outermost 
layer, may participate in interaction with the environment, while EA1 might play role 
inside the host.    
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Figure 1.18: Proposed model for developmental control of the S-layer switch in B. 
anthracis. In the exponential growth phase, transcription of sap is actively driven by σA. 
Sap (open circles) is exported to the surface, where it forms an S-layer lattice by 
homologous interactions. The synthesis of EA1 is completely inhibited, possibly 
because Sap directly represses the transcription of eag by binding to the eag promoter. 
The transcription of sap is turned off during stationary phase, possibly because the 
availability of σA is limited. This results in the release of the eag promoter from Sap 
repression and full transcription of eag is driven by σH. EA1 (closed triangles) binds 
available sites at the cell surface and establishes homologous interactions that 
destabilize the Sap lattice and facilitate propagation of the EA1 lattice. The strict co-
ordination of EA1 synthesis according to surface requirements is a consequence of the 
feedback control of eag, presumably because EA1 reduces the transcription of eag 
directly or indirectly. (Closed squares) SLH-anchoring sites not occupied by Sap. The 
S-layer proteins are shown at one surface of the cell for reasons of clarity only; the 
assembly process is not polarized (Mignot et al., 2002). 
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1.9 The objectives of the project 
B. anthracis contains homologues of several Sec pathway components: (i) two 
homologues of SecA (SecA1 and SecA2), (ii) two homologues of SecY (SecY1 and 
SecY2), (iii) three homologues of the PrsA foldase (PrsAA, PrsAB and PrsAC). In 
previous studies, SecA2 was shown to be specific for secretion of S-layer proteins: Sap 
and EA1, while SecY2 has not been shown to have any substrate specificity. Instead, it 
seems to ensure high levels of protein secretion in later phases of the growth cycle. The 
objective of this project was to get new insights into the functioning of the B. anthracis 
secondary translocase. More specifically the project aimed to: 
1. Identify components of the SecA2-dependent secretion pathway.  
2. Elucidate interactions of SecA2, its substrates and the other elements of the  
     SecA2-dependent pathway.  
3. Elucidate the role of PrsA-like foldases in secretion of substrates of the SecA2-
dependent pathway. 
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Chapter 2: Materials and Methods 
The general methods applied in this study are described in this chapter. Growth media 
and buffers are presented in Appendix A.  
2.1 Bacterial strains, plasmids and oligodeoxyribonucleotides 
A list of oligodeoxyribonucleotides is given in Appendix B. The bacterial strains and 
plasmids used in the study are described in the tables of Appendix C.  
2.2 Growth and storage of bacterial strains 
Cultures of E. coli, B. subtilis and B. anthracis were grown on solid and in liquid 
cultures in Luria-Bertani (LB) medium (unless stated otherwise) at 37°C. Liquid 
cultures were incubated with shaking at 200 rpm. When required, antibiotics and/or 
growth supplements were added as shown in the Tables 2.1 and 2.2. Strains were stored 
as 10% glycerol stocks.  
 
Table 2.1: Antibiotic stock and working concentrations 
Antibiotic (abbreviation) Solvent Stock 
concentration 
(mg.ml
-1
) 
Working 
concentration 
(μg.ml-1) 
Ampicillin (Amp) dH2O 100 100 
Chloramphenicol (Cm) 50% ethanol (v/v) 5 5 
Erythromycin (Em) 100% ethanol (v/v) 0.3 0.3 (B. subtilis) 
  5 5 (B. anthracis) 
Kanamycin (Km) dH2O 10 10 (B. subtilis) 
   50 (E. coli) 
   20 (B. anthracis) 
Lincomycin (Lm) 50% ethanol (v/v) 25 25 
 
Table 2.2: Growth supplements 
Supplement Solute Stock concentration working concentration 
IPTG dH2O 1 M or 0.1 M 1 mM or 0.1 mM or 0.5 M 
X-Gal DMF 40 mg.ml
-1 
40 μg.ml-1  
Xylose dH2O 20% (w/v) 1% (w/v) 
 
2.3 DNA isolation, purification and analysis 
2.3.1 Isolation of genomic DNA from B. subtilis and B. anthracis 
B. subtilis colonies from streak plates were picked and inoculated into 5 ml of LB broth, 
then incubated at 37
o
C overnight with shaking at 180 rpm. Overnight cultures were 
centrifuged at 2,665 g for 5 minutes and the supernatant was removed. The 
chromosomal DNA was purified from the pelleted cells using the DNeasy Blood & 
Tissue Kit (Qiagen) according to the manufacturer’s instructions. The isolation of 
genomic DNA of B. anthracis was carried out in similar way with some modifications. 
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The cell pellet obtained from centrifugation of the overnight culture was resuspended in 
550 µl of the Enzymatic Lysis Buffer (20 mM TrisCl, pH 8.0, 2 mM EDTA, 1.2% 
Triton X-100) and then added to a 2 ml tube with the amount of glass beads 
corresponding to 500 µl H2O. The cells were subjected to the disruption in the Mikro-
Dismembrator S (Braun, Germany) at 2,600 rpm for five minutes in the presence of 
glass beads. Next, supernatant was transferred to fresh 2 ml Eppendorf tube and was 
processed using the DNeasy Blood & Tissue Kit (Qiagen) according to the 
manufacturer’s instructions. The resulting purified chromosomal DNA was stored at      
-20
o
C. 
2.3.2 Purification of PCR products 
PCR products from the amplification reaction and after restriction digest were purified 
using QIAquick
TM
 PCR purification kit (Qiagen, Crawley, West Sussex, UK) according 
to the manufacturer’s instructions.  
2.3.3 Isolation of plasmid DNA from E. coli  
E. coli colonies from streak plates were picked and inoculated into 5 ml of LB broth 
with appropriate antibiotic, then incubated at 37
o
C overnight with shaking at 180 rpm. 
Overnight cultures were centrifuged at 2,665 g for 5 minutes and the supernatant was 
removed. The plasmid was purified from the pelleted cells using the GeneJET™ 
Plasmid Miniprep Kit (Fermentas) according to the manufacturer’s instructions. The 
resulting purified plasmid was stored at 4
o
C. 
2.3.4 Isolation of plasmid DNA from B. anthracis 
B. anthracis colonies from streak plates were picked and inoculated into 5 ml of LB 
broth with appropriate antibiotic, then incubated at 37
o
C overnight with shaking at 180 
rpm. Overnight cultures were centrifuged at 16,060 g for 5 minutes and the supernatant 
was removed. The plasmid was purified from the pelleted cells using the GeneJET™ 
Plasmid Miniprep Kit (Fermentas) according to the following, modified protocol: the 
pellet was resuspended in 300 µl resuspension buffer. 300 µl lysis buffer (20 mM 
TrisCl, pH8.0, 2 mM EDTA, 1.2% Triton X-100) was added and the sample was mixed 
by inverting, followed by its transfer to a 2 ml tube with the amount of glass beads 
corresponding to 200 µl H2O. The cells were disrupted by using a Micro Dismembrator 
S (Braun Biotech International, Melsungen, Germany) for 5 minutes at 2,600 rpm. The 
sample was centrifuged (16,060 g, 10 minutes). The resulting supernatant was 
transferred into 1.5 ml Eppendorf. 300 µl neutralization buffer was added and the 
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sample was mixed and centrifuged (16,060 g, 10 minutes). The supernatant was 
transferred onto the spin column and the standard protocol for GeneJET™ Plasmid 
Miniprep Kit (Fermentas) was followed. The resulting purified plasmid was stored at 
4
o
C. 
2.3.5 Recovery of DNA fragments from agarose gels 
Following gel electrophoresis, the DNA bands were visualised using a UV light 
transilluminator and the appropriate DNA band of interest was excised and transferred 
into a 1.5 ml Eppendorf tube. The DNA was purified with the GeneJet
TM
 Gel Extraction 
Kit (Fermentas), according to the manufacturer's instructions. 
2.3.6 DNA quantification 
The DNA concentration and purity was determined using the Nanodrop 
spectrophotometer ND-1000 (LabTech) following the manufacturer’s protocol. Both the 
concentrations and the purity of samples were determined from A260/A280 ratio. A ratio 
value of between 1.8 and 2 indicates good DNA purity; lower values indicate 
contamination with protein.  
2.3.7 Agarose gel electrophoresis of DNA 
DNA size and integrity was analysed by agarose gel electrophoresis using 1 x TAE or 
TBE buffer (Appendix A). The gels were made with ethidium bromide or SafeView 
(final concentration 0.5 µg/ml for both dyes). 0.8% gels were prepared for the 
separation of DNA fragments bigger than 1 kb in size; 1.3 or 1.6% gels were prepared 
for the separation of DNA fragments smaller than 1 kb. The DNA samples were 
prepared in an appropriate volume of 6 x loading dye and loaded into the gel. The 
electrophoresis was run at 2 V/cm. Following electrophoresis, DNA was visualised 
using a UV light transilluminator (GelDoc1000, Bio-Rad Laboratories Ltd. Hempel, 
Herts, UK) and the gel was photographed. DNA size was determined in relationship to 
molecular size markers, 100 bp and 1 kb molecular ladders (Promega & Fermentas) and 
2-log ladder (NEB) as appropriate.  
2.3.8 PCR 
PCR primers were designed using Primer3 software, which is available on-line: 
http://frodo.wi.mit.edu/), or were designed manually. Sequences containing appropriate 
restriction sites and 5’ overhangs were introduced into the 5' end of primers when 
needed. PCR amplification of DNA fragments was performed with Taq polymerase 
(NEB) for diagnostic PCR or Phusion polymerase (Finnenzymes) for cloning purposes. 
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The components of the PCR reaction were added according to the manufacturer’s 
instructions. The standard conditions for PCR with Taq polymerase were: 1 x (2 min 
95°C); 35 x (30 s 95°C; 30 s 5-10°C below melting temperature of the primers; 30 s up 
to 3 min 68°C, depending on the length of target gene – 1 min per 1 kb), 1 x (10 min 
72°C). Conditions for PCR with Phusion polymerase were: 1 x (2 min 98°C); 35 x (30 s 
98°C; 30 s 5°C above melting temperature of the primer with the lower melting 
temperature; 15 s up to 3 min 72°C, depending on the length of target gene – 30 s per 1 
kb), 1 x (10 min 72°C). For cloning purposes, PCR products were purified using the 
QIAquick
TM
 PCR purification kit (Qiagen) according to the manufacturer’s instructions. 
2.3.9 Sequencing 
DNA sequencing was used to verify the correct construction of the recombinant 
plasmids. Plasmid DNA was purified by GeneJET™ Plasmid Miniprep Kit (Fermentas). 
The appropriate concentration of primers and plasmids for sequencing were prepared:  
for plasmid 50-100 ng/µl, minimum 1 µg per reaction, for primer 2 pmol/µl in a 
minimum volume of 15 µl. The sequencing of DNA fragments was performed by MWG 
Biotech AG (Germany). The DNA sequence of the sequenced DNA was compared with 
the template using the on-line software ClustalW2 (http://www.ebi.ac.uk/Tools/msa/ 
clustalw2/). 
2.3.10 Restriction digest 
Plasmid DNA and amplified fragments were treated with appropriate restriction 
enzymes (FastDigest, Fermentas), according to the manufacturer’s instruction. The 
digestion reaction was run for 1 hour at 37°C. Additionally, alkaline phosphatase 
(Fermentas) was added to the plasmid digestion mixes (according to the manufacturer’s 
instructions) to dephosphorylate the sticky ends to prevent vector re-ligation.  
2.3.11 Ligation 
Plasmid and insert DNA concentrations were mixed in a ratio of 1:3 or 1:6. The amount 
of plasmid added was 50 ng or 100 ng and the amount of the insert to be added was 
calculated according to the formula: ((50 or 100 x MWi)/MWp)) x 3 (or 6), where MWi 
is the molecular size of the insert and MWp is the molecular size of the plasmid. 
Volumes of plasmid and insert to be added were calculated by dividing the amount to be 
added by the concentration of each DNA solution. 1 μl of T4 DNA ligase (1 unit/μl) and 
2 μl of the appropriate buffer (Fermentas) were added per reaction mix. ddH2O was 
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added to give a total volume of 20 μl. The ligation mix was incubated overnight at 4oC 
or for 2h at room temperature. 
2.4 Standard procedure for preparation of chemically-competent cells of E. coli  
The preparation of chemically-competent cells of E. coli was based on Inoue et al. 
(1990) with modifications. The strain of E. coli TOP10 or E. coli XL-I blue were grown 
in 5 ml LB overnight. 25 ml of fresh LB was inoculated with the overnight culture. The 
volume of overnight culture for inoculation was calculated using formula: (0.05/OD600) 
x 25 ml. The culture was incubated to an optical density of 0.5 to 0.6 at 600 nm. The 
culture was placed on ice for 10 minutes and cells were pelleted by centrifugation at 
2,665 g for 10 minutes at 4
o
C. Cells were resuspended in 8 ml ice-cold Transformation 
Buffer (Appendix A), kept on ice for 10 minutes, then centrifuged at 2,665 g for 10 
minutes at 4
o
C. The pellet was resuspended in 2 ml ice-cold Transformation Buffer 
containing 140 μl DMSO. Subsequently, the competent cells were used immediately 
and a drop of 80% glycerol was added to the remaining suspension which was then 
divided into 200-400 µl aliquots using pre-cooled 1.5 ml Eppendorf tubes. The aliquots 
were snap-freezed in liquid nitrogen and stored at -80°C. 
2.5 Transformation of E. coli  
10 μl of the ligation mix was added to 100 μl of competent cells. A positive control was 
prepared by the addition of 1 μl of uncut vector and the negative control consisted of 
100 μl of competent cells without any DNA additions. The transformation reactions 
were incubated for 10 minutes on ice. Subsequently, cells were heat shocked for 45-50 s 
at 42
o
C and incubated for 2 minutes on ice afterwards. 900 μl of SOC broth (Appendix 
A) was added to each reaction and the mixture incubated for 1.5 hour at 37°C with 
shaking. The transformants were then plated on the LB agar. IPTG, X-gal and 
ampicillin were added when appropriate to the LB agar for the selection and 
identification of the transformants.  
2.6 Bacterial Two Hybrid assay (B2H) 
To test protein-protein interactions by Bacterial Two-Hybrid assay, the BACTH System 
Kit (Euromedex) was used. The genes encoding the target proteins were cloned into 
plasmids pUT18, pUT18C, pKT25, pKT25N. The cloning was done using E.coli XL-I 
blue host strain. All pairwise combinations of T25- and T18-based clones were tested 
by co-transforming them into E.coli BTH101. Co-transformants were grown on the LB 
plates with ampicillin (100 μg/ml), kanamycin (25 μg/ml), IPTG (0.5 mM), X-gal (40 
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μg/ml). The growth of colonies indicated positive selection of co-transformants. White 
coloured colonies/spots meant no interaction between the investigated proteins, while 
blue coloured colonies/spots meant that an interaction had occurred.  
2.6.1 Preparation of chemically-competent cells of E. coli BTH101  
E. coli BTH101 was grown in 5ml LB overnight and used to inoculate 50 ml of fresh 
LB. The volume of the overnight culture for inoculation was calculated using formula: 
(0.05/OD600) x 50 ml. The culture was incubated to an optical density of 0.4 at 600 nm. 
Then, the culture was centrifuged at 3,373 g and resuspanded in 5 ml of the ice-cold    
0.1 M CaCl2. The resuspanded culture was incubated for an hour on ice, then it was 
centrifuged at 3,373 g and resuspanded in 250 µl 0.1 M CaCl2 and incubated for 30 
minutes on ice. To store the competent cells, a drop of 80% glycerol was added and the 
cells were snap-freezed in the liquid nitrogen. The cells were stored at -80C
o
. 250 µl of 
competent cells was enough for 16 co-transformations.  
2.6.2 Co-transformation of E. coli BTH101 
Competent E. coli BTH101 cells were thawed on ice. 15 μl of the cells were transferred 
to 1.5 ml Eppendorf tubes pre-cooled on ice. 0.5-1 μl of each appropriate plasmid was 
added: pUT18 or pUT18C recombinant plasmid with pKT25 or pKT25N recombinant 
plasmid. pKT25 ZIP and pUT18C ZIP were used positive control. Co-transformation of 
the empty pUT18 or pUT18C and pKT25 or pKT25N was used as negative control. The 
co-transformation mix was incubated for 20 minutes on ice followed by 2 minutes at 
42
o
C and then back on ice for 5 minutes. Next 80 μl of SOC broth was added to each 
reaction and the mixture incubated for 2 hours at 30
o
C with shaking. The transformants 
were then plated on the LB agar containing ampicillin, kanamycin, IPTG, X-gal for the 
selection and identification of co-transformants.  
2.7 Transformation of Bacillus spp. 
2.7.1 B. subtilis transformation 
Bacillus subtilis was cultured overnight in the MM competence medium (Appendix A). 
10 ml of the fresh MM competence medium was inoculated with 0.6 ml of overnight 
culture and incubated for 3 hours at 37
o
C. This was followed by addition of 10 ml of 
starvation medium (Appendix A) to the culture and the incubation was continued for 2 
hours to make cells competent. 500 ng of DNA was mixed with 0.4 ml of competent 
cells and incubated for 1 hour, followed by plating on a selective medium and overnight 
incubation.  
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2.7.2 B. anthracis transformation 
The transformation of B. anthracis was carried out by electroporation, as described by 
Koehler et al. (1994). In the case of the construction of delition mutants, 
electrotransformation was followed by growing the transformed strains first in BHI 
(Appendix A) medium with kanamycin for two days and then in BHI medium without 
the antibiotic. Cultures were screened for kanamycin-resistant, erythromycin-sensitive 
clones.  
2.8 RNA purification and analysis 
2.8.1 Total RNA purification from Bacillus spp. 
RNA was purified using the acid phenol method. Strains of B. anthracis were grown 
overnight in 5 ml LB, and used to inoculate 20 ml of fresh LB. The volume of overnight 
culture was used for inoculation was calculated using formula: (0.05/OD600) x 20 ml. 
The culture was incubated to an optical density of 0.8 at 600 nm and then 10 ml of the 
culture was added to 5 ml of frozen killing buffer (-20
o
C) mixing by invertion three 
times. The cells were harvested by centrifugation (10 minutes, 3,838 g, 4
o
C). The 
supernatant was discarded and the cells were snap-freezed in the liquid nitrogen and 
stored at -20
o
C. For RNA extraction the frozen pellets were thawed on ice and 
resuspanded in 1 ml Lysis solution I (25% sucrose, 50 mM Tris/Cl, pH 8.0, 0.25 mM 
EDTA). The cells were harvested by centrifugation (16,099 g, 5 minutes, 4
o
C) followed 
by removal of the supernatant. The pellet was resuspanded by pipetting in 300 µl Lysis 
solution II (3 mM EDTA, 200 mM NaCl) and the suspension was transferred 
immediately to the 1 ml prewarmed mixture of 500 µl Lysis solution II and 200 µl 10% 
SDS prewarmed to 95
o
C. The samples was mixed and incubated for 5 minutes at 95
o
C 
in a heating block. Next, 1 ml acid phenol solution was added to the sample and mixed 
rapidly in the reaction tube shaker for 5 minutes at room temperature. Following 
centrifugation (13,684 g, room temperature), 850 µl of the upper (aqueous) layer was 
transferred into fresh an Eppendorf tube, avoiding carry-over of the DNA-containing 
interphase. 850 µl acid phenol solution was added to the sample and mixed using a 
reaction tube shaker at room temperature for 5 minutes. Followed the centrifugation 
(13,684 g, room temperature), 700 µl of the upper aqueous phase was transferred into a 
fresh Eppendorf tube. 700 µl chloroform/isoamylalcohol was added to the sample which 
was mixed and centrifuged (13,684 g, room temperature). The upper aqueous phase was 
transferred to a fresh Eppendorf tube with 70 µl 3 M sodium acetate, pH 5.2 and the 
sample was mixed, followed by addition of 1 ml isopropanol and mixing. The sample 
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was incubated at -20
o
C overnight to precipitate RNA. Next the sample was centrifuged 
(21,918 g, 4
o
C, 15 minutes), the supernatant removed and the pellet resuspended in 70% 
ethanol. The sample was centrifuged (21,918 g, 4
o
C, 15 minutes), the supernatant was 
removed and the pellet was air dried. The RNA pellet was dissolved on ice in 50 µl 
ddH20 and the purity and quality determined with a Nanodrop ND-1000 
spectrophotometer. The ratios of A230, A260 and A280 reflect the degree of purity of DNA 
samples. The value of ratios of A260/A280 between 1.8 and 2, and A260/A230 between 2.0 
and 2.2 is indication of good quality RNA; lower values indicate contamination. The 
RNA quality and integrity was additionally assessed by gel electrophoresis by 
inspection of the 16S and 23S rRNA bands visible on an agarose gel.  
2.8.2 Northern blotting 
2.8.2.1 RNA electrophoresis 
RNA electrophoresis was done under denaturation conditions to disrupt secondary 
structures which can strongly impact on how RNA migrates through the gel. The 1.2% 
gel was prepared: 1.2 g agarose is dissolved in 10 ml 10 x MOPS (3-[N-morpholino] 
propanesulphonic acid) buffer (Appendix A) and 74 ml sterile ddH20 in the microwave, 
mixing every 10 seconds. The dissolved agarose was put to the 65
o
C oven for 30 
minutes and 18 ml of 37% (12.3 M) formaldehyde was added and incubated for another 
30 minutes at 65
o
C. The gel was poured and left to solidify for 60 minutes. RNA 
samples were prepared for loading: 5 µg RNA was added to a 1.5 ml Eppendorf tube 
and the sample was made up to 10 µl. Next, 10 µl loading dye was added and the 
sample was mixed and incubated at 65
o
C for 10 minutes. In the case of the RNA size 
marker (Invitrogen), 3 µl of ladder were added 3 µl loading dye and mixed. The pre-
electrophoresis of the empty gel was run for 10 minutes at 60 V in 1 x MOPS as the 
running buffer. The samples were loaded and the gel run at 52 V for 90 minutes. Next, 
the gel was turned around, the buffers mixed and two cables swapped to prevent buffer 
exhaustion. The gel was stained with ethidium bromide (5 µg/ml) for 2-5 minutes on the 
shaker and then washed 3 times 20 minutes on the shaker with sterile ddH2O. The 
fourth wash was done overnight at 4
o
C without shaking. The following day, the picture 
of the gel exposed to UV light and the quality and integrity of the purified RNA 
assessed by inspection of bands corresponding to the 16S and 23S RNA.  
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2.8.2.2 Immobilisation of RNA on membrane 
The transfer of RNA from the gel into the membrane was performed using a vacuum 
blotter (model 785, BioRad). The blotting was performed according to the 
manufacturer’s standard procedure with some modification. Denaturation solution (0.5 
M NaOH, 1.5 M NaCl) was applied for 5 minutes, followed by neutralisation solution 
(0.5 M Tris-HCl, 3 M NaCl). Next, 20 x SSC solution (175.3 g/l NaCl, 88.2 g/l 
trisodium citrate, adjusted to pH 7.0 with NaOH) was applied onto the membrane for 5 
hours. RNA was fixed to the nylon membrane by exposing it to UV light (60,000 J cm
-2
, 
Stratalinker, Strategene). Membranes were immediately subjected to the subsequent 
hybridization step or stored at 4
o
C.  
2.8.2.3 Generation of the probe for the detection of target gene 
The 5’ end of target gene (400 – 500 bases) was amplified by PCR with forward 
primers of 18 – 25 bases. The reverse primer, in addition to 18 – 25 bases 
complementary to the target gene, contained a T7 promoter sequence 
(ctaatacgactcactatagggaga) at 5’ end. The PCR products were checked by gel 
electrophoresis to verify the presence of the fragment of the expected size. Next, PCR 
products were purified using the QIAquick
TM
 PCR purification kit (Qiagen) according 
to the manufacturer’s instructions. The DNA was used in an in vitro transcription 
reaction to create a DIG-labelled mRNA probe, using component and volumes shown in 
the Table 2.3.   
Table 2.3: In vitro transcription reaction for the creation of the mRNA probe 
Components Volume (µl) Final concentration 
   
Purified PCR product variable 600 ng 
10 x Labelling mix (containing digoxigenin-11-
UTP, Roche Diagnostics) 
2 1 x 
10 x Transcription buffer (Roche Diagnostics) 2 1 x 
T7 RNA polymerase (400 U/µl) (Sigma)  2 20 U/ µl 
RNasin (40 U/µl) (Promega) 2 2 U/ µl 
ddH2O Fill up to 20 µl  
   
 
The mixture was incubated for 3 hours at 37
o
C. Next, 2 µl of 0.2 M EDTA (pH 8.0) was 
added to stop the transcription reaction. The labelling efficiency was determined by 
preparing serial dilutions (10
-1
 – 10-3) and applying 1 µl of each dilution as well as 
undiluted probe onto a strip of positively charged nylon membrane (Roche). The RNA 
probe was fixed to the nylon membrane by exposing the membranes to UV light (60, 
000 J cm
-2
, Stratalinker, Stratagene).  
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2.8.2.4 Hybridization  
Nylon membranes were placed in pre-hybridization buffer (0.02% SDS, 0.1% N-
laurylsarcosin, 2% blocking reagent, 5 x SSC buffer, 50% v/v foramide pre-warmed to 
65°C) in hybridization tubes (20 ml per membrane). Pre-hybridization was performed in 
a rotating hybridization oven for 1 hour at 65°C. DIG-labelled RNA probes were 
denatured for 15 minutes at 90°C in a water bath and then placed on ice. Once the pre-
hybridization was completed, the pre-hybridization buffer was discarded and the 
hybridization solution containing the probe was added (10 ml per membrane). The 
hybridization was performed at 65°C overnight in the hybridization oven.  
2.8.2.5 Stringency washes 
The hybridization buffer was removed and the membrane was washed with the Wash 
Buffer I (2 x SSC, 0.1% SDS) (2 x 5 min) followed by Wash Buffer II (0.1 x SSC, 0.1% 
SDS) (2 x 15 minutes) at 65°C in the hybridization oven.  
2.8.2.6 Immunological detection 
After the stringency washing step, the membrane was rinsed with Tween Wash Buffer 
(0.1 M Maleic acid, 0.15 M NaCl, 0.3% Tween 20; pH 7.5) for 5 minutes under high 
agitation on the table shaker. The membrane was incubated for 30 minutes in 30 ml of 
the Blocking Buffer (Appendix A). The Blocking buffer was discarded and 20 ml of the 
Blocking Buffer with 2 µl of anti-digoxigenin-AP antibody (Roche) was added to the 
container with the membrane and incubated for 30 minutes with gentle agitation. The 
membrane was washed twice with the Tween Washing Buffer (first washing for 30 
minutes, second for 1 hour). The membrane was equilibrated using 30 ml of the 
Detection Buffer (0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5) for 5 minutes. The membrane 
was transferred into the bottom sheet of plastic pocket and approximately 500 µl - 1000 
µl Detection Reagent (CDP-Star, Roche), depending on the size of the membrane, was 
applied. The membrane was covered by the top sheet of the plastic pocket and Detection 
Reagent was spread evenly on the membrane, squeezing out any air bubbles. After 5 
minute incubation in the dark, the membrane was exposed to an autoradiography film 
(Hyperfilm-ECL, Amersham Bioscience, France) in the autoradiography cassette 
(Genetic Research Instrumentation Ltd, UK). The exposure time was varied depending 
on the strength of the probe. The films were developed using a film processor (Konika). 
Alternatively, the membrane blots were exposed in ImageQuant LAS 4000 and 
ImageQuant LAS 4010 imager (GE Healthcare) and analysed by ImageQuant TL 
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software (GE Healthcare). The sizes of transcripts were determined in reference to RNA 
size marker (Invitrogen).  
2.8.3 Analysis of gene expression by quantitative RT-PCR 
RNA was purified as described in the Section 2.8.1 and used to generate cDNA by 
reverse transcription reaction, using a Moloney Murine Leukemia Virus (MMLV)-RT 
Kit (Promega, Madison, USA). The components, volumes and final concentrations of 
components of the reaction mix are given in the Table 2.4. 
Table 2.4: Reverse transcription reaction 
Components Volume (µl) Final concentration 
   
RNA (50 ng/µl) 4 200 ng 
0.5 mg/ml Random Hexamers pd(N)6 (GE Healtcare) 1 25 µg/ml 
ddH2O 9  
5 x M-MLV RT reaction buffer 4 1 x 
10mM dNTPs   1 20 U/ µl 
RNasin Ribonuclease Inhibitors (20 U/µl) (Promega) 0.5 10 U 
M-MLV RT (10 U/µl) 0.5 100 U 
   
 
First, RNA was diluted in such a way to obtain the concentration of 50 ng/µl. 4 µl of 
RNA (200 ng in total) was mixed with random hexamers pd(N)6 (GE Healtcare) and 
ddH2O and incubated for 5 minutes at 65
o
C. The remaining components were added and 
the mixture was incubated for 2 hours at 42
o
C for primer extension followed by 
denaturation of the reverse transcriptase at 70
o
C for 10 minutes. The RT products were 
subsequently diluted 1:200 and used immediately for the RT-PCR reaction or stored at -
20
o
C for the later use. The 1:200 diluted RT products were used to prepare RT-PCR 
reaction mix with the volumes and concentrations components shown in the Table 2.5. 
The primers for the reaction were designed in such a way to amplify 100 – 200 bases of 
the 5’ end of the target gene. The RT-PCR reactions mixes were prepared by benchtop 
instrument (QIAgility, Qiagen). The RT-PCR was performed using Rotor-Gene™ Q 
(Qiagen).  
Table 2.5: Relative quantitative Real-Time PCR reaction components 
Components Volume (µl) Final concentration 
   
PCR primers (10 µM) 4 0.5 µM 
SYMBR Green Master Mix (2x concentrated) 10 1 x 
RT product (1:200 diluted) 6 - 
   
 
The temperature and time profile for the PCR cycle were as shown in the Table 2.6. The 
Real-time amplification of the target and the reference genes (gyrB and gatB) were 
performed. For the purpose of analysis, the threshold level was set arbitrarily and Ct 
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values (the cycle number at which the fluorescence crosses the threshold level) were 
recorded. As Ct values are inversely proportional to the amount of template – the more 
templates in a sample, lower the Ct values are. This served as the basis of gene 
expression quantification. In this study Ct values obtained for the mutants were 
compared to those of the wild type strain to evaluate change in the gene expression in 
the mutant strains. The reference/housekeeping genes (gyrB and gatB) were used to take 
account of variations in the cDNA input and the sample-to-sample differences. Melting 
curve analysis was also performed in parallel to the RT-PCR to confirm that only a 
single, specific product was amplified.  
Table 2.6: The temperature and time profile for RT-PCR cycle 
Parameter Temperature (
o
C) Times (sec) 
   
Denaturation 95 300 
   
Amplification 95 5 
(35 cycles) 60 10 
   
Melting curve 65-95
o
C, increment 
of 1
o
C 
90s for first step, 5s for 
subsequent steps 
 
2.9 Precipitation of proteins from culture supernatants 
2.9.1 Basic protocol for precipitation of proteins from culture supernatant  
Strains of B. anthracis were grown overnight in 5 ml LB broth and used to inoculate 60 
ml of fresh LB broth without antibiotics. The volume of overnight culture for 
inoculation was calculated using formula: (0.05/OD600) x 60 ml, and the culture 
incubated with shaking at 37°C until an OD600 of 0.8. The cells were harvested by 
centrifugation at 3,838 g for 30 minutes at 4°C and the supernatant transferred carefully 
in to a 100 ml glass bottle (making sure no cells were transferred). To the transferred 
45-50 ml of supernatant, 16 ml of pre-cooled TCA was added and the mixture was 
mixed by shaking. The samples were incubated at 4°C overnight. The following day, 
the samples were centrifuged at 30,000 g at 4°C for 70 minutes and the majority of the 
supernatant decanted. 1-2 ml of the supernatant that was left, was used to, resuspend the 
pellet. The mixture was transferred into a 2 ml Eppendorf tube. Following, 
centrifugation at 20,000 g for 15 minutes at 4°C, the supernatant was decanted and the 
pellet washed with 100% ethanol 3 times, each time, with centrifugation at 20,000 g for 
15 minutes at 4°C. Subsequently, the pellet was dried at 65°C in an oven with the tube 
lids open for approximately 20 minutes. 200 μl of Urea/Thiourea were added into the 
each tube, then tubes were vortexed to dissolve the pellet and centrifuged at 20,000 g 
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for 30 minutes at 4°C. The supernatant was transferred into a clean tube and protein 
concentration was determined. 
2.9.2 Precipitation of inducible proteins from culture supernatant  
When induction of proteins was required, the basic protocol for precipitation of proteins 
from culture supernatant (Section 2.9.1) was followed with some modifications. As 
previously, the overnight culture was used to inoculate 60 ml of fresh LB (in 500 ml 
flask) without antibiotics, and the bacterial culture was incubated with shaking at 37°C 
until an OD600 of 0.8. The culture was split into 2 flasks (250 ml flasks). Into one flask, 
the inducer: 20% xylose (final concentration is 1%) or 1 M IPTG (final concentration 
10 mM), was added to induce expression. Both cultures (with and without inducer) were 
incubated with shaking at 37°C for 90 minutes. The cells were harvested by 
centrifugation at 3,838 g for 30 minutes at 4°C and the supernatant transferred carefully 
in to a 100 ml glass bottle (making sure no cells were transferred). To the transferred 
20-25 ml supernatant, 8 ml of pre-cooled TCA was added and the mixture was mixed 
by shaking. Next, the basic protocol was followed (Section 2.9.1). 
2.9.3 Extraction of EA1 protein  
The protocol was followed as in the Section 2.9.2 with some modifications. The cells 
were harvested by centrifugation at 3,838 g for 30 minutes at 4°C and the supernatant 
transferred carefully in to a 100 ml glass bottle (to make sure no cells were transferred). 
After centrifugation, the supernatant was kept on ice and the pellet was resuspended in 4 
M LiCl, 200 µM PMSF, 50 mM Tris-Cl (pH7.5), next mixed for 1h at 4℃ on the 
rotating plate, following centrifugation (21,918 g, 10 minutes, 4℃). The supernatant 
was added into the tube with the supernatant obtained after spinning down the culture. 
The samples were added to 8 ml pre-cooled TCA and mixed by shaking. Next, the basic 
protocol for precipitation of proteins from culture supernatant was followed (Section 
2.9.1).  
2.10 Purification of SecA1, SecA2 and SecH proteins 
SecA1, SecA2 and SecH were purified using E. coli BL21 as an expression host. SecA1 
and SecA2 were expressed from pGEX 6p1 as GST-tagged proteins: GST-SecA1 and 
GST-SecA2, respectively, while SecH was produced from pET16b as a His-tagged 
protein. Cultures were grown in 250 ml LB medium in at 37°C. When the OD600 
reached about ~ 0.6, expression was induced by the addition of IPTG to a final 
concentration of 0.05 mM, and the incubation continued overnight at room temperature. 
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Subsequently, the cells were harvested by centrifugation (15 minutes, 3,000 g, 4°C) and 
resuspended in 250 µl of 1 x PBS with protease inhibitor and lysozyme. The cell 
suspension was incubated on ice for 30 minutes, with mixing every 10 minutes. 
Afterwards, cells were sonicated for 5 x 10 seconds, amplitude 10%. 10 µl of the 
sonicate was withdrawn to be analysed by SDS-PAGE. The remaining sonicate was 
centrifuged (15,000 g, 15 minutes) and 5 µl of the supernatant was taken to run on the 
gel. To optimize the solubilisation of proteins, the following modifications were used: 
(1) sarcosyl was added (1% final concentration) to cell suspension, after incubation with 
lysozyme, and mixed by inversion; (2) Triton X-100 was added (1% final 
concentration) to the sonicate and mixed by inversion. Purification of GST-SecA1 and 
GST-SecA2 was continued using a column packed with Glutathione Sepharose 4 Fast 
Flow affinity chromatography medium (GE Healtcare), according to the manufacturer’s 
instructions. The protein fractions were separated on a SDS-PAGE gels, which was then 
stained with Coomassie blue. 
2.11 Determination of protein concentration 
The protein concentration was determined using 2-D Quant Kit (GE Healthcare) 
according to the manufacturer’s instructions.  
2.12 The SDS-PAGE electrophoresis 
The SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described 
in Sambrook et al. (1989) using a 5% stacking gel and a 10% separating gel with the 
components listed in Appendix A. The thickness of gels was 1 mm. Alternatively, 10% 
NuSep protein gels (Generon) or Mini-PROTEAN TGX gels (Bio-Rad) were used. 20 
μg of protein (in a total volume of 25 µl of the loading sample, including the 
bromophenol blue loading dye) was loaded per lane and the samples electrophoresed at 
80 V and then the voltage was increased to 200 V, when the bromophenol blue dye had 
reached the separation gel. The electrophoresis was performed until the loading dye just 
ran off the bottom of the gel. The gel was stained with one of the following dyes: (i) 
Coomassie Blue (G-250) as described in Sambrook et al. (1989); (ii) silver stain using 
PageSilver™ Silver Staining Kit (Thermo Scientific) according to the manufacturer’s 
instructions; (iii) SYPRO Ruby Protein Gel stain (Invitrogen) according to the 
manufacturer’s instructions.  
 
 
 
55 Chapter 2: Materials and Methods  
2.13 Pull-down experiment 
The pull-down experiment was carried out using a Flag-tagged protein and ANTI-
FLAG M2 affinity gel (Sigma-Aldrich). The culture of B. anthracis containing pKG400 
plasmid encoding the gene of interest fused in frame to the sequence of the Flag-tag, 
was grown overnight and used to inoculate 500 ml of the LB broth. The new culture 
was then grown to an OD600=0.8 and IPTG was added to a final concentration of 10 mM 
and incubated for a further 90 minutes. 250 ml culture was then withdrawn to a separate 
sterile flask, 7 ml 37 % formaldehyde was added (1 % w/v final concentration) and the 
culture was shaken gently at room temperature to facilitate protein cross-linking. 12.5 
ml of glycine was added (final concentration 0.125 M) to quench the cross-linking 
reaction with the culture was shaken for further 5 minutes at room temperature. Both 
cultures (formaldehyde-treated and untreated) were harvested by centrifugation (15,000 
g) and resuspended in TBE buffer (50 mM Tris HCl, 150 mM NaCl, pH 7.4). The cells 
were then disrupted with a dismembrator by shaking 1 ml resuspended cells with 300 µl 
glass beads at 2,600 rpm. The sample was centrifuged (21,918 g, 10 minutes, 4
o
C) and 
the supernatant transferred into 2 ml Eppendorf tube. Its volume was topped up to 1.2 
ml. The protein extracts were filtered with a 0.45 µm membrane filter to remove any 
remaining cells and particulates. ANTI-FLAG M2 affinity resin is supplied as a  
suspension in 50% glycerol. To remove the glycerol, the resin was resuspended in 1.5 
ml TBS, incubated for 10 minutes with gentle mixing using rotating plate at 4
o
C and 
then centrifuged at 1,000 g for 10 minutes. The washing step was done 6 times. ANTI-
FLAG M2 affinity resin was resuspended in 25 µl TBE and protein extracts were added 
to the suspension. The samples were incubated for ~ 2 hour with gentle mixing to 
capture the FLAG fusion proteins. The resin was collected by centrifugation (1,000 g 
for 5 minutes) and resuspended in TBE with increased NaCl concentration to increase 
the stringency of washing (50 mM Tris HCl, 500 mM NaCl, pH 7.4). The resin was 
incubated for 10 minutes with gentle mixing at 4
o
C and then centrifuged at 1,000 g for 
10 minutes. The washing step was done 6 times. 5 µl 5 x sample buffer (without 
reducing agent) was added to 30 µl sample. The samples were boiled for 20 minutes to 
reverse crosslinking and then analysed by SDS-PAGE electrophoresis. The gels were 
stained with one of the following: (i) PageSilver™ Silver Staining Kit (Thermo 
Scientific) according to the manufacturer’s instructions; (ii) SYPRO  Ruby Protein Gel 
stain (Invitrogen) according to the manufacturer’s instructions. The unique bands from 
the gel corresponding from the samples with Flag-tagged proteins were excised and sent 
for mass spectroscopy analysis.  
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2.14 Bocillin assay 
Bocillin assay was used to measure activity of penicillin binding proteins (PBPs). 
Strains of B. anthracis were grown overnight in 5 ml LB broth and used to inoculate 10 
ml of fresh LB broth. The volume of overnight culture for inoculation was calculated 
using formula: (0.05/OD600) x 10 ml. The cultures were incubated to an OD600 of 0.8. 
The cultures were centrifuged (10 minutes, 3,838 g) cells were resuspended in the 330 
µl Lysis buffer and 300 µl glass beads added. The cells were disrupted with a 
dismembrator by shaking at 2,600 rpm. The samples were centrifuged (21,918 g, 10 
minutes, 4
o
C) and 130 µl supernatant was transferred into 2 ml Eppendorf tube, Bocillin 
FL (final concentration 25 µM) was added into each sample and the samples were 
incubated for 20 minutes at room temperature. Next, 20 µl of each sample were mixed 
with 5 x loading buffer and incubated at 95
o
C for 5 minutes. The samples were 
subjected to SDS-PAGE electrophoresis (80 V for 3 hours). To visualize the labelled 
PBPs, the gels were scanned with Typhoon Scanner (Typhoon Trio, GE Healthcare) 
(emission filter: 520 Cy2, ECL + Blue, sensitivity: medium, resolution: 100 µm). 
2.15 Mass spectrometry 
The mass spectrometry analysis was done by the Pinnacle Lab (Newcastle University, 
UK). The bands from the SDS-PAGE gels were subjected to trypsin digestion and then 
analysed using a Voyager DE-STR MALDI-TOF mass spectrometer (Applied 
Biosystems Inc., Framingham, MA, USA). The resulting peptide mass fingerprint
 
data 
and the Mascot search engine program (Matrix Science Ltd, London) was used to 
identify respective proteins. Four samples were additionally subjected to HPLC/MS/MS 
analysis which generated significantly greater MASCOT confidence scores for the 
identified peptide fragments.    
2.16 Microscopy 
Cultures of the analyzed strains of B. anthracis were sampled during the exponential 
(OD600=0.6-0.8) or transitional phases (OD600=2.0-2.5). Aliquots of cultures treated 
with the FM5-95 membrane stain (final concentration 1μg/ml) and mounted onto a 
microscope slide coated with 1.2% agarose and immobilized using a glass cover slip. 
Images were acquired on an Axiovert M200 microscope (Zeiss Ltd., Oberkochen, 
Germany) with a 300 W lambda light source (Sutter Instrument Company, California, 
USA) and a Zeiss × 100 plan-neofluar oil immersion objective lens (A = 1.3). Images 
were captured on a 1395 × 1040 pixel CoolSNAP HQ camera (Photometrics, 
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Ottobrunn, Germany) controlled by Metamorph software version 6.1r3 (Universal 
Imaging Corporation Ltd., Marlow, UK). The lengths of cells were measured using 
ImageJ software (http://rsb.info.nih.gov/ij). 
2.17 Computational methods 
DNA sequence data for B. subtilis 168 and B. anthracis Ames were obtained from the 
SubtiList-database (http://genolist.pasteur.fr/SubtiList/) and AnthraList database, 
respectively (http://bioinfo.hku.hk/GenoList/index.pl?database=anthralist). The primers 
were designed using Primer3 software (available on-line: http://frodo.wi.mit.edu/). 
DNA sequence alignments were done were carried out using the ClustalW2 multiple 
sequence alignment program available online from the European Institute of 
Bioinformatics (http://www.ebi.ac.uk/Tools/clustalw2/index.html). Homology searches 
were done by blast programmes (http://blast.ncbi.nlm.nih.gov/).  
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Chapter 3: Construction of null mutants of B. anthracis 
This chapter contains description of the strategy of construction of mutants and how the 
constructed mutants were verified.  
3.1 Strategy of mutant construction  
The first mutants constructed for investigation of the secondary translocase of B. 
anthracis, prior to this thesis project, were ΔsecA2 and ΔsecY2. Their analysis revealed 
that SecA2 but not SecY2 is necessary for secretion of two proteins: Sap and EA1 (Pohl 
et al., unpublished). Additional mutants: ΔsecH, ΔsecA2H, ΔprsAA, ΔprsAB, ΔprsAC, 
Δsap-eag were constructed as a part of this thesis and analysed together with ΔsecA2 
and ΔsecY2. Their construction was performed by deletion of the target gene using the 
selectable marker approach described below. Genes of selectable markers such as 
antibiotic resistance are commonly used to facilitate the introduction or deletion of 
genes in the genome. Such markers are therefore used for the selection of clones with 
gene deletions or additions. This was the approach used to construct mutants with 
deletion of genes encoding elements of the secondary translocation system of B. 
anthracis, as shown on the example of construction of ΔsecA2 (Figure 3.1). Plasmid 
pUTE583, encoding, chloramphenicol and erythromycin resistance and a multi-cloning 
site, was used for this purpose. The plasmid also contains two origins of replication – 
one functioning in E. coli and another one in members of B. cereus group. An 
integration fragment carrying a kanamycin resistance cassette (ΩKm) surrounded by 5’ 
and 3’ flanking sequences of the target gene – of secA2 in this example - were cloned 
into the pUTE583 plasmid, giving rise to the integration vector pSA102. The 
construction of pSA102 was carried out using the E. coli XL-I blue strain as an 
intermediate host. Subsequently, pSA102 was passaged through a Dam and Dcm 
methylase-deficient strain of E. coli (GM48) as this process improves the efficiency of 
transformation into B. anthracis (Marrero and Welkos, 1995). Following transformation 
of the integration vector, a double crossover RecA-mediated integration (allelic 
replacement) event resulted in the target gene being replaced with integration fragment. 
As a result, the target gene was excised from the chromosome. The mutant strain 
carrying the targeted gene knock-out as well as the integration plasmid now containing 
the target gene was counter selected to lose the plasmid, so that the desired mutant 
genotype was achieved. The counter-selection involves passaging the mutant though 
numerous generations in liquid culture in the presence of kanamycin (to which 
resistance is encoded by ΩKm cassette of the integration fragment), but in the absence 
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of erythromycin (to which resistance gene is associated with the pUTE583 vector). 
Subcultures of the broth were plated onto agar and the resulting colonies subjected to 
the replica-plating onto plates with kanamycin and erythromycin. This procedure was 
continued until erythromycin-sensitive but kanamycin-resistant clones were identified, 
representing the required potential knockout strains. All other null mutants in this study 
were constructed in the similar way. 
 
 
 
 
 
 
 
 
 
Figure 3.1: Construction of SA102 mutant. The mutant was constructed via the plasmid 
pSA102 carrying the integration fragment: 5’ secA2 flanking fragment (upstream) - 
omega Km cassette - 3’ secA2 flanking fragment (downstream). The plasmid was 
generated by cloning the integration fragment into XbaI/HindIII restriction sites of 
pUTE583 plasmid. Upon transformation, the homologues recombination replaced the 
secA2 gene with the integration, generating the SA102 mutant. pSA102 is pUTE583-
based plasmid, which possesses chloramphenicol-resistance gene (Cm), erythromycin-
resistance gene (Em), two origins of replication: (1) pUCori: functioning in E. coli; (2) 
pBC16: functioning in B. anthracis. 
 
The deletion of the target genes was confirmed by diagnostic PCR and Northern 
blotting. Diagnostic PCR was done using following sets of primers: (i) forward 
upstream and reverse downstream primer; (ii) forward chromosomal and reverse 
primers binding within kanamycin cassette - schematic representation of the diagnostic 
PCR fragments and primers is shown on the Figure 3.2.  
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3.2 Construction B. anthracis ∆secH mutant 
Previous work has shown that SecA2 is required for the secretion of a subset of 
proteins, namely Sap and EA1 and possibly other unidentified substrates, even in the 
presence of SecA1. This observation implies the presence of a specificity factor that 
facilitates the interaction between SecA2 and its substrates and/or prevents the 
interaction of these substrates with SecA1. In an attempt to identify that specificity 
factor, the genomic context of secA2 in the members of Bacillus cereus group was 
analysed (Figure 3.3). Whenever secA2 is found in the genomes of members of this 
group, the same gene is located downstream. This gene, with the locus tag BA0881 
represented a target specificity gene and was therefore subjected to detailed analysis. 
For reasons that will become clear later in Section 4, BA0881 was renamed secH. To 
evaluate the impact of SecH on secretion, a B. anthracis ∆secH mutant was constructed. 
Deletion of secH was confirmed by diagnostic PCR (Figure 3.4), according to the 
principle shown on the Figure 3.2. 
 
Figure 3.2: Diagnostic PCR to confirm the deletion of the target gene and correct 
integration of the integration fragment into the chromosome. Two sets of primers 
were used: (1) chromosomal_fwd, which binds to the chromosome upstream the 
integration fragment, and Km_internal_rev primer amplify fragment 1 which both 
confirms chromosomal integration of the ΩKm cassette and the deletion of the target 
gene; the control PCR reaction with chromosomal DNA of the wild type strain is not 
expected to yield any product. 
(2) upstream_fwd and downstream_rev primers allow to verify that a complete 
fragment 2 is inserted, which corresponds to the combined size of: upstream fragment 
– kanamycin cassette (Ω Km) – downstream fragment; the control PCR reaction of 
the chromosomal DNA of the wild type strain will yield a fragment the size of: 
upstream fragment – target gene – downstream fragment. 
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Figure 3.3: Alignment of chromosomal sequences in the gene neighbourhoods 
associated the secA2 in members of B. cereus group. Homologous genes are shown in 
the same colours. Aligned secA2 and 0881 (renamed secH) genes are shown in the red 
frames annotated as A2 and H, respectively. Ban, Bacillus anthracis; Bce, Bacillus 
cereus; Bth, Bacillus thuringiensis; Bwe, Bacillus weihenstephanensis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Confirmation of absence of secH in B. anthracis ΔsecH. Lane M: 1 kb 
molecular ladder (Promega); Lanes 1 and 2:  PCR product amplified with 
secH_chromosomal_fwd and Km_internal_rev with template of chromosomal DNA 
of B. anthracis ΔsecH (expected product size 1052 bp) and B. anthracis wild type (no 
product expected - negative control), respectively. Lanes 3,4,5: PCR product 
amplified with secH_upstream_fwd and secH_downstream_rev with template of 
chromosomal DNA of B. anthracis ΔsecH (expected product size 3087 bp),                
B. anthracis wild type (expected product size 2574 bp) and no DNA (no product 
expected), respectively. 
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3.3 Construction of B. anthracis ΔsecA2H  
The secA2-secH-null mutant of B. anthracis (ΔsecA2H) was constructed for the purpose 
of complementation analysis to verify essentiality of SecA2 and SecH for secretion of 
Sap and EA1. The construction of ΔsecA2H was confirmed by the diagnostic PCR 
(Figure 3.5).  
                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4 Construction of ΔprsAA, ΔprsAB, ΔprsAC mutants of B.anthracis. 
 
B. anthracis has three PrsA-like proteins: PrsAA, PrsAB and PrsAC. The genes 
encoding those foldases: prsAA, prsAB, prsAC are predicted to be transcribed as 
monocistronic transcripts with their genomic contexts shown on the Figure 3.6.  
                                            
 
 
Figure 3.6: Genomic context of prsAA, prsAB and prsAC. Predicted promoters and 
terminators of prsAA, prsAB, prsAC are represented by angled arrows and omega-
like symbols, respectively.  
Figure 3.5: Confirmation of absence of secA2 and secH in B. anthracis ∆secA2H. Lane 
M: 1 kb molecular ladder (Promega); Lanes 1 and 2: PCR product amplified with 
secA2 chromosomal_fwd and Km_internal_rev with template of chromosomal DNA of 
∆secA2H (expected product size 1128 bp) and B. anthracis wt (no product expected - 
negative control), respectively. Lanes 3,4,5: PCR product amplified with 
secA2_upstream_fwd and secH_downstream_rev with template of chromosomal DNA of 
∆secA2H (expected product size 3870 bp), B. anthracis wt (expected product size 5021 
bp) and no DNA (no product expected), respectively. 
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With the aim to identify substrates for the B. anthracis PrsA-like proteins, ΔprsAA, 
ΔprsAB, ΔprsAC mutants were constructed. Their construction was confirmed by 
diagnostic PCR (Figure  3.7), according to the principle depicted on the Figure 3.2. The 
absence of expression of prsAA and prsAB was confirmed by Northern blotting in 
ΔprsAA and ΔprsAB, respectively (Figure 3.8). 
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Figure 3.7: The confirmation of absence of the prsA-like genes of B. anthracis by 
diagnostic PCR.  
 
A confirmation of absence of prsAA in B. anthracis ΔprsAA. Lanes 1 and 2 :  
PCR product amplified with prsAA_chromosomal_fwd and Km_internal_rev with 
template of chromosomal DNA of B. anthracis ΔprsAA (expected product size 1384 
bp) and B. anthracis wt (no product expected - negative control, unspecific product 
of approx. 900 bp visible, lack of prsAA expression confirmed by the Northern 
blotting: Figure 3.8), respectively. Lanes 3,4,5: PCR product amplified with 
prsAA_upstream_fwd and prsAA_downstream_rev with template of chromosomal 
DNA of B. anthracis ΔprsAA (expected product size 4000 bp), B. anthracis wt 
(expected product size 2714 bp) and no DNA (no product expected), respectively. 
 
B confirmation of absence of prsAB in B. anthracis ΔprsAB. Lanes 1 and 2 :  
PCR product amplified with prsAB_chromosomal_fwd and Km_internal_rev with 
template of chromosomal DNA of B. anthracis ΔprsAB (expected product size 1148 
bp) and B.anthracis wt (no product expected - negative control), respectively.    
Lanes 3,4,5: PCR product amplified with prsAB_upstream_fwd and 
prsAB_downstream_rev with template of chromosomal DNA of B. anthracis ΔprsAB 
(expected product size 3831 bp), B. anthracis wt (expected product size 2591 bp) and 
no DNA (no product expected), respectively. 
 
C confirmation of absence of prsAC in B. anthracis ΔprsAC. Lanes 1 and 2 :  
PCR product amplified with prsAC_chromosomal_fwd and Km_internal_rev with 
template of chromosomal DNA of B. anthracis ΔprsAC (expected product size 1027 
bp) and B.anthracis wt (no product expected - negative control), respectively. Lanes 
3,4,5: PCR product amplified with prsAC_upstream_fwd and 
prsAC_downstream_rev with template of chromosomal DNA of B. anthracis ΔprsAC 
(expected product size 3836 bp), B. anthracis wt (expected product size 2674 bp) and 
no DNA (no product expected), respectively.  
 
Lane M: 1 kb molecular ladder (Promega) 
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3.5 Construction of the B. anthracis ∆sap-eag mutant 
B. anthracis ∆sap-eag mutant was constructed to serve as a negative control strain in 
the subsequent experiments. The construction of B. anthracis ∆sap-eag was confirmed 
by diagnostic PCR (Figure 3.9). 
 
                                                              
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: The confirmation of absence of sap and eag in B. anthracis ∆sap-eag.  
Lane M: 1 kb molecular ladder (Promega); Lanes 1 and 2 : PCR product amplified 
with sap_chromosomal_fwd and Km_internal_rev with template of chromosomal DNA 
of B. anthracis ∆sap-eag (expected product size 1382 bp) and B. anthracis wt (no 
product expected - negative control), respectively. Lanes 3,4,5: PCR product amplified 
with sap_upstream_fwd and eag_downstream_rev with template of chromosomal DNA 
of B. anthracis ∆sap-eag (expected product size 3980 bp), B. anthracis wt (expected 
product size 7619 bp) and no DNA (no product expected), respectively. 
Figure 3.8: Northern blots confirming absence of expression of prsAA and 
prsAB in B. anthracis ΔprsAA and ΔprsAB, respectively. A: blot with 
prsAA-specific probe on RNA of: (1) B. anthracis wild type, (2) ΔprsAA; 
(B) blot with prsAB-specific probe on RNA of: (1) B. anthracis wild type, 
(2) B. anthracis ΔprsAB. 
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Summary 
Prior to this thesis, it was found that B. anthracis might possess a secondary 
translocation system encompassing SecA2 and SecY2. SecA2 but not SecY2 turned out 
to be involved in the secretion of S-layer proteins: Sap and EA1 (Pohl et al., 
unpublished). To learn more about SecA2-based secondary translocase, a range of null 
mutants: ΔsecH, ΔsecA2H, ΔprsAA, ΔprsAB, ΔprsAC, Δsap-eag was generated for 
subsequent analysis to be performed together with previously constructed mutants 
ΔsecA2 and ΔsecY2. Out of the deleted genes, the role of BA0881 was not previously 
investigated. As this gene is located in the same operon as secA2, we thought that it 
might be implicated in the SecA2-mediated translocation, possibly conferring SecA2 
specificity to its substrates. We re-named BA0881 as ‘secH’.  
Acknowledgement: Northern blotting experiments were done in collaboration with             
Dr. Susanne Pohl. 
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Chapter 4: Investigation of protein secretion in B. anthracis ΔsecH and 
ΔsecA2H 
4.1 SecH enhances EA1 and Sap secretion 
We found that BA0881 gene (renamed as secH) is located downstream secA2 in the 
same operon (Section 3.2) suggesting that BA0881 (SecH) could be implicated in 
SecA2-mediated secretion of Sap and EA1. To evaluate that, extracellular proteins were 
extracted (Section 2.9.1) from ΔsecH and subjected to SDS-PAGE and 2D-PAGE. SDS-
PAGE analysis showed that, as compared to the wild type strain, the ΔsecH mutant has 
a reduced ability to secrete Sap and EA1. However, unlike the secA2 mutant, it was 
still capable of secreting significant amounts of the surface associated proteins (Figure 
4.1). This data were confirmed by 2D-PAGE analysis, clearly showing a reduction is 
Sap and EA1 secretion compared with the wild type strain (Figure 4.2). Deletion of 
secH therefore decreases, but does not abolish Sap and EA1 secretion, indicating that 
SecH is required for the efficient secretion of these proteins. Thus, SecH seems to be a 
factor conferring partial specificity of SecA2 to its substrates; however, other specificity 
factor(s) remain to be identified. As BA0881 was clearly shown to encode a protein 
involved in secretion, it justified renaming it as secH, as ‘’H’’ was next free letter 
available in the nomenclature of the components of the Sec pathway.  
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Figure 4.1: SDS-PAGE analysis of the extracellular proteins in the supernatant fraction 
of strains B. anthracis wild type, ΔsecA2, ΔsecH. As Sap and EA1 are similar in size, 
they are visible as single band – of approximately 90 kDa on the Tris-Glycin gel. 
LMW-SDS marker (GE Healthcare) was used. 
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4.2 Complementation of B. anthracis ∆secA2H to confirm that SecA2, but not 
SecH, is essential for Sap and EA1 secretion 
A complementation approach was used to confirm that SecA2 but not SecH is necessary 
for Sap and EA1 secretion. For that purpose we decided to clone secA2 and secH gene 
individually and in combination, into an expression vector, so that those genes could be 
expressed in B. anthracis ∆secA2H, and so that the effect of that expression on Sap and 
EA1 secretion could be investigated. Since a suitable expression plasmid was not 
available, the first task was to construct such a plasmid that was able to replicate in      
B. anthracis and which would possess an inducible promoter from which the gene of 
interest could be expressed. Next, the constructed expression plasmid was transformed 
into B. anthracis to analyse the influence of various Sec pathway components on the 
secretion of Sap and EA1. 
4.2.1 Construction of the complementation plasmid 
In the first instance we attempted to use existing plasmids previously used for the 
expression of genes in the related B. subtilis, namely pLOSS and pHT01. We therefore 
attempted to transform B. anthracis with pLOSS and pHT01. However, no 
transformants were obtained after repeated attempts, presumably because origins of 
replication on those vectors are not functional in B. anthracis. Therefore, an expression 
Figure 4.2: False-coloured 2D gel overlays of B. anthracis extracellular proteins 
isolated from the wild-type and the ΔsecH mutant. The extracellular proteome of 
ΔsecH showed a reduction but not the abolishment in the secretion of the major 
surface-associated antigens, Sap and EA1 (orange spots).  
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vector specific for B. anthracis was constructed based on pUTE583, used previously to 
construct null mutants (Section 3.1). A fragment from pHT01 encoding the IPTG-
inducible Pgrac promoter and lacI repressor gene was cloned into pUTE583 to obtain 
pKG400 (Figure 4.3).  
 
Figure 4.3: Construction of the B. anthracis expression vector pKG400. A fragment 
encoding the IPTG-inducible Pgrac promoter and lacI repressor gene was excised from 
pHT01 following digestion with SacI and SmaI restriction enzymes. The resulting 
fragment was ligated into pUTE583 digested with the same enzymes to generate 
pKG400. Apart from Pgrac promoter and lacI repressor gene, pKG400 also contains 
pUTE583-related sequences: chloramphenicol-resistance gene (Cm), erythromycin-
resistance gene (Em), two origins of replication: one functioning in E. coli (pUCori) and 
another one in B. anthracis (pBC16). 
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4.2.2 Complementation of B. anthracis ∆secA2H to confirm that SecA2, but not 
SecH, is essential for Sap and EA1 secretion 
Previously, we found that SecA2 is necessary for secretion of Sap and EA1, while SecH 
enhances secretion of these proteins, but is not essential for this process. To establish 
whether SecA2 alone, or a combination of SecA2 and SecH was responsible for the 
failure to secrete Sap and EA1, a ∆secA2-secH double null mutant (called ∆secA2H) 
was generated and complemented with: (i) secA2; (ii) secH; (iii) secA2, secH. Using 
pKG400 as the expression vector, the following complementation plasmids were 
constructed: pKG401 (pKG400-secA2-secH), pKG402 (pKG400-secA2), and pKG403 
(pKG400-secH). The plasmids were transformed into B. anthracis ∆secA2H and 
expression of the genes of interest was induced at an OD600=0.8 with 10 mM IPTG, 
followed by incubation for a further 90 minutes and extraction of proteins from the 
supernatant fraction (Section 2.9.2). The extracellular proteins of the complementation 
strains, with and without induction, were analysed by SDS-PAGE (Figure 4.4). The data 
showed that Sap and EA1 secretion was restored in the ∆secA2H mutant following 
complementation with secA2-secH (pKG401) and secA2 (pKG402), but not with secH 
(pKG403). This confirmed previous data that SecA2 but not SecH was essential for Sap 
and EA1 secretion.  
 
 
 
 
 
Figure 4.4: SDS-PAGE gel of the extracted proteins of supernatant fractions of the 
∆secA2H (B. anthracis ∆secA2-secH) complemented with: (1) secA2 and secH; (2) 
secA2; (3) secH. The expression of the target genes located on pKG400 was induced 
with 10 mM IPTG (+). The non-induced plasmid-containing strains were used as 
controls (-). The sample extracted from the culture media of B. anthracis wild type 
was used as a positive control for Sap and EA1 secretion. Marker = PageRuler™ 
Prestained Protein Ladder (Fermentas).   
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4.3 Discussion 
The question that arises in relation to SecA2, and that was addressed in this thesis, is 
what confers SecA2 specificity to its substrates? Analysis of the signal peptides of Sap 
and EA1 revealed that they are almost identical, except for a single conservative amino 
acid substitution at position 23. Since signal peptides are known to be involved in 
targeting secretory preprotein substrates to the secretion apparatus, it is likely that they 
are at least partially involved in the determining substrate specificity. Additionally, the 
bioinformatic analysis of the genomic context of secA2 revealed that whenever secA2 is 
found in the genome of a member of the B. cereus group, including, B. anthracis, the 
same gene is located downstream and in the same operon. In B. anthracis Ames this 
gene is annotated as BA0881. As a result of the reduction in Sap and EA1 secretion in a 
BA0881-null mutant, as shown by SDS-PAGE and 2D-PAGE analyses, we have 
renamed this gene a secH. SecH enhances the secretion of Sap and EA1, but is not 
essential for this process. Complementation of the ΔsecA2H mutant, both jointly and 
individually with secA2 and secH, confirmed that SecA2 alone without the participation 
of SecH is able to drive the secretion of EA1 and Sap while SecH does not. This 
observation reinforces the view that SecH is an accessory component of the secondary 
translocation system that serves to enhance the efficiency of EA1 and Sap secretion. 
However, these results mean that there must exist another, yet not detected, factor which 
directs EA1 and Sap specifically to SecA2 instead of SecA1. It would be possible that 
the specificity factor would be preventing interaction of Sap and EA1 with SecA1 and 
facilitating the interaction with SecA2. 
In relation to the observed SecA2 specificity towards Sap and EA1, it might be 
also possible that SecA2 is responsible not for the secretion of those of proteins, but it 
might be involved in the secretion of other proteins that are part of the secretion 
machinery. For example, SecA2 could be responsible for the secretion of a foldase 
involved in folding of Sap and EA1 on the cell surface. Lack of that foldase would lead 
to the degradation of S-layers proteins and consequently to their absence in the 
secretome. Similarly, lack of one or more of the seven Sip signal peptidases, could also 
lead to the absence of Sap and EA1 in the secretome. At the moment it is not known if 
Sip signal peptidases have any substrate specificity. It can not be excluded that Sap and 
EA1 are substrates for a specific Sip and that that Sip is a substrate for SecA2. Equally, 
it can not be excluded that Sap and EA1 are substrates for a foldase which is, in turn, a 
substrate for SecA2.  
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Chapter 5: Studies of the B. anthracis secondary translocase in  
B. subtilis 
 
5.1 Complementation analysis of SecY of B. subtilis (Bsu SecY) by SecY2 of B. 
anthracis (Ban SecY2) 
 
5.1.1 Introduction 
It has been shown previously that B. anthracis SecA1 but not SecA2 can complement B. 
subtilis SecA. We now wished to determine whether B. anthracis SecY2 could 
complement B. subtilis SecY. SecY2 shows a high level of similarity to both Bsu SecY 
and Ban SecY1, and recent evidence has emerged that its role is to maintain secretion 
capacity during the stationary phase of the growth cycle (Pohl et al., unpublished). This 
would require it to form an active translocase that interacts with both SecA1 and SecA2 
rather than with SecA2 alone. To investigate this possibility we decided to check if Ban 
SecY2 can complement Bsu SecY. In B. subtilis, complementation can be carried out by 
locating the test gene on the chromosome at an ectopic location under the control of an 
inducible promoter. The target gene is then placed under the control of a different 
controllable promoter. This system allows both the target and the test gene to be 
expressed independently. In the present study the complementation system was 
established using integration vectors. First, the 5’ end of the target gene was cloned into 
an integration vector in such a way that it placed its expression under the control of an 
IPTG inducible promoter. Upon transformation into B. subtilis, the vector was 
integrated into the chromosome via a single crossover recombination. The test gene was 
cloned intact under the control of a xylose-inducible promoter and introduced into the 
amyE locus via a double crossover recombination. Once the complementation strain 
was established, the addition of either IPTG or xylose to the growth medium should 
allow the growth and phenotype of the cells to be established when either the test or 
target protein is being synthesised. A main limitation of this approach is the polar 
effects of the integration event on genes downstream of the target gene. In the case of 
secY, two known essential genes, adk (adenylate kinase) and map (methionine 
aminopeptidase), are located downstream and in the same operon. This means that 
irrespective of the expression of secY, the lack of induction of adk and map would lead 
to cell death. 
This SecY complementation study employed two types of integration vector: (i) 
pMUTIN4, a single crossover vector with an IPTG-inducible Pspac promoter and (ii) 
pJPRI, a double crossover replacement vector that is targeted to the amyE locus and 
 
72 Chapter 5: Studies of the B. anthracis secondary translocase in B.subtilis 
xylose-inducible promoter. In this study, the 5’ end of Bsu secY gene, together with its 
ribosome binding site, was amplified and cloned into pMUTIN4 downstream of the Pspac 
promoter. Upon transformation into B. subtilis selecting for erythromycin resistance, a 
single crossover recombination leads the integration of the vector into the chromosome 
in such a way that secY is placed under control of Pspac promoter. Thus the target secY 
can be expressed only in the presence of IPTG. SecY is essential for viability, thus the 
growth of the mutant with secY under control of Pspac promoter should be dependent on 
the presence of IPTG.    
The secY2, adk, map genes from B. anthracis were inserted into pJPRI. Upon 
transformation and selection for chloramphenicol resistance, a double crossover 
recombination at the amyE locus places the test gene under control of the xylose-
dependent promoter. As integration takes place within the amyE gene, which encodes α-
amylase AmyE, the ability of the mutant to hydrolyse starch becomes reduced: when 
grown on starch agar and stained with iodine, a reduced zone of starch hydrolysis is 
visible around individual colonies.   
The B. subtilis strain used for the complementation test was constructed with 
both vectors integrated into the chromosome, placing secY under the control of the 
IPTG-inducible promoter and secY2 under the control of the xylose-inducible promoter. 
If SecY2 can complement SecY, then the complementation strain should be able to 
grow in the presence of xylose and the absence of IPTG. For the reasons mentioned 
earlier in this section, the complementation strategy needed to be modified to include 
copies of adk and map downstream of the B. anthracis secY2. Induction with xylose 
would therefore lead to the production of SecY2, Adk and Map, compensating for the 
absence of the latter two enzymes in the absence of IPTG. The genomic map of secY 
and secY2 loci of the mutant to be created is depicted graphically in the Figure 5.1. 
 
Bsu secY adk map Ban secY2 adk map
pMUTIN4-based insert pJPR1-based insert
PxylPspac
 
Figure 5.1: The genomic map of secY and secY2 loci of the mutant strain for 
complementation analysis of Bsu SecY by Ban SecY2. 
 
 
 
 
 
 
73 Chapter 5: Studies of the B. anthracis secondary translocase in B.subtilis 
5.1.2 Construction of a B. subtilis 168 mutant for the complementation analysis 
using pMUTIN4 and pJPRI 
 
In order to construct a strain of B. subtilis for the complementation analysis of Bsu 
SecY by Ban SecY2, the following recombinant plasmids were constructed: pMUTIN4-
secY5’ (pKG101) and pJPRI-secY2-adk-map (pKG203). In the case of the construction 
of the pMUTIN4-based mutant, the 5’ end of Bsu secY, including its RBS (370bp) was 
amplified using primers secY_fwd and secY_rev. Next both, the amplified fragment and 
pMUTIN4 were subjected to the restriction digestion with BamHI and NotI and were 
ligated together. The ligation products were transformed into E. coli TOP10 and the 
transformants were selected on LB agar containing ampicillin. Recombinant plasmid 
(pKG101) was recovered and subjected to a diagnostic PCR reaction (Figure 5.3), 
restriction digest and sequencing to confirm the presence of the required insert in the 
vector.  
Construction of the recombinant pJPRI (pKG203) vector involved the 
amplification and subsequent cloning of three full-length genes into the vector: B. 
anthracis secY2, B. subtilis adk and map. secY2 was amplified primers: secY2_fwd and 
secY_rev. adk and map were amplified with one set of primers: adk_fwd and map_rev. 
Next secY2 and adk-map amplified fragments were subjected to the restriction digestion 
with restriction enzymes BamHI, SpeI, and SpeI, NotI, respectively. The secY2 and adk-
map fragments were ligated separately into pJPRI, to generate pJPRI-secY2 (pKG201) 
and pJPRI-adk-map (pKG202), respectively. In the next stage, the adk-map fragment of 
pKG202 was cloned into pKG201 downstream of secY2, through ligation into SpeI and 
NotI restriction sites, resulting in plasmid pJPRI-secY2-adk-map (pKG203) (Figure 
5.2). The presence of the required fragments was confirmed by PCR, restriction digest 
(Figure 5.4) and sequencing.  
                         
 
Figure 5.2: Genetic map of pKG203 with secY2, adk, map under control of 
xylose-dependent promoter. 5’amyE and amyE3’: 5’ and 3’ terminus of 
amyE locus, respectively; cat: chloramphenicol resistance gene; bla: β-
lactamase gene, ori_Eco: origin of replication. 
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Attempts were made to transform plasmids pKG101 and pKG203 into B. subtilis 168. 
The repeated attempts made to transform pKG101 into B. subtilis to create B. subtilis 
secY::pMUT-Bsu-secY-F (KG101) were unsuccessful. In contrast, transformation of 
pKG203 into the amyE locus was successful, generating strain KG203 (amyE::Pxyl Bsu 
secY2-adk-map). The KG203 transformants were selected on LB plates containing 
chloramphenicol and xylose. The integration of pKG203 to the target amyE locus was 
initially confirmed by growing the transformants on the LB-starch agar to confirm that 
the transformants exhibited reduced zones of starch hydrolysis, indicating that the amyE 
gene had been inactivated. The authenticity of the insert was subsequently verified by 
diagnostic PCR using primers for: (1) the insert (secY2_fwd & map_rev), (2) the Pxyl 
promoter located upstream the insert (Pxyl_fwd) and (3) the sequence downstream the 
insert (amyE_rev) (Figure 5.5).  
Figure 5.3: Confirmation of the 
presence of secY in pKG101 by 
PCR. Lanes 1: 2-log molecular 
marker (NEB). Lanes 2-7: PCR 
products (370 bp) of clones 1-6, 
respectively; Lane 7: positive 
control (chromosomal DNA of B. 
subtilis as a template); Lane 8: 
negative control (no DNA). 
Figure 5.4: Confirmation of 
presence of secY2, adk and map in 
pKG203 by a restriction triple 
digest. Lane 1: 1 kb molecular 
marker (Promega). Lanes 1-4: 
pKG203 digested with enzymes: 
BamHI, SpeI, NotI, clones 1-4, 
respectively. Size of inserts: secY2 
(1406 bp); adk-map (1459 bp). 
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Figure 5.5: Diagnostic PCR to confirm the presence and orientation of secY2-adk-map 
fragment in strain KG203. (A) Schematic representation of secY2-adk-map region in 
KG203 after integration of pKG203. Filled thick arrows represent structural genes. The 
amyE integration site is represented by green boxes and the amyE promoter (PamyE) and 
xylose-inducible promoter (Pxyl) represented by a thick, angled arrows. The arrows 
beneath the genes indicate the location and the orientation of the primers, while thick 
lines indicate their expected PCR products. (B) Gel separated PCR products of the 
diagnostic PCR verifying the correct construction of KG203. Lane M: 1 kb molecular 
ladder (Promega); Lanes 1-6: PCR products amplified with following sets of primers: 
(1) Lane 1:  secY2_fwd & map_rev, expected product size 2871 bp (2) Lane 2: Pxyl 
_fwd and secY2_rev, expected product size 1515 bp; (3) Lane 3: Pxyl _fwd and 
map_rev, expected product size 2981 bp; (4) Lane 4: secY2_fwd & amyE_rev, expected 
product size 3337 bp; (5) Lane 5: adk_fwd & amyE_rev, expected product size 1934 
bp; (6) Lane 6: Pxyl _fwd and amyE_rev, expected product size 3447 bp.  
 
Strain KG203 was subsequently transformed with pMAP65 (generating strain KG204). 
pMAP65 encodes an additional copy of lacI repressor gene that reduces the non-
induced level of expression of the pMUTIN4-derived Pspac promoter. KG204 was then 
transformed with pKG101, selecting 13 transformants of KG205 on LB agar 
supplemented with erythromycin, lincomycin, chloramphenicol with inducers IPTG and 
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xylose. Diagnostic PCR was used to determine whether pKG101 had integrated into the 
secY locus of KG205. However, this transformant failed to generate the PCR amplicons 
expected for the integrant (Figure 5.6). Specifically, a PCR product was generated with 
primers Pmut_fwd and Pmut_rev, which are located upstream and downstream of the 
cloned gene, respectively, in pMUTIN4. Following pMUTIN4 integration into the 
chromosome these primers should become oriented away from each other, so no PCR 
product should have been generated with this primer pair. These results suggested that 
the integration of pKG101 did not occur correctly and consequently that secY was not 
put under control of Pspac (IPTG-inducible) promoter in KG205.    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: Diagnostic PCR to confirm the presence and orientation of secY in KG205. 
(A) Schematic representation secY region of KG205 after integration of pMUT- secY-F. 
Filled arrows represent structural genes: the lacZ reporter gene, lacI, secY, ampicillin 
(Amp
R
), erythromycin (Em
R
) resistance genes. secYΔ is 5’-end of secY. Promoters (PsecY 
and PSPAC ) are marked with a thick, angled arrow. The arrows below the genes indicate 
the location and orientation of the oligonucleotide primers, whilst the bold lines indicate 
their expected PCR products. The numbers above the bold lines correspond to the lanes 
of the agarose electrophoresis gels shown in panels B. (B) Gel separated PCR products 
of the diagnostic PCR verifying the correct construction of KG205. Lanes M: 100 bp 
molecular marker (Promega); Lanes 1-4: amplified with following sets of primers: 
Lane 1: secY_ins_fwd & secY_ins_rev, expected product size 370 bp; Lane 2: 
secY_ins_fwd and Pmut_rev, expected product size 430 bp; Lane 3: Pmut_fwd and 
secY_ins_rev, expected product size 514 bp; Lane 4: Pmut_fwd & Pmut_rev, no product 
expected in KG205. 
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In spite of the apparent failure to integrate pKG101 correctly into the 
chromosome, the dependency of KG205 strain on the inducers IPTG and xylose was 
tested. Two clones KG205-1 and KG205-12 were inoculated into LB broth (25 ml) 
containing erythromycin, lincomycin, chloramphenicol, kanamycin, IPTG and xylose 
and their cultures were incubated for five to six hours until it reached exponential phase. 
Following three washings with LB broth without any supplements, serial dilutions of 
the culture were plated on LB agar with erythromycin, lincomycin, kanamycin, 
chloramphenicol and (1) without inducers (IPTG or xylose), (2) with IPTG, (3) with 
xylose. Both clones were dependent on xylose, forming big colonies on the plates with 
xylose (colonies of KG205-1 are shown on Figure 5.7), but colony count from a xylose 
plate of the clone 1 was 10-fold higher on agar with xylose than on the agar with IPTG 
or without any inducer, while bacterial count of the clone 12 didn't exhibit a significant 
difference (Figure 5.8). 
LB agar with 
xylose
LB agar
without  
inducers
LB agar with 
IPTG
 
Figure 5.7: Growth of xylose-dependant clone KG205-1 on the LB agar with 
erythromycin and lincomycin and without inducers (10
-4
 dilution shown) or with 
inducers (xylose (10
-6
 dilution shown) or IPTG (10
-4
 dilution shown)).  
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Figure 5.8: Determination of the dependency of KG205 on xylose. The strain was 
grown on LB agar supplemented with: (1) neither IPTG nor xylose, (2) 1 mM IPTG, (3) 
1 % (w/v) xylose.  
 
However, when colonies of clones 1 and 12 growing on a xylose plate were 
subsequently restreaked onto an LB agar plate with or without inducers, then both 
clones grew only in the presence of xylose (Figure 5.9).  
                          
Figure 5.9: Growth of xylose-dependant KG205-1 and KG205-12 restreaked from 
dilution plate with xylose onto the LB agar with erythromycin and lincomycin and 
without or with inducers (xylose and/or IPTG). 
 
This suggests that the original isolate was unstable and subject to a rearrangement 
potentially involving the inactivation of some or all of the native secY/adk/map genes, 
thus requiring these genes to be expressed from xylose-dependent promoter for its 
viability. However, KG205-1 and KG205-12, from the LB agar with xylose shown on 
the Figures 5.7 and 5.9 were not able to grow in LB broth with xylose, meaning that 
they lose their xylose-dependence in the liquid culture. Due to instability of KG205-1 
and KG205-12, further analysis of the mutant was not possible and this part of the 
project was discontinued.   
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5.2 The specificity of Sap and EA1 secretion is lost in B. subtilis 
B. anthracis encodes two homologues of B. subtilis SecA, namely SecA1 and SecA2. 
Analysis has shown that B. anthracis SecA1 but not SecA2 can functionally 
complement B. subtilis SecA. The deletion of secA2 in B. anthracis does not affect 
bacterial growth, but has a severe negative impact on the secretion of the two surface-
associated proteins, i.e. Sap and EA1. In the light of these findings, it was predicted that 
SecA2 functions to export a subset of proteins, namely Sap and EA1, which are either 
inefficiently exported via SecA1 or encode a specific SecA1 avoidance mechanism. 
Bioinformatic analysis revealed that the signal peptides of Sap and EA1 are almost 
identical, differing only by a single conservative substitution, suggesting that the signal 
peptides might be involved in conferring SecA2 specificity to its substrates (Pohl et al., 
unpublished). Secondly, we found that SecH protein enhances SecA2-mediated 
secretion of Sap and EA1. To investigate if signal peptide conferred SecA2 specificity 
to its substrates and to get more information on participation of SecH in facilitating of 
secretion of those substrates, the B. subtilis genome was engineered to produce Sap and 
EA1 as well as other elements of B. anthracis translocation system. Firstly, the ability 
of B. subtilis SecA (Bsu SecA) and B. anthracis SecA1 (Ban SecA1) to complement B. 
anthracis SecA2 (Ban SecA2) was analysed. Then, it was investigated how secretion of 
Sap and EA1 is influenced, in SecA and SecA1 backgrounds, by the presence of SecA2 
and SecH.  The common problem in B. subtilis is degradation of secretory proteins by 
the quality control proteases, once they have been translocate (Wong S-L., 1995). That 
is why, B. subtilis WB600 (strain deficient in six quality control proteases) was used as 
a host for the production of Sap and EA1 to decrease the risk of them being degraded.  
Analysis of complementation of Ban SecA2 by Bsu SecA 
Previous studies had shown that PrsAB was essential for the secretion of both Sap and 
EA1 in B. subtilis (Pohl et al., unpublished), and therefore two xylose-dependent 
operons (prsAB, sap and prsAB, eag) were selected for these studies. The operons were 
introduced into B. subtilis 168 via integration vector pJPRI, which is a double crossover 
replacement vector that is targeted to the amyE locus. Upon transformation and 
selection for chloramphenicol resistance, a double crossover recombination at the amyE 
locus placed the prsAB-sap and prsAB-eag under control of the xylose-dependent 
promoter, resulting in two strains AB06Jsap1 (amyE::prsAB-sap) (Figure 5.10A) and 
AB06Jeag1 (amyE::prsAB-eag) (Figure 5.10B).  
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SDS-PAGE analysis of proteins of the supernatant fraction showed, that when 
the expression of either prsAB, eag or prsAB, sap was induced in B. subtilis with xylose 
two additional bands were observed compared to the uninduced control (Figure 5.11). 
The bands had apparent molecular size of ~ 90 kDa and ~ 125 kDa. Since the estimated 
sizes of the mature Sap and EA1 proteins are 86.6 kDa and 91.4 kDa, respectively, the 
lower of the two bands (~ 90 kDa) was expected to represent the mature versions of 
these proteins. The question arises as to the nature of the bands at ~ 125 kDa. We 
considered the possibility that the lower (~ 90 kD) band corresponded to an unmodified 
version of Sap or EA1, but that the upper band was the result of translational read-
through from the upstream PrsAB gene, resulting in a fusion protein of Sap or EA1 with 
PrsAB. Since PrsAB is 34 kDa in size, this would generate a fusion protein of 
approximately the right size, namely ~ 120-125 kDa. However, the sequencing analysis 
of both proteins showed that they are translated in different reading frames and there is 
a single STOP codon between the two - sequencing of prsAB-eag junction in 
AB06Jeag1 strain showed that the STOP codon of prsAB was intact (Figure 5.12).  
                    
 
 
 
Figure 5.10: Genomic  map of amyE locus of (A) AB06Jsap1 and (B) AB06Jeag1 
Figure 5.11: Secretion of EA1 and Sap by Bsu SecA in B. subtilis. ‘-‘ = no 
xylose; ‘+’ = xylose addition (1% (w/v)). prsAB-eag: prsAB and eag genes; 
prsAB-eag: prsAB and eag genes. In the xylose induced samples, two additional 
bands of apparent molecular size of ~ 90 kDa and ~ 125 kDa are visible.  
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We therefore excised the representative ~ 125 kDa bands from the gel shown on the 
Figure 5.11 and subjected them to MALDI-TOF-MS analysis. In the case of the band 
corresponding to the strain expressing eag, the protein was identified as EA1 (Table 
6.1), while the band corresponding to the strain expressing sap, the protein was 
identified as Sap (Table 5.2). We re-analysed the mass spectrometry data by removing 
the peaks associated with either Sap or EA1 and reanalysing the data using the 
MASCOT software. None of the remaining peptides matched peptides from PrsAB, 
indicating that that a PrsAB-Sap/EA1 fusion was unlikely to account for the less mobile 
version of these S-layer proteins. Following this analysis, the most likely explanation 
for the two Sap/EA1 band that occur exclusively in B. subtilis is that they are due to 
their folding into structures that run aberrantly in SDS-PAGE gels. If this structure 
retards their motility in SDS-PAGE, then the larger bands might represent full-length 
copies of the respective proteins, while the smaller bands may represent a degradation 
product. Therefore the analysis of proteins in the culture supernatant by 2D-PAGE was 
performed (by Dr. Susanne Pohl) (Figures 5.13 and 5.14).  
 
 
prsAB-eag       TCTCCGCAAGGAAATTAAAAAAGCACAACCTTATTTTTTCAGATAAGGTTGTGCTTGGAT 
300 
sequenced       TCTCCGCAAGGAAATTAAAAAAGCACAACCTTATTTTTTCAGATAAGGTTGTGCTTGGAT 
128 
                ************************************************************ 
 
prsAB-eag       CCTAGCATATTCCTGAAGGAGGAAATTTATAAAATGGCAAAGACTAACTCTTACAAAAAA 
360 
sequenced       CCTAGCATATTCCTGAAGGAGGAAATTTATAAAATGGCAAAGACTAACTCTTACAAAAAA 
188 
                ************************************************************ 
 
prsAB-eag       GTAATCGCAGGTACAATGACAGCAGCAATGGTAGCAGGTATTGTATCTCCAGTAGCAGCA 
420 
sequenced       GTAATCGCAGGTACAATGACAGCAGCAATGGTAGCAGGTATTGTATCTCCAGTAGCAGCA 
248 
                ************************************************************ 
 
prsAB-eag       GCAGGTAAATCATTCCCAGACGTTCCAGCTGGACATTGGGCAGAAGGTTCTATTAATTAC 
480 
sequenced       GCAGGTAAATCATTCCCAGACGTTCCAGCTGGACATTGGGCAGAAGGTTCTATTAATTAC 
308 
                ************************************************************ 
 
prsAB-eag       TTAGTAGATAAAGGTGCAATTACAGGTAAGCCAGACGGTACATATGGTCCAACCGAATCA 
540 
sequenced       TTAGTAGATAAAGGTGCAATTACAGGTAAGCCAGACGGTACATATGGTCCAACCGAATCA 
368 
                ************************************************************ 
 
Figure 5.12: Alignment of sequences of the sequenced prsAB-eag junction in 
AB06Jeag1 with the template sequence. STOP codon of prsAB is highlighted in orange; 
START codon of eag is highlighted in green.  
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The induction of sap and eag expression together with prsAB results in the appearance 
of two bands consisting of clusters of spots. One spot of each band (upper and lower) 
was analysed by mass spectroscopy (MALDI-TOF-MS). Spot 1 of the upper band on 
the Figure 5.13B and spot 3 of the upper band on the Figure 5.14B were identified as 
full length, mature proteins of EA1 and Sap, respectively. The presence of the full 
length proteins was based on the detection by mass spectroscopy of peptides through the 
entire proteins, apart from the signal peptide (first thirty amino acids) (Figures 5.15 and 
5.17), which is absent from the mature, secreted protein. Spot 2, the lower band on the 
Figure 5.13: 2D PAGE analysis of the extracellular proteins of B. subtilis amyE:: 
prsAB_eag (AB06Jeag1) isolated from (A) non-induced sample  and (B) induced 
sample (xylose 1% w/v). EA1 is visible as two bands of spot clusters. Spots 1 and 2 
were excised from the gel and analysed by mass spectroscopy (MALDI-TOF-MS).  
Figure 5.14: 2D PAGE analysis of the extracellular proteins of B. subtilis 168 amyE:: 
prsAB_sap (AB06Jsap1) isolated from (A) non-induced sample and(B) induces sample 
(xylose 1% w/v). Sap is visible as two bands of spot clusters. Spots 3 and 4 were 
excised from the gel and analysed by mass spectroscopy (MALDI-TOF-MS).  
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Figure 5.13B and spot 4 of the lower band on the Figure 5.14B were identified as 
truncated proteins of EA1 and Sap, respectively. The N-terminal region of EA1 and Sap 
appears to be missing as the mass spectra obtained from these proteins generally lacked 
peptides corresponding to the first 200 amino acids (Figures 5.16 and 5.18). In the case 
of the spot 2 of the lower band of Sap (spot 4) a single mass spectroscopic peak 
corresponds in size to a single peptide within the first 200 residues. Since this was the 
only peptide that was putatively identified within this region, it was not considered 
significant. Overall, the mass spectroscopic analysis indicated that the higher molecular 
mass (upper) bands of Sap and EA1 observed in the supernatant fraction of B. subtilis 
were likely to correspond to the mature protein, which migrate aberrantly in SDS-PAGE 
gels, possibly due to the fact that they are structural protein that are not able to form 
globular-like structures in the presence of SDS and mercaptoethanol. The lower 
molecular band appears to be consistent with degradation products of mature EA1 and 
Sap proteins that are missing approximately 200 residues of their N-termini. This is 
likely to be the result of a proteolytic cleavage of EA1 and Sap occurring in B. subtilis 
but not their native host, B. anthracis. This is consistent with the common observation 
that heterologous proteins are degraded by quality control proteases (Wong S-L., 1995). 
The strain WB600 used here is deficient in six quality control proteases (Wu et al., 
1991), but this strain still exhibits some proteoltyic activity. Previously, it was observed  
that when endo-beta-1,4-glucanase was produced in B. subtilis WB600, two its forms 
could be found: the intact one and the partially cleaved one. However, when endo-beta-
1,4-glucanase was produced in B. subtilis WB700, which is deficient in seven proteases, 
then the enzyme was almost exclusively found in the intact form (Yang et al., 2004).  
So, the occurrence of truncated form of Sap and EA1 results from the proteolytic 
activity remaining in the WB600 strain. 
In conclusion, Bsu SecA can replace Ban SecA2 in respect to secretion of Sap 
and EA1 meaning that SecA2-related specificity of secretion of those proteins is lost in 
B. subtilis.  
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  1 MAKTNSYKKV IAGTMTAAMV AGVVSPVAAA GKTFPDVPAD HWGIDSINYL 
 51 VEKGAVKGND KGMFEPGKEL TRAEAATMMA QILNLPIDKD AKPSFADSQG 
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651 KEGKEVDATD AQVTVQNNSV ITVGQGAKAG ETYKVTVVLD GKLITTHSFK 
701 VVDTAPTAKG LAVEFTSTSL KEVAPNADLK AALLNILSVD GVPATTAKAT 
751 VSNVEFVSAD TNVVAENGTV GAKGATSIYV KNLTVVKDGK EQKVEFDKAV 
801 QVAVSIKEAK PATK 
 
Figure 5.15: The sequence of EA1 (including signal peptide in bold), showing 
(red) the peptides identified in spot 1 (Figure 5.13B) by MALDI-TOF-MS. 
Figure 5.16: The sequence of EA1 (including signal peptide in bold), showing 
(red) the peptides identified in spot 2 (Figure 5.13B) by MALDI-TOF-MS. 
 
Figure 5.17: The sequence of Sap (including signal peptide in bold), showing 
(red) the peptides identified in spot 3 (Figure 5.14B) by MALDI-TOF-MS. 
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Analysis of complementation of Ban SecA2 by Ban SecA1 
To gain new insights about SecA2 substrate recognition, Sap and EA1 secretion by Ban 
SecA1 was also investigated in B. subtilis. The strain of B. subtilis 168 was constructed 
in which Bsu secA was replaced with Ban secA1. To replace Bsu secA with Ban secA1, a 
gene replacement approach was used. The kanamycin resistance gene was cloned 
together with secA1 into vector pGEM in such a way that both the kanamycin resistance 
and secA1 genes were placed between flanking regions containing upstream and 
downstream of Bsu secA. Introduction of the recombinant plasmid into strains 
AB06Jsap1 (amyE::prsAB-sap) and AB06Jeag1 (amyE::prsAB-eag), followed by 
selection with kanamycin, resulted in isolation of clones of GQ32 (secA::secA1, 
amyE::prsAB-eag) and GQ34 (secA::secA1, amyE::prsAB-sap) in which the native Bsu 
secA had been replaced by Ban secA1. This was confirmed by diagnostic PCR. 
Unexpectedly, SecA1 facilitated effective secretion of both S-layer proteins, as when 
eag and sap expression was induced in B. subtilis by the addition of xylose, two 
additional and very prominent bands were observed with estimated sizes of ~ 90 kDa 
and ~ 125 kDa (Figure 5.19).  
In conclusion, Ban SecA1, like Bsu SecA, can replace Ban SecA2 in respect to 
secretion of Sap and EA1 meaning that SecA2-related specificity of secretion of those 
proteins is lost in B. subtilis.  
Figure 5.18: The sequence of Sap (including signal peptide in bold), showing 
(red) the peptides identified in spot 4 (Figure 5.14B) by MALDI-TOF-MS. 
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Figure 5.19: Secretion of EA1 and Sap by Ban SecA1 in GQ32 (secA::secA1, 
amyE::prsAB-eag) and GQ34 (secA::secA1, amyE::prsAB-sap) mutants of B.subtilis. ‘-‘ 
= no xylose; ‘+’ = xylose addition (1% (w/v)). prsAB-eag: prsAB and eag genes; prsAB-
eag: prsAB and eag genes. In the xylose induced samples, two additional bands of 
apparent molecular size of ~ 90 kDa and ~ 125 kDa are visible. 
 
Analysis of Sap and EA1 secretion, in SecA and SecA1 backgrounds, in the 
presence of SecA2 and SecH 
As SecH was shown to enhance the secretion of Sap and EA1 in B. anthracis, we 
considered the possibility that this protein was either involved in conferring SecA2 
specificity to its substrates and/or preventing their secretion by SecA1. Consequently, 
secH and secA2 was cloned into AB06Jeag1 (amyE::prsAB-eag) and GQ32 
(secA::secA1, amyE::prsAB-eag) individually or in combination. The introduction of 
those genes was performed via integration of pAX01 which is double crossover 
replacement vector that is targeted to the lacA locus. Upon transformation and selection 
for erythromycin resistance, a double crossover recombination, at the lacA locus, placed 
the secA2 and secH under control of the xylose-dependent promoter. As a result, the 
following strains were created: (1) GQ48 (lacA::secA2, amyE::prsAB-eag), (2) GQ72 
(lacA::secH, amyE::prsAB-eag), (3) GQ69 (lacA::secA2secH, amyE::prsAB-eag), (4) 
GQ65 (secA::secA1, lacA::secA2, amyE::prsAB-eag), (5) GQ74 (secA::secA1, 
lacA::secH, amyE::prsAB-eag), (6) GQ75 (secA::secA1, lacA::secA2-secH, 
amyE::prsAB-eag) (Figure 5.20).  
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Figure 5.20: Genomic maps of secA/secA1, amyE and lacA loci of the constructed mutants: (1) 
GQ48, (2) GQ72, (3) GQ69, (4) GQ65, (5) GQ74 and (6) GQ75.  
  
 
90 Chapter 5: Studies of the B. anthracis secondary translocase in B.subtilis 
The strains: AB06Jeag1, GQ32, GQ48, GQ72, GQ69, GQ65, GQ74 and GQ75 were 
grown in nutrient medium and their extracellular protein profiles were compared to 
determine the influence of Bsu SecA, Ban SecA1, Ban SecA2 and SecH on EA1 
secretion. The protein profiles of the B. subtilis mutants (Figures 5.21 and 5.22) indicate 
that:  
(i) Ban SecA1 is more efficient at secreting EA1 than the native Bsu SecA. 
(ii) SecA2 and SecH individually have a small inhibitory influence on the secretion 
of EA1 in strains encoding Bsu SecA, but together they increase the secretion 
of this protein. 
(iii) When Bsu SecA is replaced with Ban SecA1, the presence of either SecA2 or 
SecH reduces the yield of EA1. 
(iv) When Bsu SecA is replaced with Ban SecA1, the presence of both SecA2 and 
SecH restores the level of secretion of EA1 to that of SecA1 alone. 
 
                
Figure 5.21:  Secretion of EA1 with or without the presence of Ban SecA1, SecA2 and 
SecH in B. subtilis encoding its nature SecA. Four mutants (AB06Jeag1: Bsu 
amyE::prsAB-eag; GQ48: lacA::secA2, amyE::prsAB-eag; GQ69: lacA::secA2secH, 
amyE::prsAB-eag; GQ72: lacA::secH, amyE::prsAB-eag) have been tested. The 
presence of the various genes in the mutants is shown above the gel lanes.  ‘-‘ = no 
xylose; ‘+’ = xylose addition (1% (w/v)). In the induced samples (+), there are two 
additional bands of two sizes of approx. 90 kDa and 120-130 kDa visible corresponding 
to EA1. Marker: SeeBlue Plus Prestained Standard (Invitrogen).  
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Figure 5.22:  Secretion of EA1with participation of Ban SecA1, SecA2 and SecH in B. 
subtilis secA::secA1. Four mutants (GQ32: Bsu secA::secA1, amyE::prsAB-eag; GQ65: 
Bsu secA::secA1, lacA::secA2, amyE::prsAB-eag; GQ74: Bsu secA::secA1, lacA::secH, 
amyE::prsAB-eag; GQ75: Bsu secA::secA1, lacA::secA2-secH, amyE::prsAB-eag) have 
been tested. The presence of the various genes in the mutants is shown above the gel 
lanes. ‘-‘ = no xylose; ‘+’ = xylose addition (1% (w/v)). In the induced samples (+), 
there are two additional bands of two sizes of approx. 90 kDa and 120-130 kDa visible 
corresponding to EA1. Marker: SeeBlue Plus Prestained Standard (Invitrogen). 
 
Overall, the data in Figures 5.21 and 5.22 show that SecH moderately reduced the 
secretion of EA1 by Bsu SecA and Ban SecA1, and does not confer SecA2 the 
specificity to EA1 in B. subtilis. However, the results indicate that SecH and SecA2 
interact in some way to influence the secretion of EA1 in B. subtilis.  
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5.3 Discussion 
B. anthracis possesses two homologues of B. subtilis components of the secretory 
machine: (i) SecA (SecA1 and SecA2) and SecY (SecY1 and SecY2). The 
complementation analysis showed that B. anthracis SecA1, but not SecA2 can 
complement B. subtilis SecA (Pohl et al., unpublished) Thus, B. subtilis SecA and       
B. anthracis SecA1 are functional homologues. B. anthracis SecA2 was shown to be 
involved in the secretion of S-layer proteins, Sap and EA1 (Section 1.7). This finding 
meant that there must be a factor or factors conferring the specificity of SecA2 for its 
substrates. Two possible specificity factors were identified: (1) the signal peptides of 
EA1 and Sap which are almost identical and (2) SecH protein which enhances the 
secretion of Sap and EA1 in B. anthracis.  
When Sap and EA1 are expressed in B. subtilis strains 168, both are secreted at a 
significant concentrations provided PrsAB is present. This implies that B. subtilis SecA 
is able to facilitate this secretion. This prompted consider whether Ban SecA1 has a Sap 
and EA1 avoidance mechanism – that there is a factor preventing the interaction 
between Sap, EA1 and SecA1. Consequently, B. subtilis SecA was replaced with B. 
anthracis SecA1. Not only was Sap and EA1 secreted by these strains of B. subtilis, but 
secretion was enhanced. These results mean that SecA2-related specificity of Sap and 
EA1 secretion is lost in B. subtilis. Thus, this indicates that the signal peptide is not the 
factor responsible for conferring SecA2 specificity to its substrates in B.anthracis. 
However, we can not exclude that it contributes to that task by cooperating with some 
yet unknown factors. 
Next, we looked at the effects of SecA2 and SecH, on Sap and EA1 secretion, in 
the Bsu SecA and Ban SecA1 backgrounds. When SecH was present in those 
backgrounds, the secretion of the S-layer proteins decreased. When both SecA2 and 
SecH were present, the secretion of Sap and EA1 was restored to the level observed in 
the mutant expressing secA or secA1, but not secA2 and secH. These observations may 
suggest that SecH has a role in preventing the interaction between SecA1 and S-layer 
proteins and enhancing the interaction between SecA2 and those proteins. However, 
there must be an additional factor that is present in B. anthracis but not B. subtilis, 
which ensures that the secretion of Sap and EA1 is dependent on SecA2 but not on 
SecA1. 
This project attempted also to determine whether B. anthracis SecY2 could 
complement SecY of B. subtilis. SecY2 is not essential for viability in B. anthracis and 
it may function cooperatively with SecY1 to assure high-level of secretion of the S-
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layer proteins throughout the bacterial growth cycle as SecY1 is highly expressed 
during exponential phase while SecY2 is highly expressed during stationary phase. A                        
B. subtilis strain containing the secY2, adk and map genes under the control of xylose 
promoter was successfully constructed (strain KG204). However, the construction of a 
strain with an IPTG-dependent secY encountered problems. When pKG101, containing 
secY under control of IPTG-inducible promoter, was transformed into KG204. The 
resulting transformants did not have a correctly integrated copy of pKG101 in its 
chromosome. However, when two of these transformants were passaged through the LB 
broth with erythromycin, lincomycin, chloramphenicol, kanamycin, IPTG and xylose, 
xylose-dependent variants were selected on LB+xylose plates, suggesting these clones 
must be relying on B. anthracis SecY2 rather than Bsu SecY for growth. However, 
further analysis of the xylose-dependent mutants was not possible as they were unstable, 
and failed to grow in the LB broth with either xylose or IPTG. As result this part of the 
project was discontinued. The failure to generate a strain for complementation analysis 
might have been due to toxicity associated with increased amounts of SecY, a 
membrane pore-forming protein, as shown by Kihara et al. (1995). In their study, the 
relationship between FtsH and SecY expression was investigated. FtsH is a cellular 
protease that degrades SecY uncoupled to SecE. When SecY was overexpressed in an 
E. coli ftsH mutant, a deleterious impact on the bacterial growth and protein export was 
observed. It is also possible that overexpression of adk and map from the inducible 
promoter leads to high levels of Adk and Map, which has toxic effect of cells. The 
alternative way to check if SecY2 can complement Bsu SecY would be to delete Bsu 
secY in KG204 (amyE::Pxyl Bsu secY2-adk-map), while expressing secY2. If secY2 can 
complement Bsu secY, then secY2-positive, Bsu secY-negative strain should be viable.  
 
Acknowledgement: Experimental work presented in this Section was done in 
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Chapter 6: Identification of factor(s) conferring SecA2 substrate 
specificity using the pull-down technique 
Previously, we showed that SecA2 mediates specifically secretion of Sap and EA1 
proteins. To identify a factor or factors which coffer SecA2 specificity to its substrates, 
we analysed the genomic context of secA2 gene in B. anthracis and found secA2 is 
located within an operon containing also a downstream gene that was re-named secH. 
When secH was deleted from the genome of B. anthracis Sap and EA1 secretion was 
reduced but not abolished. This result suggests that SecH participates in the secretion of 
Sap and EA1, but there must be an additional specificity factor/s (which might 
cooperate with SecH) responsible for S-layer proteins being secreted by SecA2 but not 
by SecA1. To identify that/those specificity factor/s, the pull-down technique was 
attempted. 
6.1. The principle of the pull-down technique 
The so-called pull-down technique is an approach to identify putative protein:protein 
interactions in vivo, using a ‘bait’ and ‘pray’ approach. The ‘bait’ is a target protein that 
can be immobilised on an affinity column by virtue of it encoding an affinity tag. The 
“prey” protein is any protein that interacts with the immobilised ‘bait’ after the cells 
have been lysed and soluble fraction applied to the affinity column. The putative 
interacting proteins are stabilised in vivo by reversibly cross-linking with formaldehyde, 
so that captured ‘pray’ will not dissociate during the subsequent cell lysis and 
processing events. Once the sample has been applied to the affinity column, the resin is 
washed extensively to eliminate non-specific protein binding to the matrix. After 
washing, the complex is eluted from the resin and the cross-linking between proteins 
reversed by boiling in the sample buffer. Finally, the proteins are separated by SDS-
PAGE and the individual protein identified immunologically or by mass-spectroscopy. 
In this study, the pull-down assay was done in the batch format. The analysed proteins 
were fused to the FLAG-tag and produced in the host strain from an expression vector. 
The steps of the pull-down assay used in this study are shown on the Figure 6.1.  
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6.2. An attempt to identify proteins interacting with SecA2, SecH and Sap 
In order to identify factor(s) potentially conferring substrate specificity to SecA2, a pull-
down experiment was performed with a Flag tag-labelled version of SecA2, SecH and 
Sap. The Flag-tagged SecA2, SecH, Sap bait proteins were expressed from vectors 
pKG400-FLAG-secA2, pKG400-FLAG-secH, pKG400-FLAG-sap, respectively. The 
vectors were constructed by amplifying the secA2, secH and sap genes with the Flag-tag 
sequence (GAT TAC AAG GAT GAC GAC GAT AAG) incorporated in-frame into the 
forward primer. The amplified fragments were then cloned into the pKG400 expression 
plasmid. Subsequently pKG400-FLAG-secA2, pKG400-FLAG-secH, pKG400-FLAG-
sap plasmids, as well as empty vector, were transformed into B. anthracis ∆secA2, B. 
anthracis ∆secH, B. anthracis ∆sap-eag, respectively. Cultures of the transformed 
strains were grown LB broth and induced with 10 mM IPTG and grown for a further 90 
minutes. The procedure for cross-linking and the extraction of proteins is described in 
the Section 2.13. The proteins obtained in the pull-down experiment were separated by 
SDS-PAGE and stained with either SyproRuby Protein Gel Stain (Invitrogen) or 
PageSilver Staining Kit (Fermentas). The unique bands were selected for the samples 
with tagged proteins with and without cross-linking with formaldehyde. The negative 
controls were samples obtained for the strains with the empty plasmid (pKG400), with 
Figure 6.1: The pull-down assay of Flag-tagged proteins in the batch format. The assay 
was done in the following steps: (1) Interacting proteins were cross-linked with 
formaldehyde; (2) Cell lysate, containing FLAG-tagged protein (pray) was mixed with 
agarose beads coated with anti–FLAG antibodies (bait); (3) Unspecifically bound 
proteins were washed away in the washing step; (4) Flag-tagged protein were eluted and 
cross-linking reversed by boiling samples in the sample buffer; (5) Proteins were 
analysed by SDS-PAGE; (6) Protein bands were excised and identified by mass 
spectroscopy. 
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and without formaldehyde treatment. The gels using SecA2 and Sap, were identical 
irrespective of the presence of the their respective expression plasmids, and only the 
pull-down experiment with SecH showed some unique bands (Figure 6.2), which were 
subsequently extracted and identified by mass spectroscopy.  
 
   
 
 
 
The extracted bands were analysed by MALDI-TOF, however, the samples contained 
insufficient protein to provide positive identifications. The low yield of proteins was 
found to be due to the inefficiency of extraction of intracellular proteins from                
B. anthracis. The preferred method to break open cells of B. anthracis, which was used 
in this instance, is to subject cells to shearing by vigorously shaking cell pellets with 
glass beads at high-speed cell dismembrator. The limitation of this method is that only 
small volume of culture can be processed. In this pull-down experiment, intracellular 
proteins were extracted from cell pellets obtained from 250 ml of culture. Although the 
concentrations of proteins remaining after washing were relatively low, sufficient 
material was obtained for mass spectroscopy. The four samples, which gave the clearest 
spectra by MALDI-TOF-MS were further subjected to liquid chromatography-mass 
spectrometry (LC/MS/MS) analysis. The fingerprint data for the protein identified by 
LC/MS/MS are shown in the Table 6.1.  
Figure 6.2: SDS-PAGE analysis of proteins, recovered from the pull-down experiments, 
stained with: (A) SyproRuby Protein Gel Stain; (B) PageSilver Staining Kit. The bait and 
prey proteins were obtained from B. anthracis ∆secH transformed with pKG400-FLAG-
secH with (+) and without (-) formaldehyde treatment. B. anthracis ∆secH transformed 
with an empty pKG400 vector (pKG400) was used as a negative control. The unique 
bands (circled) for the samples with Flag-tagged SecH, with and without formaldehyde 
treatment were selected by comparison with the negative control.  
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Band 1 was matched with a significant score to a single peptide, namely ribosomal 
protein L3. Bands 2 and 6 were both matched to proteins with a significant score, 
ribose-phosphate pyrophosphokinase and SecH (BA_0881) itself, respectively. Band 8 
was also matched to a protein, namely the membrane-bound transcriptional regulator 
LytR, but the match was not significant. However, the expected and observed species 
identified by LC/MS/MS are about the same, making this protein a candidate worth 
further investigation. The possibility that SecH interacts with 50S protein L3 might 
indicate that SecH forms a complex with ribosome. As SecH was shown by bacterial-
two hybrid assay, to interact with SecA2 and its substrate, this observation might 
indicate that SecH, SecA2, and its substrate may form a complex with the ribosome. 
The other protein identified in the pull-down experiment, ribose-phosphate 
pyrophosphokinase is an intracellular enzyme catalysing the formation of D-ribose 5-
phosphate, but what would be the reason for its interacting with SecH is unclear. 
6.3 Discussion 
In the search for factors conferring substrate specificity on SecA2, a pull-down assay 
was employed. However, since we did not have time to optimise the methods for B. 
anthracis the results were ambiguous. Nevertheless, one protein identified in this 
analysis, LytR, is worth further investigation. LytR belongs to the LytR-CpsA-Psr 
family of cell envelope-associated transcription attenuators. Members of LytR family 
are also essential for optimal cell division in S. aureus (Over et al., 2011). LytR is a 
putative transmembrane protein, harbouring a predicted extracytoplasmic LytR-CpsA-
Psr domain. First described in B. subtilis, LytR was shown to act as an attenuator of the 
lytABC operon and of its own expression. The lytABC operon encodes a putative 
lipoprotein (LytA), an N-acetylmuramoyl-L-alanine amidase (LytC) and its modifier 
LytB (Lazarevic et al., 1992). In Streptococcus pneumoniae LytR is essential for cell 
division (Johnsborg and Håvarstein, 2009) and its deletion affects septum formation. 
Consequently, cells of a lytR-null mutant are highly variable in both size and shape with 
some cells 2-3 times larger than the wild type. The mutant also forms irregularly shaped 
mini cells. LytR could be implicated as a sensor of cell wall stress or as an additional 
substrate for SecA2. The failure to transport it to the membrane is likely to lead to 
changes in the cell morphology observed in the secA2-null mutant (Section 12.1). The 
possible interaction between SecH and the L3 protein of the 50S ribosomal protein 
could indicate that SecH interacts with ribosomes.  
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Chapter 7: Substrate specificity of PrsA-like proteins in B. anthracis 
7.1 Introduction 
B. anthracis possesses three homologues of the B. subtilis PrsA-like foldase: PrsAA, 
PrsAB, PrsAC. All three homologues complement B. subtilis PrsA with respect to the 
secretion of B. anthracis recombinant protective antigen and the B. licheniformis           
α-amylase, AmyL (Williams et al., 2003). However, the complementation with PrsAC 
led to an altered colony morphology, implying that PrsA-like proteins exhibit some 
substrate specificity. It was also shown that, in B. subtilis, Sap and EA1 proteins of B. 
anthracis can only be found to be secreted in the presence of PrsAB (Pohl et al., 
unpublished). In an attempt to identify substrates for the B. anthracis PrsA-like proteins, 
we generated null mutations in the genes encoding these foldases: prsAA, prsAB and 
prsAC yielding ΔprsAA, ΔprsAB and ΔprsAC mutants, respectively (Section 3.4).  
 
7.2 Analysis of the extracellular proteins of B. anthracis ΔprsAA, ΔprsAB and   
      ΔprsAC 
SDS-PAGE and 2D-PAGE was used to analyse the pattern of extracellular proteins 
produced by these mutants in comparison with the wild type (Figures 7.1 and 7.2). The 
resulting gels showed that the secretion of Sap and EA1 was abolished in ΔprsAB, 
indicating that the PrsA-like proteins of B. anthracis exhibit substrate specificity and 
that PrsAB, but not PrsAA or PrsAC is required for the secretion of these S-layer 
proteins. 
 
 
 
 
                              
             
  
Figure 7.1: SDS-PAGE analysis of the extracellular proteins in the supernatant 
fractions of B. anthracis null mutants: ΔprsAA, ΔprsAB and ΔprsAC. The secretion of 
EA1 and Sap, which co-migrate as a single ~ 90 kDa band, is abolished in the ΔprsAB 
mutant. Marker: SeeBlue Plus Prestained Standard (Invitrogen). 
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Master Gel Image: prsAA_8
Sample Gel Image: 4_WT_schwarz gelabelt_-2-
_C170608_S210608_extra_8 Created by Delta2D - http://www.decodon.com
Wild-type/ 
ΔprsAA 
Wild-type/ 
ΔprsAB 
 
Wild-type/ 
ΔprsAC 
 
  Mutant                      Wild-type 
Both 
Proteins present in: 
Figure 7.2: False-coloured 2D gel overlays of B. anthracis extracellular proteins 
isolated from the wild-type and ΔprsAA, ΔprsAB and ΔprsAC mutants. The 
extracellular proteome of ΔprsAB showed a dramatic reduction in the secretion of 
two of the major surface-associated antigens, Sap and EA1, resulting in them 
generating red spots. In contrast, the extracellular proteomes of the ΔprsAA and 
ΔprsAC gave identical profiles to that of the wild-type (yellow spots).  
Sap EA1 
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7.3 Discussion 
Interestingly, apart from SecA2, PrsAB foldase was also found to be involved in the 
secretion of both: Sap and EA1. Why have B. anthracis evolved to have specific 
components of the translocation system involved specifically in secretion of S-layer 
proteins? It could indicate importance of the S-layer. However, as it was mentioned in 
the Section 1.8, the role of S-layer in B. anthracis is not clear. In vivo, the EA1 S-layer 
predominates when the toxins and capsule are produced, while the Sap S-layer 
predominates in non-capsulated bacteria (Mignot et al., 2004). This may indicate that 
Sap and EA1 play distinct roles in vivo. Sap, as the outermost layer, may participate in 
interaction with the environment, while EA1 might play role inside the host. 
The only other substrate-specificity for PrsA-like foldase was demonstrated in 
Listeria monocytogenes. This bacterium, encodes two PrsA-like proteins, PrsA1 and 
PrsA2. PrsA2 was shown to be essential for the virulence of L. monocytogenes in mice 
(Alonzo et al., 2009; Zemansky et al., 2009), and in its absence, cell-to-cell spreading 
and flagellar motility are impaired, while activities of virulence factors such as 
listeriolysin-O and the broad-range phosphatidyl-choline phospholipase are reduced 
(Alonzo et al., 2009; Zemansky et al., 2009). The secretion of several other proteins 
were also abolished in the absence of PrsA2 (Alonzo and Freitag, 2010). It can not be 
excluded that PrsAB, like Listeria monocytogenes, possesses specificity also to other 
substrates then Sap and EA1.  
There is also a possibility that PrsAB might be a substrate for SecA2 and that the 
lack of Sap and EA1 in the secretome of B. anthracis secA2, results from the absence 
of PrsAB on cell surface in that mutant. PrsAB is a foldase, a membrane-anchored 
protein, and the secretion of that group of proteins was not investigated in this thesis 
and it can not be excluded that PrsAB is a substrate for SecA2. It is also possible that 
PrsAB is responsible for folding a specific Sip signal peptidase that, in turn, might be 
responsible for processing of Sap and EA1. The lack of that signal peptidase might be 
the direct reason for the lack of Sap and EA1 in the secretome of B. anthracis secA2 
and/or B. anthracis prsAB. 
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Chapter 8: Dealing with the issue of polar effects of gene expression in 
secA2-null mutant of B. anthracis 
The deletion and/or insertion of genes in the genome has the potential to exert polar 
effects on neighbouring genes by causing changes in their expression. In this study the 
selectable marker approach was used to delete target genes; the target gene being 
replaced by the gene of the selectable marker i.e. kanamycin resistance gene. This 
manipulation of the genome could potentially affect gene expression of the surrounding 
genes. Therfore we analysed the expression of genes in the proximity the gene deletions 
in the strains investigated in this study.  
8.1 Analysis of secA2 and secH expression in B. anthracis null mutants 
Since secA2 and secH are adjacent on the chromosome, we used Northern blot analysis 
to determine whether they were co-expressed from the same promoter. Total RNA was 
extracted from the wild type strain and a series of mutants. Following agarose 
electrophoresis and blotting, the RNA was hybridised with labelled secA2- and secH-
specific probes. In the case of the wild type strain and B. anthracis ΔsecY2, both probes 
hybridised to a single transcript of ~ 3200 bases, the expected size of a bicistronic 
transcript. In the case of the ΔsecH mutant, two bands of the approximate size of 2350 
bases and 5200 bases were detected with the secA2-specific probe. 2350 bases band 
corresponds in size to the transcript of secA2 while 5200 bases band indicates the 
incomplete transcriptional termination within the downstream ΩKm cassette. As 
expected, no secH specific transcript was detected in the ΔsecH mutant. When the 
ΔsecA2H mutant was analysed, neither secA2 nor secH transcripts were detected. 
Finally, Northern blot analysis revealed that secH was not expressed in the ΔsecA2 
mutant, indicating that phenotypically it behaved similarly to the ΔsecA2H mutant 
(Figure 8.1).  
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8.2 Construction of secA2-null mutant expressing secH 
The lack of expression of secH in the B. anthracis ΔsecA2 mutant was likely to be due 
to the polar effect of kanamycin cassette used as a marker to construct that mutant, 
resulting in transcription termination. It was therefore necessary to construct a ΔsecA2 
mutant in which the expression of secH was not affected. In the first place we attempted 
to develop a ‘clean’ deletion approach exploiting the endogenous Dif/Xer recombination 
system. This type of system was employed successfully in B. subtilis (Bloor and 
Cranenburgh, 2006). The Dif/Xer recombination systems can be used for creating 
‘clean’ deletions or gene replacements without the need to maintain a selective gene. 
The Dif/Xer recombination systems involve two Xer-like recombinases, e.g. RipX and 
CodV in B. subtilis or XerC and XerD in E. coli. These recognise 28-nucleotide dif 
motifs that are normally located at or near the chromosome replication terminus (Leslie 
and Sherratt, 1995; Sciochetti et al., 2001). dif motifs consist of two inverted sequences 
separated by a hexanucleotide. The action of the recombinases on dif sites allows 
resolution of dimeric chromosomes that can be generated during DNA replication. 
Dif/Xer recombination systems are found in most bacterial species containing circular 
genomes (Carnoy and Roten, 2009). The Dif/Xer system can be employed to eliminate 
the selectable marker introduced into the bacterial chromosome as a part of the insertion 
cassette, with the aim of target gene knock-out or replacement. The concept of the gene 
Figure 8.1: Northern blots of RNA from various B. anthracis strains: (1) wild type, (2) 
ΔsecY2, (3) ΔsecA2, (4) ΔsecH, (5) ΔsecA2H, with secA2- and secH-specific probes 
(Figure A and B, respectively). As secA2 and secH are located in the same operon, they 
also are located on the same transcript, corresponding approximately to their combined 
size (3250 bases). RNA of ΔsecH gives a positive signal with secA2-specific probe – 
two bands are visible: lower band corresponding to the transcript of secA2 only i.e. 
2350 bases and unidentified upper band (approx. 5200 bases). On the Figure B, 16S 
rRNA (approx. 3000 bases) and 23S rRNA (approx. 1500 bases) are visible.    
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deletion using Dif/Xer system is depicted on the Figure 8.2 (Bloor and Cranenburgh, 
2006). 
              
 
 
 
 
The construction of mutants using Dif/Xer system is similar to the selectable marker 
approach employed to construct mutants in this study. The difference is that the 
selectable marker gene is flanked by dif sites (Figure 8.3). Target gene on the 
chromosome is replaced with the integration fragment and the clones carrying the 
integrants are selected by a selective agent to which they are resistant, due to presence 
of the gene encoding the selectable marker. When the clones with deletion of the target 
gene are grown without selection pressure, then the action of native Xer recombinases, 
excises the gene resistance marker located between them. To identify dif sites in 
bacterial genomes, Le Bourgeois et al. (2007) used homology searches with B. subtilis 
dif sites as query against complete genomes taking into account such parameters as: (1) 
occurrence only once per genome, and (2) localisation in the replication terminus (terC). 
The result of the query for some bacteria is summarised in the Table 8.1. 
 
 
 
 
 
 
 
Figure 8.2: Deletion of a target chromosomal gene and subsequent 
removal of the selectable marker (e.g., antibiotic resistance) gene by Xer 
recombination at flanking dif sites (Xer-cise). Shaded regions represent 
homology between the integration cassette and genes flanking the target 
gene (Bloor and Cranenburgh, 2006).  
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Table 8.1: Localisation of dif sites in some bacteria. Variable nucleotides are 
underlined. The sequence recognised by CodV/XerC, by RipX/XerD and the core of the 
dif sequence are shown (Le Bourgeois et al., 2007). 
 
The dif sequence of B. anthracis (ACTGCCTATAATATATATTATGTTAACT) was 
used to generate the integration vector for secA2 deletion. The plasmid pKG307 was 
constructed consisting of pUTE583 containing an integration fragment consisting of the 
kanamycin cassette flanked by 29 bp dif sites and then by 5’ and 3’ sequences flanking 
the secA2 gene (Figure 8.3). 
 
Figure 8.3: pKG307 plasmid for the ‘clean’ deletion of secA2. Upstream (5’ sequence 
flanking secA2) and downstream fragments (3’sequence flanking secA2) are separated 
by the kanamycin resistance gene (Ω Km) which is flanked by dif sites. Erythromycin 
(Em) and chloramphenicol (Cm) resistance genes are shown. 
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The dif sites were introduced on the either side of the kanamycin cassette to provide 
targets for its removal via the CodV/RipX recombinases, leaving a single 29 bp scar. 
The dif-km-dif fragment was amplified with primers DifKmF and DifKmRev 
(Appendix B) and the resulting 2200 bp amplicon cloned into the SmaI restriction site 
of pUTE583 containing upstream and downstream flanking fragments of secA2, 
generating pKG307. The construction of pKG307 was carried out using the E. coli XL-I 
blue strain as an intermediate host. Subsequently, pKG307 was passaged through a Dam 
and Dcm methylase-deficient strain of E. coli (GM48) and the following transformation 
of the integration vector, a double crossover RecA-mediated integration (allelic 
replacement) event resulted in the target gene being replaced with the integration 
fragment. As a result, the entire target gene was excised from the chromosome. The 
mutant strain carrying the targeted gene knock-out, as well as the integration plasmid 
now containing the target gene was counter selected for loss of the plasmid, so that the 
desired mutant genotype could be isolated. The counter-selection involved passaging 
the mutant through numerous generations in liquid culture. Selection was made for 
ΩKm cassette, but not the erythromycin resistance gene associated with the pUTE583 
vector. Subcultures of the broth were plated onto agar and the resulting colonies replica 
plated onto LB agar containing kanamycin or erythromycin. The expected result was the 
isolation of clones that were kanamycin-resistant and erythromycin-sensitive. This 
would indicate the removal of secA2 from the chromosome by allelic exchange and the 
loss of the pUTE583 plasmid. Despite testing approximately 1500 colonies, no 
erythromycin sensitive clones were found. Instead, we frequently identified clones that 
were erythromycin resistant and kanamycin-sensitive, suggesting that there was high 
frequency deletion of the kanamycin cassette from the plasmid before allelic exchange 
event could take place, presumably mediated by the Xer recombinase. It therefore 
appears that the excision of the kanamycin cassette by Dif/Xer recombination system 
was too efficient with respect to the frequency of the chromosome integration event for 
this system to be used in B. anthracis. As the Dif/Xer recombination system was not 
successful in obtaining a clean deletion of secA2, an alternative approach was used in 
which a copy of the native secA2H promoter (PsecA2H) was used to drive secH 
expression. To achieve this, a ΔsecA2 mutant was generated using pUTE583, as 
described in Section 3.1. However, the technique was modified so that the integration 
fragment contained an upstream secA2 fragment lacking PsecA2H while the downstream 
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fragment had the PsecA2H cloned at its 5’end to drive secH expression (Figure 8.4). 
 
Figure 8.4: Construction of a B. anthracis ∆secA2-null mutant expressing secH 
(∆secA2*). The pUTE583-based plasmid encodes an integration fragment in which the 
site of PsecA2H (left-pointed arrow in the yellow box) has been repositioned to facilitate 
the expression of secH following integration. Two crossed lines represent double 
crossing over occurring between the target region and the integration fragment.  
Following the selection of integrants and the confirmation of their structure by 
diagnostic PCR, the expression of secA2 and secH by the newly generated ∆secA2 
mutant (annotated as ∆secA2*) was analysed by Northern blotting (Figure 8.5). 
Genomic maps, of the wild type and the mutants analysed, are shown on the Figure 8.6. 
 
Figure 8.5: Northern blot analysis with secA2-specific probe (A) and secH-specific 
probe (B) for the following strains: (1) B. anthracis wild type, (2) ∆secA2*, (3) 
∆secA2H, (4) ΔsecH, (5) ∆secA2. For the genomic maps of the mutants see Figure 8.6.  
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Northern blot analysis of the wild type detected the presence of a 3250 bases transcript 
by both the secA2- and secH-specific probes, confirming that these genes are co-
transcribed (Figure 8.5, lane 1). In B. anthracis ∆secA2* (A2-H+), there was a complete 
lack of signal from the secA2-specific probe, while a ~ 0.9 kb transcript, consistent with 
the size of the secH gene, was detected with the secH-specific probe (Figure 8.5, lane 
2). Transcripts were not detected with either of these probes in the double deletion 
mutant B. anthracis ∆secA2H or the B. anthracis ∆secA2 (A2-H-) mutant in which 
PsecA2H was not relocated (Figure 8.5, lanes 3 and 5). Finally, a ~ 2.4 kb transcript was 
detected by the secA2-specific probe in the ΔsecH mutant, consistent with the size of 
secA2, but as expected, there was no secH transcript (Figure 8.5, lane 4).   
 
Figure 8.6: Genomic maps of secA2-secH locus of the B. anthracis strains: (1) wild 
type, (2) ∆secA2*, (3) ∆secA2H, (4) ΔsecH, (5) ∆secA2. 
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8.3 Polar effects on the expression of csaA and csaB in ∆secA2* 
We have already demonstrated that inactivation of the secA2 in the B. anthracis ∆secA2 
mutant led to the down-regulation of secH, located immediately downstream and in the 
same operon as secA2. We now consider potential polar affects on csaAB operon. These 
genes, described in more detail in the Section 1.8.2, are located between the secA2–
secH operon and sap. Deletion of the genes upstream or downstream of csaAB, by 
allelic replacement with the kanamycin resistance cassette, could potentially affect the 
expression of csaAB. To check the expression of csaA-csaB operon, total RNA was 
extracted from the cultures of mutants B. anthracis ∆secA2*, B. anthracis ∆secA2,        
B. anthracis ΔsecH, B. anthracis ∆secA2H, B. anthracis ∆sap-eag, B. anthracis 
∆prsAB, and wild type strains, grown to OD600=0.8. The extracted RNA was subjected 
to Northern blotting with csaA- and csaB-specific probes (Figure 8.7). The results 
confirm that csaAB are transcribed from a single transcript of ~ 2.8 kb that runs with a 
similar mobility to that of the 23S rRNA. There are two additional bands visible in the 
lower section of blots, with one corresponding presumably to 16S and the other one 
might be constituted by some RNA processing product. The data also indicate that in B. 
anthracis ∆secA2* the expression of csaA and csaB has been down-regulated. However, 
the expression of these genes in each of the other constructed mutants was not affected.  
 
 
 
 
 
   
    
 
 
 
 
 
 
 
Figure 8.7: Northern blots of RNA from B. anthracis strains: (1) ΔsecA2, (2) wild 
type, (3)  ΔsecA2*, (4) ) ΔsecA2H, (5) ΔsecH, (6) ) ΔprsAB, (7) Δsap-eag with (A) 
csaA- specific and (B) csaB-specific probes.  
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transcript of 
 csaA +csaB 
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8.4 Secretion of Sap and EA1 is abolished in secA2* 
It was shown that in B. anthracis ΔsecA2 the secretion of Sap and EA1 becomes 
abolished (Section 1.8.1). However, the Northern blot analysis showed the expression 
of secH is down-regulated in ΔsecA2 (Section 8.1). Thus, the secA2-null mutant with 
unaffected secH expression was constructed (ΔsecA2*). The extracellular proteins of 
the ΔsecA2* mutant were analysed by SDS-PAGE, following growth to OD 0.8 in LB 
medium at 37°C (Figure 8.8). This showed that SecA2 alone, rather than SecA2 and 
SecH, was absolutely necessary for the secretion of Sap and EA1, and that SecH simply 
improves the efficiency of their secretion (Section 4).  
                                 
 
 
 
 
 
 
 
 
Acknowledgement: Northern blotting experiments were done in collaboration with             
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Figure 8.8: Secretion of Sap and EA1 by the ΔsecA2* mutant. The protein 
corresponding to Sap and EA1 (~90 kDa, circled) is visible in the wild type strain but 
not the ΔsecA2* mutant. Marker = PageRuler™ Prestained Protein Ladder 
(Fermentas). 
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8.5 Discussion 
Prior to this thesis, it was found that SecA2 of B. anthracis is involved in the secretion 
of S-layer proteins: Sap and EA1 (Pohl et al., unpublished). In this study, we also 
investigated the role of the gene BA0881, which function was not previously identified. 
As this gene is located in the same operon as secA2, we thought that it might be 
implicated in the SecA2-mediated translocation, possibly conferring SecA2 specificity 
to its substrates. We re-named BA0881 as ‘secH’. Selectable marker approach was used 
to delete target genes, the target gene being replaced by the gene of the selectable 
marker i.e. kanamycin resistance gene. However, gene deletions generated using this 
approach may result in polar effects, if neighbouring genes are located in the same 
operon or in close proximity. Indeed, Northern blot analysis showed that the ΔsecA2 
does not express secH and consequently behaves phenotypically like ΔsecA2H. 
Attempts were made to construct a ∆secA2 mutant expressing secH. In the first place 
the Dif/Xer system was used in an attempt to create a markerless secA2 mutation, but 
this was unsuccessful because, possibly, the kanamycin resistance cassette was excised 
from the plasmid too efficiently and before the double crossing-over event had an 
opportunity to take place. The modified selectable marker approach employed to 
construct other mutants in this study was successful in generating a ∆secA2 mutant 
expressing secH (ΔsecA2*). The construct was made in such a way that secH was 
expressed from the PsecA2H promoter.  The absence of Sap and EA1 secretion was 
confirmed in ΔsecA2* by SDS-PAGE analysis, thus confirming the absolute 
requirement of SecA2 but not SecH for the secretion of S-layer proteins. Analysis of 
this mutant, however, showed that expression of csaA and csaB genes, located in close 
proximity to secA2-secH operon, is affected. As csaA and csaB encode products which 
are responsible for the attachment of all SLH domain-containing proteins to the 
peptidoglycan, including Sap and EA1 (Mesnage et al., 2000; Kern et al., 2010), then 
ΔsecA2* could have the display of SLH-containing proteins, other than Sap and EA1, 
reduced or abolished.  
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Chapter 9: Growth analysis of created null mutants 
The growth analysis was done to determine if the mutants being analysed have the 
similar pattern of growth and to determine what OD600 values correspond to 
exponential, transitional and stationary phases. The growth of the B. anthracis wild type 
in LB broth was compared with that of several mutants, namely: ΔsecA2, ΔsecA2*, 
∆secH, ΔsecA2H, ∆prsAA, ∆prsAB, ∆prsAC, ∆sap-eag. LB broth cultures were 
inoculated with overnight cultures and incubated at 37
o
C with shaking (180 rpm). 
Samples were taken every 60 minutes to measure OD600 of each culture. The OD600 
values were plotted against time and resulting growth curves are shown on the Figures 
9.1 and 9.2. 
 
  
 
 
Figure 9.1: Growth curves of B. anthracis UM23C1-2 (wild type), ΔsecH, ΔprsAA, 
ΔprsAC. Bacterial cultures were grown with shaking (180 rpm). Samples were taken every 
60 minutes to measure OD600. The OD600 values were plotted against time. 
Figure 9.2: Growth curves of B. anthracis UM23C1-2 (wild type), ΔsecA2, ΔsecA2*, 
ΔsecA2H, ΔprsAB and Δsap-eag. Bacterial cultures were grown with shaking (180 
rpm). Samples were taken every 60 minutes to measure OD600. The OD600 values were 
plotted against time. 
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The analysis of the strains of B. anthracis (Figures 9.1 and 9.2) shows that they all  
enter the exponential phase around OD600 of 0.1; the transitional phase starts around 
OD600 of 1.3 and the stationary phase around OD600 of 3.0. Knowing what values of 
OD600 correspond to which growth phase it was subsequently possible to design 
experiments investigating changes in the gene expression and in the cell morphology in 
the specific growth phases.  
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Chapter 10: Analysis of gene expression of sap and eag in  
B. anthracis mutants 
 
Since, the deletion of the B. anthracis secA2 gene abolishes the secretion of Sap and 
EA1, it was assumed that these proteins would accumulate in the cytoplasm. However, 
analysis of the intracellular fraction of B. anthracis ∆secA2 mutant failed to detect any 
significant accumulation of EA1 and Sap in the cytoplasm (Figure 10.2). This 
observation suggests that SecA2 acts not only as a molecular motor for the secretion of 
EA1 and Sap, but also plays a chaperone-like role. Hence, in the absence of SecA2, its 
substrates are prone to degradation. However, the absence of EA1 and Sap from the 
cytoplasm, might also have been due to the down-regulation of their gene expression. 
This possibility was investigated initially by Northern blot, followed by qPCR analysis.  
10.1 Investigation of sap and eag expression by Northern blotting and qPCR 
Total RNA was isolated from cultures of wild type B. anthracis as well as secA2  
(secA2-null mutant which encodes secH, but fails to expresses it), ∆secH, ∆secA2H, 
∆prsAA, ∆prsAB, ∆prsAC, ∆secY2. The extracted RNA (2 µg) was subjected to 
Northern blotting against sap- and eag-specific probes. The analysis of the blots shows 
that expression of both eag and sap is down-regulated in the secA2 and ∆prsAB 
mutants (Figure 10.1).  
                     A 
 
 
 
 
   
                         
                    B 
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Figure 10.1: Northern blot analysis of: (1) B. anthracis wild type, (2) secA2, (3) 
secY2, (4) ΔsecH, (5) ΔsecA2H, (6) ΔprsAA, (7) ΔprsAB, (8) ΔprsAC with A, eag-
specific probe; B, sap-specific probe. RNA was extracted from LB broth culture at an 
OD
600 
of ~ 0.8. 
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The down-regulation of sap and eag in the secA2 and ∆prsAB mutants was 
unexpected, particularly since SecA2 and PrsAB have different cellular locations: 
SecA2 being cytoplasmic and PrsAB tethered to the outer leaf of the cytoplasmic 
membrane. Since the absence of either SecA2 or PrsAB results in decreased sap and 
eag expression, it is likely that their influence on sap and eag expression is indirect. 
One possibility that we consider is that the absence of this protein might trigger cell 
wall stress. However, it is important to recognise that the stress might not be the 
absence of either Sap or EA1, but to an as yet unidentified substrate of SecA2 and 
PrsAB. The altered cell morphology of cells of the secA2 and ∆prsAB mutants 
(Figures 12.1 and 12.2, Section 12.1) tends to support this hypothesis.  
The influence of SecA2 and PrsAB on the expression of sap and eag was further 
investigated by relative quantitative PCR. In addition to the mutants analysed by 
Northern blotting (Figure 10.1), secA2* (secA2-null mutant expressing secH) was 
analysed to distinguish between the effects of ∆secA2 and ∆secH. RNA was isolated 
from cultures harvested in the exponential (OD600 ~ 0.8), transitional (OD600 ~ 2.2) and 
stationary (OD600 ~ 4.5) phases and qPCR was performed as described in the Section 
2.8.3.  
Ct values obtained for the analysed strains were used to calculate the fold 
change of expression eag and sap in the analysed mutants. Firstly, the change of 
expression of those genes during bacterial growth cycle was analysed. The fold change 
of expression of eag and sap was calculated for the transitional and stationary phases in 
reference to the exponential phase (Table 10.1, first two columns). In the case of the 
wild type, eag expression decreased in the transitional phase, and peaked in the 
stationary phase, while sap expression did not change much in the transitional phase, 
but exhibited strong down-regulation of sap in the stationary phase. This observation is 
consistent with the growth phase-dependent manner of Sap and EA1 production, where 
Sap is produced predominantly in the exponential phase and EA1 in the stationary phase 
with sap expression peaking at the exponential phase and that of eag at the stationary 
phase (Mignot et al., 2002). In the case of eag, in the analysed mutants, the pattern of 
change in the gene expression was also similar to the wild type, although the increase in 
eag expression in the stationary phase was not so big, apart from the ΔprsAC mutant. In 
case of sap, in ΔsecH, ΔsecA2H, ΔprsAA, ΔprsAC, ΔsecY2 as in the wild type, the gene 
expression did not change much in the transitional phase, and down-regulation of sap 
was observed in the stationary phase. However, apart from the ΔprsAC mutant, the 
decrease in eag expression in the stationary phase in those strains was not so big as in 
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the wild type. In secA2 and ∆prsAB, sap was down-regulated in the transitional phase 
but its expression in the stationary phase increased towards the level observed in 
exponential phase. secA2* showed no much difference in sap expression in both 
transitional and stationary phases.  
Table 10.1: The fold change of expression eag and sap in the analysed mutants by 
qPCR. The first two columns show the fold change of expression of those genes during 
bacterial growth cycle (in the transitional and stationary phase in reference to the 
expression in exponential phase). The three last three columns show the fold change in 
expression of eag and sap in reference to the wild type strain; ∆sap-eag was used as a 
negative control strain.   
  Fold change with respect 
to the exponential phase 
Fold change with respect to the  
wild-type 
 
eag 
Strain transitional 
phase 
stationary 
phase 
exponential  
phase 
transitional 
phase 
stationary 
phase 
Wild type -4.8 12.9 - - - 
secA2 -1.3 1.6 -9.6 -2.6 -72.5 
secA2* -5.3 3.3 1.2 1.2 -3.0 
ΔsecH -20.1 1.8 3.5 -1.2 -2.0 
secA2H -14.4 2.3 3.0 1.0 -1.8 
secY2 -24.5 1.7 7.8 1.6 1.1 
sap-eag - - -1484.7 -331.3 -1329.2 
prsAA -17.1 1.6 5.7 1.6 -1.4 
prsAB -2.2 3.1 -8.5 -3.8 -35.2 
secAC -8.7 11.9 -1.1 -2.0 -1.2 
       
sap Wild type -1.8 -48.5 - - - 
secA2 -5.8 -1.8 -3.8 -12.3 7.1 
secA2* -0.8 -1.5 -4.1 -1.9 8.1 
ΔsecH -0.2 -5.6 -13.3 -1.5 -1.5 
secA2H -0.3 -11.7 -6.9 -1.3 -1.6 
secY2 -0.4 -9.9 -4.7 1.0 1.0 
sap-eag - - -15329.3 -7650.7 -166.3 
prsAA -0.2 -5.5 -9.3 -1.3 -1.0 
prsAB -3.1 -1.4 -3.9 -6.8 9.0 
secAC -0.6 -25.1 -1.4 2.0 1.4 
 
Secondly, the Ct values obtained for the wild type strain were used as reference 
points to calculate the fold change in expression of eag and sap in the analysed mutants 
in reference to the wild type (Table 10.1, last three columns; Figure 10.2). The down-
regulation of eag and sap, observed in the Northern blotting experiment, was confirmed 
in both exponential and transitional phase in the secA2 and ∆prsAB mutants. In 
stationary phase, eag was down-regulated while sap was up-regulated. Unexpectedly, 
∆secA2H, although phenotypically similar to ∆secA2, since neither expresses secH, did 
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not show the same pattern of changes in eag and sap expression. In ∆secA2H, eag was 
overexpressed, while sap was down-regulated in the exponential phase; little or no 
variation was observed in transitional and stationary phase. ∆secA2* showed a similar 
pattern of gene expression to ∆secA2 and ∆prsAB in the stationary phase (down-
regulation of eag, up-regulation of sap); However, in the transitional phase sap and eag 
∆secA2* showed no significant change in expression, while in the exponential phase 
there was no change in expression of eag, but down-regulation of sap. It is noteworthy 
that four mutants: ΔsecH, ΔsecA2H, ΔprsAA, ΔsecY2, exhibited the same pattern of 
expression in the exponential phase: up-regulation of eag and down-regulation of sap. 
The analysis of eag and sap expression confirmed that the absence of SecA2 and PrsAB 
resulted in changes in the expression of sap and eag. It was interesting to note that the 
expression pattern of the three mutants with lesions at the secA2, secH locus, namely 
∆secA2*, ∆secA2 and ∆secA2H differed significantly. The differences in expression in 
∆secA2* as compared to ∆secA2 and ∆secA2H may be the result of the presence in the 
former of a functional secH gene. The reasons for differences in the expression pattern 
of ∆secA2 and ∆secA2H are not clear, since phenotypically they are similar; neither is 
able to express secA2 or secH. The deletion of other genes (secY2, secH, prsAA, prsAC) 
whose products are involved in secretion also caused changes in sap and eag 
expression. The expression of eag was up-regulated and of sap was down-regulated in 
the exponential phase in ΔsecY2, ΔsecH and ΔprsAA; while the expression of eag was 
down-regulated and of sap up-regulated in the transitional phase in ΔprsAC.  
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Figure 10.2: Changes in the expression of eag and sap in various secretion 
mutants of B. anthracis compared to the wild type. RNA was isolated from 
cultures in: A. exponential (OD  0.8); B. transitional (OD  2.2); C. 
stationary phase (OD  4.5). The expression was determined by SYBR green 
real-time relative quantitative PCR (qRT-PCR), normalised against the 
reference gene gyrB. Error bars represent standard deviations   
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10.2 Discussion 
In the absence of SecA2 and PrsAB, no EA1 and Sap are detected either in the 
culture supernatant or in the cytoplasm. The latter observation suggests that SecA2 
might have a chaperone function. We therefore decided to study the effect of various 
secretion mutants on eag and sap expression. The initial conclusions drawn from 
Northern blotting analysis indicated that a lack of SecA2 and PrsAB had a supressing 
effect on expression of eag and sap. These data were supported by subsequent qPCR 
experiments. Moreover, qPCR showed that this observation extends to other 
components of secretion machinery occurring both inside (SecY2, SecH) as well 
outside (PrsAA, PrsAC) the cell. Since SecA2 and PrsAB are active in different cellular 
compartments this suggests that the effect on eag and sap expression was indirect. Such 
one indirect effect might come from the putative cell wall stress caused by the lack or 
reduction in presence of S-layer proteins on the surface of the cell wall in ∆secA2*, 
∆secA2, ΔsecH, ΔsecA2H, ΔprsAB or due to the absence of an as yet unidentified 
component(s) of the cell envelope that is/are substrate(s) of PrsAA, PrsAC, PrsAB, 
SecA2, SecH, SecY2.  
The cell wall stress, which could be induced by the lack or reduction of the cell 
surface components, could lead to the triggering of a two-component signal 
transduction system, such as WalRK, which has been shown previously to sense cell 
wall stress (Cao et al., 2000, Dubrac et al., 2007). WalRK is a typical two-component 
system consisting of a transmembrane sensor kinase, (WalK) and the response regulator 
(WalR). The sensor kinase WalK senses a signal that leads to its activation via 
autophosphorylation. WalK in turn phosphorylates its cognate transcriptional response 
regulator WalR, the activated form of which modulates its own gene expression and that 
of members of the WalRK regulon. Members of WalRK regulon encode proteins such 
as autolysins, that are involved in the cell wall metabolism (Dubrac et al., 2008). It is 
possible that activation of the two-component system, like WalRK could lead to the 
modulation of sap and eag expression. Alternatively, the cell wall stress could be 
related to the transcriptional attenuator, LytR which was identified as potentially 
interacting with SecH in the pull-down experiment (Section 6.2). If LytR was also a 
substrate for SecA2 and possibly PrsAB, then the absence of SecA2 and PrsAB would 
lead to the decrease or absence of LytR in the cytoplasmic membrane. The function of 
LytR is attenuating the expression of genes encoding autolysins. Consequently, absence 
of LytR could lead to the derepression of those autolysins as observed in B. subtilis and 
S. pneumoniae (Lazarevic et al., 1992; Johnsborg and Håvarstein, 2009). This would, in 
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turn, lead to cell wall perturbations. The resulting cell wall stress would then be 
detected by a two-component system, which might modulate eag and sap expression in 
analysed mutants.  
It is also noteworthy that the results of the qPCR experiment of this study 
correlate the expression pattern of sap and eag and the phase-dependent production of 
Sap and EA1 previously observed by Mignon et al. (2002). They showed that when 
grown in rich media, B. anthracis exhibits growth-phase dependant manner of Sap and 
EA1 production, where Sap is produced predominantly in the exponential phase and 
EA1 in the stationary phase with sap expression peaking at the exponential phase and 
that of eag at the stationary phase. In this study, the similar pattern of expression was 
found to be present in the wild type strain: the decrease of sap expression and the 
increase of eag expression in the stationary phase, implying that the highest expression 
of sap takes place in the exponential phase while that of eag in the stationary phase. In 
the analysed mutants, overall, the expression of eag was also increased in the stationary 
phase, while the expression of sap was decreased in the stationary phase in ΔsecH, 
ΔsecA2H, ΔprsAA, ΔprsAC, ΔsecY2 mutants, while in secA2 and ∆prsAB, secA2* 
not much change was observed.  
In many instances when sap was up-regulated, eag was down-regulated: this 
was observed in the transitional phase for ΔprsAC, and in the stationary phase for 
secA2, secA2*, ∆prsAB. The opposite pattern of expression: sap down-regulation and 
eag up-regulation was observed commonly in the exponential phase in: ΔsecH, 
ΔsecA2H, ΔprsAA, ΔsecY2. This observations correlate with findings by Mignon et al. 
(2002) that Sap binds to the promoter of eag, supressing its expression. Thus when sap 
was up-regulated, implying increased production of Sap, then eag expression was 
probably supressed due to the increased Sap levels binding to the eag promoter. 
Similarly, when sap was down-regulated, so less Sap was produced, then the level of 
eag expression increased, as the eag promoter was predicted not to be repressed by Sap. 
The analysis of expression of sap and eag in ∆secA2*, ΔsecH, ΔsecA2H, 
ΔprsAB, ΔsecY2 is being continued by microarray analysis, to get more insights what is 
happening on the transcriptional level in those mutants. The microarray experiments 
have been already done, but the microarray data are awaiting analysis and they are not 
included in this thesis.  
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Chapter 11: Analysis of B. anthracis null mutants complemented with 
sap and eag 
A complementation approach was used to confirm the roles of and to get new insights 
into various components of the alternative Sec pathways on the secretion of EA1 and 
Sap. To achieve that, genes of interest were cloned into an expression plasmid pKG400. 
The recombinant plasmids were then introduced into various B. anthracis null mutant 
strains. Next, the constructed expression plasmid was transformed into B. anthracis to 
analyse the influence of various Sec pathway components on the secretion of Sap and 
EA1. 
11.1 Secretion of Sap and EA1 in B. anthracis null mutants complemented with eag 
and sap 
In a set of reciprocal experiments, the sap and eag genes were cloned on the 
complementation plasmid pKG400 and transformed into B. anthracis wild type as well 
as into various mutant strains. The aim was to monitor Sap and EA1 secretion under 
conditions in which their expression could be controlled independently of their intrinsic 
promoters and associated regulatory sequences. Consequently, the entire coding 
sequences of eag and sap were cloned independently downstream of the Pgrac promoter 
of pKG400, to generate pKG400-sap and pKG400-eag. By transforming these plasmids 
into strains lacking various components of the accessary Sec pathway, and analysing the 
resulting supernatant fractions by SDS-PAGE, it was possible to evaluate the effect of 
these components on the secretion of Sap and EA1 without the complication of any 
feedback regulation.   
The sap and eag genes were cloned independently into the pKG400 expression 
vector and subsequently transformed into B. anthracis wild type and ∆secA2*, ∆secH, 
∆secA2H, ∆prsAB and ∆sap-eag mutants. The presence of the complementation 
plasmid and its authenticity in each strain was confirmed by restriction digest analysis 
of purified plasmids. The B. anthracis strains complemented with pKG400-sap and 
pKG400-eag were grown to an OD600 of 0.8 when sap or eag expression was induced 
with IPTG. The cultures were incubated by a further 90 minutes and then proteins 
extracted from the supernatant were analysed by SDS-PAGE. The procedures for 
extracting proteins for the strains complemented with sap and eag differed slightly due 
to their cell wall binding characteristics. The extraction of extracellular proteins from 
the strains complemented with sap was carried out according to the standard procedure 
(Section 2.9.2). As EA1 binds more strongly to the cell wall, the extraction of 
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extracellular proteins from the strains complemented with eag was carried using a 
modified protocol (Section 2.9.3). In this method, lithium chloride was used to break 
non-covalent interactions between the cell wall and EA1 with the effect of releasing 
more of this protein into the supernatant. The TCA-precipitated extracellular proteins 
were subsequently analysed by SDS-PAGE (Figures 11.1 and 11.2). B. anthracis wild 
type and the ∆sap-eag mutant served as positive and negative control strain, 
respectively. Interestingly and unexpectedly, the secretion of Sap was decreased in the 
wild type strain in the presence of the non-induced pKG400-sap complementation 
plasmid. Similarly, ΔsecH complemented with the non-induced pKG400-sap plasmid 
showed negligible secretion of Sap compared with the induced sample, even though the 
previous experiments had clearly shown that Sap is secreted in the absence of secH. 
These results suggest that the additional copies of sap on the complementation plasmid 
lead to a down-regulation of sap expression. It raises the possibility of the existence of 
an antisense RNA species within sap with an inhibitory effect on sap expression. In 
contrast, similar levels of EA1 secretion were observed from the B. anthracis wild type 
complemented with pKG400-eag irrespective of whether the eag gene was induced, and 
for the wild type with the empty vector (pKG400-empty). In the case of the ΔsecH 
mutant, EA1 was secreted irrespective of whether the inducer was added, although the 
level of secretion increased in the presence of IPTG.  
Complementation of the ∆prsAB mutant with either sap or eag gave very 
different results. In the absence of induction, very little S-layer protein was observed in 
either case. However, when sap was induced, the concentration of Sap in the culture 
medium was similar to that of the wild type. In contrast, very little EA1 was observed in 
the culture medium when eag was induced. These results suggest that one or more of 
the following: (1) EA1 is more dependent on PrsAB than Sap, (2) that PrsAA and/or 
PrsAC can complement PrsAB with respect to Sap but not EA1 secretion (3), that Sap is 
more/equally dependent on PrsAB than EA1 and that the absence of EA1 is due to it 
interacting more strongly with the cell wall, meaning that less is secreted into the 
culture medium.  
Finally, the complementation of the ∆sap-eag mutant with either Sap or EA1 
also gave very contrasting results. While the secretion of Sap was restored by the 
induced pKG400-sap strain, very little EA1 was observed in the culture medium of the 
induced pKG400-eag strain. We concluded that this was likely to be due to the strong 
binding of EA1 to the cell wall due to the absence of Sap. 
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Figure 11.1: Complementation of B. anthracis wild type (wt) and ΔsecA2*, ΔsecH, 
ΔsecA2H, ΔprsAB, Δsap-eag mutants with the pKG400-sap complementation 
plasmid. Expression of sap was induced with 10 mM IPTG (+). Non-induced cultures 
(-) served as negative controls of expression. The B. anthracis wild type and ∆sap-
eag null mutant served as positive and negative control stain, respectively. Sap is 
visible as a band of ~ 90kDa. 
Figure 11.2: Complementation of B. anthracis wild type (wt) and ΔsecA2*, ΔsecH, 
ΔsecA2H, ΔprsAB, Δsap-eag mutants with pKG400-eag complementation plasmid. 
The expression of eag was induced with 10 mM IPTG (+). Non-induced cultures (-) 
served as negative controls of expression. The B. anthracis wild type and ∆sap-eag 
null mutant served as positive and negative control stain, respectively. EA1 is visible 
as a band of ~ 90kDa. 
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B. anthracis ΔsecA2* complemented with sap or eag shows some degree of restoration 
of Sap and EA1 secretion although at a much lower than in the B. anthracis wild type or 
ΔsecH, ΔprsAB, Δsap-eag mutant strains complemented with sap. This confirms the 
importance in SecA2 in Sap secretion, but also indicates that SecA1 can complement 
SecA2. This observation is consistent with studies in B. subtilis (Section 5) showing 
that both B. subtilis SecA and B. anthracis SecA1 can mediate Sap and EA1secretion. 
In ΔsecA2H, the ability to restore Sap and EA1 secretion is very low, confirming 
importance of SecH in the secretion of Sap and EA1 in participation with SecA2.  
One possible explanation for some of the unexpected results obtained during the 
complementation studies was that some as yet unidentified factor interfered with the 
expression of the sap or eag genes that were not induced in some cases. We therefore 
carried out Northern blotting analyses on the complementation strains with or without 
induction (Figures 11.3 and 11.4). Upon induction, the expression of sap and eag 
increased in all the strains. It is noteworthy that the non-induced wild-type strain of B. 
anthracis encoding pKG400-sap, which shows reduced secretion of Sap, nevertheless 
shows a level of sap mRNA that is at least comparable to that of the wild type without 
the empty plasmid. This might indicate that putative inhibitory sRNA (small, 
regulatory) binds to the sap mRNA preventing or reducing its translation. The induced 
levels of sap and eag mRNA in the complemented ΔsecA2H, ΔprsAB, Δsap-eag (and 
ΔsecH in the case of pKG400-sap) are much higher than that of the complemented wild 
type strain. The reason for this increased level of expression was not investigated. The 
minimal level of Sap in the supernatant of the ΔsecA2H mutant complemented with sap, 
in spite of its very high expression, confirms again crucial importance of SecA2 for 
secretion. At the same time, the minimal level of Sap secretion in this complemented 
strain is again suggestive of the participation of SecA1. 
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Figure 11.3: Northern blot analysis of the complementation of B. anthracis 
wild type (wt), ΔsecH, ΔsecA2H, ΔprsAB, Δsap-eag strains with pKG400-
sap. The expression of sap was induced with 10 mM IPTG (+). Non-
induced cultures (-) served as negative controls. 
Figure 11.4: Northern blot analysis of the complementation of B. anthracis 
wild type (wt), ΔsecH, ΔsecA2H, ΔprsAB, Δsap-eag with pKG400-eag. The 
expression of eag was induced with 10 mM IPTG (+). Non-induced cultures 
(-) served as negative controls. 
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11.2 Discussion 
Complementation analysis allowed us to reinforce previous findings as well as get new 
insights about the secondary translocase of B. anthracis. Previous experiments showed 
the essential role of SecA2 for Sap and EA1 secretion. Similarly, studies in which the 
ΔsecA2* and ΔsecA2H mutants were complemented with inducible sap and eag genes 
also confirmed the importance of SecA2 in Sap and EA1 secretion. However, these 
studies also show that SecA1 can mediate the secretion of these proteins in the absence 
of SecA2. This observation confirms data obtained from B. subtilis in which Sap and 
EA1 were secreted by cells in which either B. subtilis SecA or B. anthracis SecA1 were 
the only SecA-like proteins (Section 5). These observations support a model in which 
SecA1, SecA2 and SecH might form a complex with these substrates prior to their 
translocation through the SecYEG translocation channel.  
As shown in Section 7, PrsAB is essential for the secretion of Sap and EA1 in B. 
subtilis. Moreover, the deletion of prsAB, but not prsAA or prsAC prevents Sap and 
EA1 secretion in B. anthracis. Because the expression of eag and sap is down- 
regulated in the ΔprsAB mutant, it was necessary to study the role of PrsAB in strains in 
which sap and eag expression was maintained. These showed contrasting results. EA1 
appears to be significantly more dependent on PrsAB-mediated folding than Sap. This 
implies either that Sap is less PrsAB-dependent or that PrsAA and/or PrsAC may 
contribute to its folding. Thus, the lack of secretion of Sap and to some extent EA1 in 
the non-complemented ΔprsAB mutant might be due to the suppression of sap and eag 
expression from their native promoters. The putative cell wall stress mediated 
suppression in ΔprsAB could be triggered not only by absence of the S-layer proteins 
but also by an as yet unidentified PrsAB substrate(s) involved in cell wall metabolism.  
In conclusion, these complementation studies add to the complexity of eag and sap 
regulation and the extent of their interaction with the cell wall. Complementation of     
B. anthracis wild type and B. anthracis ΔsecH with sap suggest that there may also be 
inhibitory regulation of the sap expression by sRNA species encoded within sap gene. 
The inhibition might be achieved by preventing protein synthesis from sap mRNA.  
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Chapter 12: Analysis of cell morphology of B. anthracis mutants 
12.1 Analysis of cell morphology by florescent microscopy 
The deletion of genes encoding proteins involved in the secretion processes (SecA2, 
SecH, SecY2, PrsAA, PrsAB, PrsAC) and S-layer proteins (Sap and EA1), which were 
investigated in this study, could lead to changes in cell morphology. Firstly, absence or 
shortage of S-layer in ΔsecA2*, ΔsecH, ΔsecA2H, ΔprsAB, Δsap-eag mutants could be 
causing some changes to the cell shape as S-layer is part of the cell envelope. If it is the 
case, it would indicate that the S-layer takes part in maintaining cell shape. If there was 
no change to the cell shape in Δsap-eag, but it could be observed in ΔsecA2*, ΔsecH, 
ΔsecA2H, ΔprsAB, it would indicate that those mutants were defective in secretion of 
other substrate(s) than Sap and EA1 that are involved in the cell wall metabolism. 
Changes to the cell morphology of ΔsecY2 and ΔprsAA and ΔprsAC also would suggest 
their participation in secretion of substrates is important for maintaining the cell shape. 
To carry out evaluation of the cell morphology of the mutants being analysed, 
fluorescence microscopy was carried out. Cultures of B. anthracis wild type as well as 
ΔsecA2*, ΔsecH, ΔsecA2H, ΔprsAA, ΔprsAB, ΔprsAC, Δsap-eag were sampled during 
the exponential (OD600=0.6-0.8) and transitional (OD600=2.0-2.5) phases. Aliquots of 
cultures were treated with the FM5-95 membrane stain (final concentration 1μg/ml) and 
mounted onto a microscope slide coated with 1.2% agarose and immobilized using a 
glass cover slip and images were acquired on an Axiovert M200 microscope (Zeiss Ltd., 
Oberkochen, Germany) (Section 2.16). The lengths of cells were measured using 
ImageJ software (http://rsb.info.nih.gov/ij) and the data are presented in the Table 12.1 
together with the number of cells counted and variance values. The percentage of 
change of the cell length in relation to the wild type of B. anthracis is presented in the 
Table 12.2 (columns 1 and 2). Considerable differences were observed in shapes and/or 
sizes for cells of the B. anthracis ΔsecA2*, ΔprsAA and ΔprsAB mutants, both during 
the exponential and transitional phases (Figures 12.1 and 12.2, respectively). The 
significance of the change in their cell length in comparison with the wild type was 
confirmed statistically using the unpaired t-test, with p values below the significance 
level (0.05) for those strains (Table 12.2, columns 3 and 4). Cells of wild type B. 
anthracis, used as a control, were short and straight with average lengths of 4.01 µm 
and 3.97 µm in the exponential and transitional phase, respectively. Cells of ΔsecA2* 
were filamentous and some were twisted, with an average length of 7.95 µm in 
exponential phase and 8.56 µm in the transitional phase. Cells of ΔprsAB were also on 
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average longer and somewhat more twisted than the wild type with average lengths of 
5.45 µm and 5.15 µm in the exponential and transitional phase, respectively. Cells of 
the ΔprsAA mutant were on average longer and somewhat twisted in comparison to the 
wild type, with average lengths of 4.95 µm and 4.76 µm in the exponential and 
transitional phase, respectively.  
Histograms were used to illustrate the range of cell lengths of the wild type and 
mutants (Figures 12.3 and 12.4). The lengths of the wild type ranged from 2.0-7.0 µm in 
exponential phase and 2.0-9.0 µm in transitional phase. Overall, the range of cell length 
was related to the average length of cells in the analysed mutants. In all cases the range 
of lengths of the ΔprsAA, ΔprsAB, ΔsecA2* mutants was much larger; 2.0-45 µm and 
2.0-30 µm in the case of the ΔsecA2* mutant in the exponential and transitional phase, 
respectively; 2.5-15.0 µm and 2.0-12.0 µm for the ΔprsAB mutant in the exponential 
and transitional phase, respectively, and 2.0-12.0 µm and 1.0-9.0 µm for the ΔprsAA 
mutant in the exponential and transitional phase, respectively. The shapes, average 
lengths and range of lengths of the other mutants (ΔsecH, ΔsecA2H, ΔprsAC, Δsap-eag 
and ΔsecY2) were not significantly different from those of the wild type (Table 12.1 and 
12.2, Figures 12.1 and 12.2). 
 
Table 12.1: The average lengths of cells during exponential and transitional phase of 
the analysed B. anthracis wild type and mutants. The range of lengths of B. anthracis 
wild type, ΔsecA2*, ΔprsAA, and ΔprsAB are shown on histograms (Figures 13.3 and 
13.4). The number of cell counted is shown in columns 3 and 4. Variance is presented in 
columns 5 and 6. 
 Growth phase 
 exponential transitional exponential transitional exponential transitional 
 average length (µm) 
 
Number of cells 
counted (n) 
Variance 
Wild type 4.01 3.97 100 121 0.88 0.86 
ΔsecA2* 7.95 8.56 121 103 24.50 20.19 
ΔsecH 3.76 3.55 102 102 0.57 0.85 
ΔsecA2H 3.89 3.75 103 121 0.81 0.78 
ΔprsAA 4.95 4.76 101 98 2.47 1.45 
ΔprsAB 5.45 5.15 103 113 4.85 4.12 
ΔprsAC 3.90 3.86 107 114 0.65 0.74 
Δsap-eag 3.42 3.56 102 105 0.60 0.81 
ΔsecY2 4.12 3.69 107 106 0.58 0.85 
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Table 12.2: The change in the cell length, in relation to the wild type in exponential and 
transitional phases, is presented in first two columns; two last columns show statistical 
significance of change of cell length of the null mutnt strains in comparison to the cell 
length of the B. anthracis wild type evaluated by unpaired t-test. The significance level 
= 0.05. 
  Growth phase 
  exponential transitional exponential transitional 
  change in average 
length (%) 
p values 
Wild 
type 
     
ΔsecA2*  +98 +116 1.7E-35 6.0E-39 
ΔsecH  -6.0 -11 0.70 0.98 
ΔsecA2H  -3 -6 0.87 0.98 
ΔprsAA  +23 +20 3.1E-19 7.4E-21 
ΔprsAB  +36 +30 3.6E-29 6.6E-22 
ΔprsAC  -3 -3 0.98 0.99 
Δsap-eag  -15 -10 0.93 1.00 
ΔsecY2  +3 -7 0.06 0.97 
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Figure 12.1: Micrographs of B. anthracis wild type and ΔsecA2*, ΔsecH ΔsecA2H, 
ΔprsAA, ΔprsAB, ΔprsAC, Δsap-eag and ΔsecY2 mutants in exponential phase. Cells 
were stained with the membrane stain FM5-43FX.  
wild type B. anthracis wild type ΔsecA2* ΔsecA2H 
ΔsecH ΔprsAB 
 
ΔprsAA 
 
ΔprsAC 
 
Δsap-eag 
 
ΔsecY2 
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Figure 12.2: Micrographs of B. anthracis wild type and ΔsecA2*, ΔsecH ΔsecA2H, ΔprsAA, 
ΔprsAB, ΔprsAC, Δsap-eag and ΔsecY2 mutants in transitional phase. Cells were stained with 
the membrane stain FM5-43FX.  
wild type B. anthracis wild type ΔsecA2H 
 
ΔsecH ΔprsAB 
 
ΔprsAA 
 
Δsap-eag 
 
ΔsecY2 
 
ΔprsAC 
 
 
ΔsecA2* 
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Figure 12.3: Histograms of the distributions of cell length during exponential 
phase of B. anthracis wild type and prsAA, prsAB, secA2* mutants. 
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Figure 12.4: Histograms of the distributions of cell length during transitional phase 
of the B. anthracis wild type prsAA, prsAB, secA2* mutants. 
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12.2 The secretion of penicillin binding proteins (PBPs)  
The alternations of cell morphology in prsAA, prsAB, secA2* are possibly caused 
by reduction of secretion and activity of enzymes involved in cell wall metabolism. One 
group of those enzymes are penicillin-binding proteins. To evaluate if they contribute to 
the alterations in the cell shape of prsAA, prsAB, secA2* their activity was 
analysed. Penicillin-binding proteins are membrane-bound enzymes involved in the 
synthesis of the peptidoglycan (Macheboeuf et al., 2006). There are three types of 
PBPs: (i) transpeptidases; (ii) transglycosylases; (iii) bifunctional transpeptidase-
transglycosylases. Transglycosylase activity is responsible for polymerisation of the 
peptidoglycan, while transpeptidase activity is responsible for the cross-linking of 
peptidoglycan strands. PBPs bind penicillins because β-lactams are structural analogues 
of their natural substrates, the D-alanyl-D-alanine substituents of the crosslinking 
peptide of peptidoglycan. Deletion of PBPs leads to changes in cell morphology (length 
and shape). If secretion of one or more PBPs was to be altered in the prsAA, prsAB, 
secA2*, it might account for the observed changes in their cell morphology. We 
therefore used the Bocillin assay (Section 2.14) to determine the presence of PBPs in 
these mutants. There is no published detailed information on the PBPs of B. anthracis 
and therefore we annotated PBPs visualised in the Bocillin assay by reference to those 
of B. subtilis and E. coli. Six PBPs are detected in E. coli (PBP 1a, 1b, 2, 3, 4 and 5) 
(Zhao et al., 1999), while seven are detected in B. subtilis (PBP 1a, 1b, 2a, 2b, 3, 4, and 
5) (Hyyryläinen et al., 2010). To confirm that annotation of gel-separated PBPs in B. 
anthracis is correct would require the generation of null mutants for each PBP identified 
in the B. anthracis genome, and comparing their profiles with that of the wild type. As 
this was beyond scope of this thesis, this has not been done. As the Bocillin assay for 
PBPs looked more like that of E. coli, its annotation was used for B. anthracis. Analysis 
of the PBPs visualised by the Bocillin assay indicated that the PBP profiles of each of 
the mutants was the same as the wild type excepting that of prsAA in which the 
presence of several bands, putatively named PBP1a/b, PBP2, PBP3 and PBP4 were 
reduced (Figure 12.5).  
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12.3 Discussion 
The analysis of cell size data indicates that B. anthracis secA2*, ∆prsAA and ∆prsAB 
mutants show an increase in average cell length and range of cell length when compared 
with the wild type. The secA2* and ∆prsAB mutants also showed changes of cell 
morphology; the cells were longer and twisted in comparison with the short, straight 
cells of the wild type and other mutants. This suggests that SecA2 and PrsAB may have 
substrates other than that of Sap and EA1 that are involved in cell division, for example 
one or more autolysins, which are enzymes involved in cell wall metabolism. Currently, 
it is not clear whether these putative additional substrates are the same for SecA2 and 
PrsAB or distinct, since the cell morphologies of the secA2* and ∆prsAB are similar 
but not identical. However, PrsA-like proteins are known to have distinct but 
overlapping substrate specificities and that PrsAA and or AC may, to some extent, 
compensate for the lack of PrsAB. The analysis of the cell morphology also suggests 
that a substrate of PrsAA is also involved in the cell wall metabolism. This correlates 
with the results of the Bocillin assay, which showed a decrease in the activity of some of 
penicillin binding proteins (PBP1a and 1b, PBP2, PBP3, PBP4). The question arises as 
to why the cell morphology of the secA2* mutant is changed, while that of ∆secA2H is 
not. The genes of two proteins involved in the modification of B. anthracis cell wall, 
namely CsaA and CsaB, are located upstream of secA2 and we used Northern blot 
analysis to analyse their expression in the secA2* and ∆secA2H mutants (Section 8.3). 
Figure 12.5: Bocillin assay of the PBPs of B. anthracis strains:  (1) wild type, (2) 
secA2*, (3) secA2H, (4) prsAA, (5) prsAB, (6) prsAC, (7) sap-eag 
visualised by Fluorography. The presence of PPB1a/b, PBP2, PBP3 and PBP4 is 
reduced in the ∆prsAA mutant but not in the other analysed mutants. 
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The resulting data indicated that csaA/B were down-regulated in the secA2* mutant. 
As csaA and csaB encode products which are responsible for the attachment of all SLH 
domain-containing proteins to the peptidoglycan, including Sap and EA1 (Mesnage et 
al., 2000; Kern et al., 2010), then secA2* could have the display of SLH-containing 
proteins, other than Sap and EA1, reduced or abolished. This conclusion would be 
consistent with the observation that cells of B. anthracis csaB-null mutant, like that of 
the secA2*  mutant, are filamentous and twisted (Mesnage et al., 2000).  
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Chapter 13: Investigation of interactions between elements of 
 translocation system 
 
In biological systems, the complex processes that take place are often due to the specific 
interactions that occur between individual components or groups of components. In this 
study, the bacterial-two hybrid system was employed to investigate interactions between 
elements of the Sec translocation system and between those elements and their 
substrates. An attempt was also made to purify SecA1, SecA2 and SecH for analysis by 
isothermal calorimetry and resolution of their crystal structures. 
13.1 Bacterial-two hybrid assay (B2H)  
The bacterial-two hybrid technique facilitates the analysis of potential protein-protein 
interactions. Briefly, the two-hybrid system uses the Bordetella pertussis enzyme, 
adenylate cyclase, involved in the synthesis of cyclic AMP (cAMP). Cyclic AMP is the 
secondary messenger which, together with the catabolite activator protein (CAP), is 
responsible for the induction of catabolite repressed genes such as lacZ. In the bacterial 
two hybrid system, two fragments of the cya gene, T25 and T18, are cloned 
independently into “bait” and “prey” plasmids. The target interacting proteins are then 
cloned in-frame with the T25 or T18 fragments and transformed into the same strain of 
E. coli, which lacks adenylate cyclase activity (∆cya). Interaction between the target 
proteins results in a functional complementation between the T25 and T18 fragments. 
The ‘reconstituted’ Cya leads to the synthesis of cyclic AMP which, in turn, interacts 
with CAP to induce the expression of the reporter gene, for example lacZ. Expression of 
lacZ can be readily detected on plates containing X-gal (Figure 13.1).  
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Analysis of the interaction between components of the Sec pathway and substrates 
Sap and EA1 by B2H 
 
In this study the bacterial two-hybrid system was used to identify putative interactions 
between components of the SecA1 and SecA2 secretory machines and SecA2 substrates 
Sap and EA1. The mutual interactions of the following proteins were investigated: 
SecA1, SecA2, SecY1, SecY2, SecH, Sap, EA1 as well as SecA of B. subtilis. The 
coding regions of each of the above proteins were cloned in-frame into four vectors: (i) 
5’-T25-target gene-3’, (ii) 5’- target gene-T25-3’, (iii) 5’-T18-target gene-3’, (iv) 5’- 
target gene-T18-3’. Virtually all pairwise combinations of T25- and T18-based clones 
were tested by co-transforming them into E. coli ∆cya, selecting on LB agar plates 
 
Figure 13.1: Detection of in vivo interactions between two proteins of interest with the 
bacterial two-hybrid system based on the reconstitution of adenylate cyclase activity 
(diagram from BACTH manual). T25 and T18 are fragments of the Bordetella pertussis 
adenylate cyclase. Both fragments, T18 and T25, form a catalytic domain which 
converts ATP into cAMP (A). When T25 and T18 are apart, then no cAMP is produced 
(B). In a bacterial two hybrid assay, two proteins of interest (X and Y) are fused to T18 
and T25. If the proteins X and Y interact with each other, then T18 and T25 fragments 
are brought together to restore adenylate cyclase activity and be able to produce cAMP 
(C). cAMP interacts with CAP to induce expression of a number of operons such as the 
lac or mal operons (D). The consequence of induction of the lac operon is the production 
of β-galactosidase, the activity of which can be readily detected on the LB agar 
containing X-gal substrate, as X-gal cleaved by β-galactosidase, yields blue coloured 
colonies. 
 
139 Chapter 13: Investigation of interactions between elements of translocation system 
containing kanamycin, ampicillin, IPTG and X-gal. The presence of blue colonies 
indicated a putative positive interaction. To summarize the results visually, the matrix 
of interactions between analysed components of the Sec pathway was made (Figure 
13.2). The table of all reciprocal interactions between T18- and T25-fusion proteins is 
presented in the Appendix D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consistent with the observation that SecA exists in monomer-dimer equilibrium, but 
with the balance shifted towards the dimeric form (Woodbury et al., 2002; Vassylyev et 
 
Figure 13.2: Results of bacterial-two hybrid (B2H) analysis of putative interactions 
between components of the Sec pathway of B. anthracis. The matrix shows the 
results of the B2H assay for putative interactions between components of the B. 
anthracis secondary Sec translocation systems and its putative substrates, as well as 
the SecA/A1 proteins of B. subtilis and B. anthracis. The proteins tested were B. 
anthracis SecA1, SecA2, SecY1, SecY2, SecH, EA1 and Sap, and B. subtilis SecA 
(Bsu SecA). The proteins were fused to T18 and T25 domains of the Bordetella 
pertussis adenylate cyclase. Positive results, showing putative in vivo interactions 
between target proteins are indicated by blue colonies/spots. Negative results are 
indicated by yellow colonies/spots. Abbrevations: + ve: positive control; -ve: 
negative control. 
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al., 2006; Papanikolau et al., 2007), the SecA-like proteins, SecA (B. subtilis), SecA1 
and SecA2 (B. anthracis) were shown to interact with themselves in the bacterial-two 
hybrid assay. Interestingly, SecA1 showed an interaction with SecA2, giving rise to the 
possibility that SecA1 and SecA2 interact in vivo to form a dimer. The only other 
interaction shown by SecA1 was with SecY2. SecA2 interactions were the most 
extensive and apart from the interaction with itself, SecA2 was shown to interact with 
SecY1, SecY2, SecH and EA1.  
In the case of testing interaction between Sap and EA1 against components of 
the Sec pathway, only the N-terminus of the Sap and EA1 pre-proteins was used. To 
achieve that 5’ends of sap and eag were cloned in frame into T18 and T25 fragments of 
bacterial two hybrid vectors. The 5’ ends of those genes encoded signal peptide and N-
terminus of the mature protein (80 amino acids in case of EA1 and 67 amino acids in 
case of Sap). This approach was used as according the predominant concept the leader 
peptide, located on the N-terminus of secretory proteins is responsible for targeting 
them for secretion, with the signal peptide making initial interaction between a secretory 
protein and SecA (described in detail in the Section 1.5.1). Using the N-terminus of S-
layer proteins was sufficient to show interaction between SecA2 and EA1, but not 
between SecA2 and Sap. As there was no interaction between SecA2 and the N-
terminus of Sap, the whole gene was cloned, but still without positive interaction being 
observed (data not shown), although this interaction might have been expected since 
Sap is a putative SecA2 substrate (Section 1.7 and 8.4). The occurrence of interaction 
between SecA2 and N-terminal terminus of EA1 shown by bacterial two-hybrid assay 
indicates importance of N-terminus of EA1 for its interaction with SecA2 and we are 
currently unable to rule out interactions with the C-terminus of this protein. Moreover, it 
is noteworthy EA1 N-terminus interactions with both SecA2 and SecH were mediated 
by C-terminal fusions of T18 and T25 with EA1 N-terminus (Appendix D).  This might 
suggest the importance of the signal peptide for those interactions.   
SecH was shown to interact with both SecA2 and EA1, suggesting that SecH 
helps to facilitate interaction between SecA2 and its substrate. This is consistent with 
the data obtained with the secH-null mutant (Section 4). In this respect we considered 
the possibility that SecH might a functional homologue of SecB, which facilitates the 
interaction between SecA and its substrates in Gram-negative bacteria. In the bacterial 
two-hybrid assay, SecH interacts with itself, suggesting it functions as dimer or higher 
order multimer. For comparison, SecB is a tetramer, forming a dimer of dimers. There 
is no structure of SecH available, but it was possible to obtain a prediction of its 
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structure using I-Tasser structural prediction software available on-line at 
http://zhanglab.ccmb.med.umich.edu/I-TASSER/ (Figure 13.3A). The structure of SecB 
has been resolved (Dekker at al., 2003) and it is shown on Figure 13.3B. SecB has 
extensive β-sheets which serve as the interaction interface with its substrate proteins. 
The cores of each monomer is formed by β-sheets linked by α-helices. Similarly, SecH 
is predicted to have extensive β-sheets joined by α-helices.  
              
BA
 
 
 
The predicted structural similarity of SecH as well as its interaction with both the 
SecA2 molecular motor and its substrate may support the hypothesis that SecB and 
SecH are potentially functional homologues.  
13.2 Purification of SecA1, SecA2, SecH 
Attempts were made to purify SecA1, SecA2 and SecH for in vitro interaction studies 
and for crystallisation and subsequent structural studies. GST tagged SecA1 and SecA2, 
and His-tagged SecH were expressed in E. coli BL21 and purified according to the 
protocol described in Section 2.10. To improve solubility of SecA1, SecA2 and SecH 
they were grown overnight at room temperature and induced with low concentration of 
the inducer IPTG (50 µM). The harvested culture was treated with 1% sarcosyl or 2% 
sodium deoxycholate for 30 minutes on ice prior to sonication. And then the sonicate as 
well as the supernatant fractions were analysed by SDS-PAGE. The procedure with 
treatment of the harvested culture with 1% sarkosyl gave considerable amount of 
soluble proteins: SecA1, SecA2, SecH (Figure 13.4 A and B). 
Three attempts were made to purify the soluble fractions of sarcosyl-treated 
samples containing GST-SecA1 and GST-SecA2 using glutathione affinity columns. 
Figure 13.3: I-Tasser structure prediction of (A) SecH: β-sheets are shown in yellow, α-
helices are shown in purple, loops are visible as white strands; (B) SecB: four subunits 
composed of β-sheets (β1-4) linked by α-helices and loops. 
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However, the amount of the SecA1 and SecA2 proteins obtained in the eluates were 
insufficient: relatively small amount of GST-SecA1 were detected in the eluate fractions 
(1-4) (Figure 13.5) and no GST-SecA2 (Figure 13.6) was found in the elute. The 
proteins were found in the flow-through, indicating the lack of binding of the GST-tag 
to the glutathione. The lack of binding of GST-tagged SecA1 and SecA2 to the 
glutathione column could be due to GST-SecA1 and GST-SecA2 being folded in such a 
way that glutathione-binding domain of GST would be hidden within GST-protein 
complex, thus not available for interaction. 
 
 
        
Figure 13.4 (A and B): Optimisation of soluble SecA1, SecA2 and SecH production. 
GST-SecA1, GST-SecA2 and His-SecH were expressed in E. coli BL21. Sonicated cell 
pellets were treated with either 1% sarcosyl or 2% sodium deoxycholate to solubilise 
released proteins and then analysed by SDS-PAGE. Proteins corresponding in size to 
GST-SecA1, GST-SecA2, His-SecH (125 kDa, 119, 34 kDa, respectively) are visible in 
the crude sonicate samples and in the supernatant samples. More soluble protein was 
observed after treatment 1% sarcosyl rather than 2% sodium deoxycholate.  
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Figure 13.5: Purification of GST-SecA1 (~ 125 kDa) using a glutathione affinity 
column. The supernatant flow-through, elution fractions (1-7) were analysed by SDS-
PAGE. Elution buffer used: 10 mM glutathione in 50 mM Tris-Cl. 
  
 
 
Figure 13.6: Purification of GST-SecA2 (~ 119 kDa) using a glutathione affinity 
column. The supernatant flow-through, wash and elution fractions (1-7) were analysed 
by SDS-PAGE. Elution buffer used: 10 mM glutathione in 50 mM Tris-Cl. 
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13.3 Discussion 
Interactions between elements of the translocation system and EA1 and Sap were 
investigated in order to learn more about how the system functions. Previously, we 
found that SecA2 drives secretion of EA1 and Sap with SecH enhancing the process. 
More insights into interactions between SecA2, its substrates and SecH were provided 
by bacterial two-hybrid analysis. This analysis showed that both SecA2 and SecH were 
able to interact with each other as well as with EA1. As SecH enhances the secretion of 
EA1, this observation may suggest that all three proteins form a tertiary complex, with 
SecH possibly enhancing the interaction between SecA2 and its substrate. In this respect 
SecH would act as a functional homologue of SecB, which facilities the interaction 
between SecA and its cognate substrates in Gram-negative bacteria. However, while 
SecB is essential for that interaction, SecH is not, but serves to increase efficiency of the 
interaction. No interaction between SecH and Sap was observed, showing either the 
limitation of bacterial two-hybrid system or a genuine lack of interaction between these 
proteins. It might be that Sap is not a substrate for SecH, but its secretion might be 
mediated by SRP.  However, the reduction in Sap secretion in the secH-null mutant is 
strongly suggestive of an involvement of SecH. SecH was also shown to interact with 
itself, and is likely to form at least as dimer. SecB, by comparison, forms a dimer of 
dimers (so effectively tetramer) (Dekker et al., 2003). However, since SecB is 
approximately half the size of SecH, a SecH dimer would be similar in size to a SecB 
tetramer. The predicted structure of SecH, like that of SecB, has extensive β-sheets on 
one of its flattened surfaces and α-helices on the other. Consequently, the similarity of 
the SecB and SecH structures provides tentative support that they share similar 
functions.  
Interestingly, our bacterial two-hybrid analysis also demonstrated potential 
interactions between SecA1 and SecA2, indicating possibility of forming a 
SecA1/SecA2 dimer. How might such a dimer be functional? In a Mycobacterium 
smegmatis strains engineered to deplete SecA1, the export of the SecA2-dependent 
substrate Msmeg1712 was severely impaired at low SecA1 concentrations, indicating 
SecA1 is required for SecA2-dependent export (Rigel et al., 2009). A similar situation 
may also apply to B. anthracis, with a SecA2/SecA1 dimer required for the secretion of 
Sap and EA1. In addition, SecA2 was able to interact with both SecY1 and SecY2, 
supporting our model that both SecY1 and SecY2 can form components of a 
translocation channel that is common for all Sec-dependent substrates. We only detected 
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an interaction between SecY2 and SecA1. However, this is likely to be due to limitation 
of the two-hybrid system, since the secY2-null mutant did not affect the secretion of the 
extracellular proteins, indicating that SecY1 must also interact with SecA1.  
To confirm interactions between SecH and other components of the SecA2 
pathway and its substrates, biophysical studies such as isothermal calorimetry (ITC) or 
surface plasmon resonance (SPR) need to be performed. However, attempts to purify 
SecA1, SecA2 and SecH have been made but were unsuccessful. It was possible to 
solubilise SecH, but its purification was not followed due to time constraint. 
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Chapter 14: General discussion 
In this thesis an investigation of the components of the secondary Sec translocase of B. 
anthracis was undertaken. Prior to this study, it was shown that B. anthracis encodes 
two homologues of SecA (SecA1/SecA2) and two homologues of secY (SecY1/SecY2). 
Based on the analysis the neighbourhoods of these genes, the effects of gene deletions 
and complementation studies, SecA1 and SecY1 were likely to be the direct functional 
homologues of B. subtilis SecA and SecY. SecA2 was shown to be required for the 
secretion of the two major S-layer proteins, namely Sap and EA1, while SecY2 did not 
show any substrate specificity. Instead, SecY2 appears to function to ensure high level 
of secretion of Sec-dependent substrates throughout the entire growth cycle (Pohl et al., 
unpublished) since, in contrast to SecY1, it is up-regulated during stationary phase. 
More specifically, these studies have attempted to address the question as to how SecA2 
recognises and distinguishes between its substrates rather than the other ~ 400 proteins 
with similar signal peptides.  
A bioinformatic analysis of the secA2 locus of other members of the B. cereus 
group indicated that whenever secA2 was present in a genome, immediately 
downstream and in the same operon was a second gene that we named secH. The 
product of secH was subsequently found to be unique to members of the B. cereus 
group, and was not found in other bacterial species that encoded SecA2 homologues. In 
its absence, the lack of SecH was shown not to be essential for Sap and EA1 secretion, 
but did reduce its efficiency.  
The bacterial two-hybrid assay was used to explore potential interactions 
between components of the B. anthracis Sec pathways. These experiments provided 
insights into how SecH might function. SecH was shown to interact with itself, SecA2 
and EA1, but interestingly, not SecA1. This suggested that a multimeric SecH forms 
part of a tripartite complex with SecA2 and one or both of its substrates. Interestingly, 
SecA1 and SecA2 also appear to interact, thus raising the possibility that the functional 
unit for secretion of Sap and EA1 could be a SecA1/SecA2 dimer. The support for this 
observation comes from a complementation analysis in which sap and eag were over-
expressed from a non-native, inducible promoter in the ΔsecA2* mutant, in which a 
detectable level of Sap and EA1 secretion was observed. This suggests that 
SecA1/SecA2 substrate specificity might not be as stringent as originally thought and 
these proteins may exhibit some overlapping specificity. This observation correlates 
well with observations from similar studies in Mycobacterium smegmatis. In strains of 
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M. smegmatis engineered to deplete SecA1, the export of the SecA2-dependent 
substrate Msmeg1712 was severely impaired at low SecA1 concentrations, indicating 
SecA1 is required for SecA2-dependent export (Rigel et al., 2009). 
Another candidate factor for conferring SecA2 specificity for Sap and EA1 is 
their signal peptides which, excepting for a single conservative amino acid substitution, 
are almost identical. However, studies in B. subtilis revealed that both its native SecA, 
as well as B. anthracis SecA1 can facilitate Sap and EA1 secretion. This indicates that, 
in B. subtilis at least, the signal peptide does not provide specificity for SecA2-mediated 
secretion. During the course of this work we identified SecH as a novel component of 
the Sap/EA1 secretion pathway. However, expressing SecH in B. subtilis in the 
presence B. anthracis SecA1 had an inhibitory effect on secretion of EA1, while the co-
expression of SecA1, SecA2 and SecH restored Sap and EA1 secretion to the level 
observed in the mutant expressing SecA1. These observations suggest that SecH has a 
role in preventing the interaction between SecA1 and S-layer proteins and enhancing the 
interaction between SecA2 and these proteins. However, there appear to be additional, 
as yet unknown factor(s) that determine the strict requirement of SecA2 for Sap and 
EA1 secretion of in B. anthracis.  
B. anthracis encodes three functional homologues of the B. subtilis PrsA 
lipoprotein (Williams et al., 2003). Only PrsAB was shown to be involved in the 
secretion of Sap and EA1 in both B. subtilis and B. anthracis. PrsAB was previously 
shown to increase the secretion of B. anthracis protective antigen from B. subtilis 
(William et al., 2003), and we cannot rule out the possibility that it has other substrates. 
We also attempted to identify specific substrates for PrsAA and PrsAC by 2D PAGE 
analysis, but were not successful. However, since the lethal phenotype of B. subtilis 
PrsA is due to its requirement for folding penicillin-binding proteins (PBPs), we carried 
out cell morphology analyses by fluorescent microscopy and a Bocillin assay. We 
observed distinct cell morphology changes for PrsAA and PrsAB mutants, suggesting 
that they may also have additional specific substrates involved in the cell wall 
metabolism. This was confirmed in the case of PrsAA since the Bocillin showed defects 
in a number of the PBPs, indicating that, as is the case of B. subtilis, PrsAA is required 
for their folding. However, unlike prsA of B. subtilis, prsAA is not an essential gene, 
presumably because of a degree of overlapping substrate specificity between the PrsA-
like protein in B. anthracis, as first proposed by Williams and colleagues (2003). No 
specific substrate was identified for PrsAC. The ΔsecA2* mutant was also subject to 
fluorescence microscopy analysis and shown to have altered cell morphology. However, 
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the generation of this mutant resulted in the down-regulation of csaB, located 
immediately upstream of sceA2, but encoded on the opposite strand. We therefore 
cannot rule out at this stage that the resulting change in morphology is due to a 
reduction in cell wall pyruvylation.  
The absence of SecA2, SecH, PrsAA, PrsAB and PrsAC resulted in alterations 
in the expression of eag and sap at some point of the growth cycle. This was most 
noticeable in the case of SecA2 and PrsAB. As SecA2 and SecH are intracellular 
proteins and PrsAA, PrsAB, PrsAC extracellular, it is likely that changes in sap and eag 
expression are indirect, possibly mediated by a cell wall stress response. We have not 
investigated this possibility further, although this clearly needs to be done. 
In the respect of the future research on the SecA2-mediated transport of 
substrates of the Sec pathway a number of potential priorities have been identified. The 
purification of Sec pathway components such as B. subtilis SecA and B. anthracis 
SecA1, SecA2, SecH, EA1 and Sap would facilitate a series of in vitro protein 
interaction studies (e.g. surface plasmon resonance, isothermal calorimetry) to confirm 
the in vivo interactions observed in this study. Additionally, the purified proteins could 
potentially be used to determine the structures of SecA1, SecA2 and SecH. A second 
priority would be to attempt to identify additional substrates of SecA2, PrsAA and 
PrsAB. This could be achieved by comparing the protein profiles of cell wall and 
membrane fractions isolated from the wild type and ∆secA2, ∆prsAA, ∆prsAB mutants. 
The pull-down technique, attempted in this study, needs to be optimised for B. anthracis 
and would provide an ideal starting point for such studies.  
The role of Sap and EA1 signal peptide in the secretion of these proteins by 
SecA2 should be investigated further. The expression plasmid pKG400, created as part 
of this project, could be used for this purpose. This would require cloning of a gene 
encoding the mature portion of secretory protein that was not a substrate for SecA2, in-
frame with the sap or eag signal sequence. The reciprocal experiment should also be 
carried out in which the mature regions of sap or eag are cloned in-frame with a signal 
sequence from a SecA1-depenent substrate. The secretion of the resulting proteins 
would then be analysed by PAGE. If the secretion of Sap/EA1 with an alternative signal 
peptide were observed in the secA2-null mutant, this would provide good evidence for 
the role of the signal peptide in targeting protein substrates to SecA2 in B. anthracis. 
The same conclusion would be obtained if the secretion of a SecA1-dependent protein 
with the Sap/EA1 signal peptide, produced from the expression plasmid, were not 
increased in the secA2-null mutant, but if it were increased in the wild type strain. 
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Finally, the patterns of gene expression of the null mutants of ∆secA2*, 
∆secA2H, ∆secH, ∆prsAB is being subjected to a transcriptome analysis using 
microarrays, to gain insights into the regulation of sap and eag expression. The RNA 
from those strains (harvested in the exponential and stationary phases) was isolated and 
sent for the microarray analysis. However as the data were obtained just before finishing 
writing this thesis they have still to be analysed. 
 
 
150 References  
References 
Agaisse, H., Gominet, M., Økstad, O.A., Kolstø, A.B., Lereclus, D., (1999). PlcR is a 
pleiotropic regulator of extracellular virulence factor gene expression in Bacillus 
thuringiensis. Molecular Microbiology, 32: 1043–53. 
Ahn, J.S., Chandramohan, L., Liou, L.E., Bayles, K.W., (2006). Characterization of 
CidR-mediated regulation in Bacillus anthracis reveals a previously undetected role of 
S-layer proteins as murein hydrolases. Molecular Microbiology, 62: 1158–1169. 
Akimaru, J., Matsuyama, S.I., Tokuda, H., Mizushima, S., (1991). Reconstitution of 
a protein translocation system containing purified SecY, SecE, and SecA from 
Escherichia coli. Proceedings of the National Academy of Sciences of the United States 
of America, 88: 6545–49. 
Akiyama, Y. and Ito, K., (1987). Topology analysis of the SecY protein, an integral 
membrane protein involved in protein export in Escherichia coli. EMBO Journal, 6: 
3465–3470. 
Alileche, A., Serfass, E. R., Muehlbauer, S. M., Porcelli, S. A., Brojatsch, J., (2005). 
Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the 
adaptive immune response. PLoS Pathogens, 1: e19.  
Alonzo III, F., Port, G.C., Cao, M., Freitag, N.E., (2009). The posttranslocation 
chaperone PrsA2 contributes to multiple facets of Listeria monocytogenes pathogenesis. 
Infection & Immunity, 77: 2612–2623. 
Alonzo, F., III and Freitag, N.E., (2010). Listeria monocytogenes PrsA2 is required 
for virulence factor secretion and bacterial viability within the host cell cytosol. 
Infection & Immunity, 78: 4944–4957.   
Anagnostopoulos, C. and Spizizen, J., (1961). Requirements for transformation in 
Bacillus subtilis. Journal of Bacteriology, 81: 741-746. 
Antelmann, H., Darmon, E., Noone, D., Veening, J.W., Westers, H., Bron, S., 
Kuipers, O.P., Devine, K.M., Hecker, M., van Dijl, J.M., (2003). The extracellular 
proteome of Bacillus subtilis under secretion stress conditions. Molecular Microbiology, 
49: 143–156. 
Archambaud, C., Nahori, M.A., Pizarro-Cerda, J., Cossart, P., and Dussurget, O., 
(2006). Control of Listeria superoxide dismutase by phosphorylation. Journal of 
Biological Chemistry, 281: 31812–31822. 
 
151 References  
Ash, C., Farrow, J.A.E., Wallbanks, S., Collins, M.D., (1991). Phylogenetic 
heterogeneity of the genus Bacillus revealed by comparative analysis of small-subunit-
ribosomal RNA sequences. Letters in Applied Microbiology, 13: 202-206. 
Antikainen, J., Anton, L., Sillanpää, J., Korhonen, T.K. (2002). Domains in the S-
layer protein CbsA of Lactobacillus crispatus involved in adherence to collagens, 
laminin and lipoteichoic acids and in self-assembly. Molecular Microbiology, 46: 381–
394. 
Avall-Jaaskelainen, S., Kylä-Nikkilä, K., Kahala M., Miikkulainen-Lahti, T., 
Palva, A., (2002). Surface display of foreign epitopes on the Lactobacillus brevis S-
layer. Applied and Environmental Microbiology, 68: 5943–5951. 
Baars, L., Ytterberg, A.J., Drew, D., Wagner, S., Thilo, C., van Wijk, K.J., and J. 
de Gier, W., (2006). Defining the role of the Escherichia coli chaperone SecB using 
comparative proteomics. Journal of Biological Chemistry, 281: 10024–34. 
Bahl, H., Scholz, H., Bayan, N., Chami, M., Leblon, G., Gulik-Krzywicki, T., 
Shechter, E., Fouet, A., Mesnage, S., Tosi-Couture, E., Gounon, P., Mock, M., 
Conway de Macario, E., Macario, A.J., Fernandez-Herrero, L.A., Olabarria, G., 
Berenguer, J., Blaser, M.J., Kuen, B., Lubitz, W., Sara, M., Pouwels, P.H., Kolen, 
C.P., Boot, H.J., Resch, S., (1997). Molecular biology of S-layers. FEMS Microbiology 
Reviews, 20: 47–98. 
Baud, C., Karamanou, S., Sianidis, G., Vrontou, E., Politou, A.S., Economou, A., 
(2002). Allosteric communication between signal peptides and the SecA protein DEAD 
motor ATPase domain. Journal of Biological Chemistry, 277: 13724–13731. 
Baumeister, W. and Lembcke, G., (1992). Structural features of archaebacterial cell 
envelopes. Journal of  Bioenergetics and Biomembranes, 24: 567–575. 
Bavykin, S. G., Lysov, Y. P., Zakhariev, V., Kelly, J. J., Jackman, J., Stahl, D. A., 
Cherni, A., (2004). Use of 16S rRNA, 23S rRNA, and gyrB gene sequence analysis to 
determine phylogenetic relationships of Bacillus cereus group microorganisms. Journal 
of Clinical Microbiology, 42: 3711-3730. 
Bechtluft, P., Kedrov, A., Slotboom, D.-J., Nouwen, N., Tans, S.J.,, Driessen, A. J. 
M., (2010). Tight hydrophobic contacts with the SecB chaperone prevent folding of 
substrate proteins. Biochemistry, 49: 2380–2388. 
 
152 References  
Beckmann, R., Bubeck, D., Grassucci, R., Penczek, P., Verschoor, A., Blobel, G., 
Frank, J., (1997). Alignment of conduits for the nascent polypeptide chain in the 
ribosome-Sec61 complex. Science, 278: 2123–2126. 
Beckmann, R., Spahn, C.M., Eswar, N., Helmers, J., Penczek, P.A., Sali, A., Frank, 
J., Blobel G., (2001). Architecture of the protein-conducting channel associated with 
the translating 80S ribosome. Cell, 107: 361–372. 
Bendtsen, J.D., Binnewies, T.T., Hallin, P.F., Sicheritz-Ponten, T., Ussery, D.W., 
(2005). Genome update: prediction of secreted proteins in 225 bacterial proteomes. 
Microbiology, 151: 1725–1727. 
Bensing, B.A. and Sullam, P.M., (2002). An accessory sec locus of Streptococcus 
gordonii is required for export of the surface protein GspB and for normal levels of 
binding to human platelets. Molecular Microbiology, 44: 1081–1094. 
Bensing, B.A., Takamatsu, D., Sullam, P.M., (2005). Determinants of the 
streptococcal surface glycoprotein GspB that facilitate export by the accessory Sec 
system. Molecular Microbiology, 58:1468-81. 
Van den Berg, B., Clemons Jr, W.M., Collinson, I., Modis, Y., Hartmann, E., 
Harrison S.C., Rapoport, T.A., (2004). X-ray structure of a protein-conducting 
channel. Nature, 427: 36-44. 
Beveridge, T.J. and Murray, R.G.E., (1976). Reassembly in vitro of the superficial 
cell wall components of Spirillum putridiconchylium. Journal of Ultrastructure 
Research, 55: 105 -118. 
Beveridge, T.J., (1994). Bacterial s-layers. Current Opinion in Structural Biology. 4: 
204 - 212. 
Bhatnagar, R. and Batra, S., (2001). Anthrax toxin. Critical Reviews in Microbiology. 
27: 167–200. 
Blaser, M.J., Smith, P.F., Repine, J.E., Joiner, K.A., (1988). Pathogenesis of 
Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind 
C3b explains serum and phagocytosis resistance. Journal of Clinical Investigation, 81: 
1434–1444. 
Bloor, A.E. and Cranenburgh, R.M., (2006). An efficient method of selectable 
marker gene excision by Xer recombination for gene replacement in bacterial 
chromosomes. Applied and Environmental Microbiology, 72: 2520–2525. 
 
153 References  
Bohle, B., Breitwieser, A., Zwölfer, B., Jahn-Schmid, B., S´ara, M., Sleytr, U.B., 
Ebner, C., (2004). A novel approach to specific allergy treatment: the recombinant 
fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen 
allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with 
immunomodulating capacity. Journal of Immunology, 172: 6642–6648. 
Bohr, M.T., (2002). Nanotechnology goals and challenges for electronic application. 
IEEE Transactions on Nanotechnology, 1: 56–62. 
Bolhuis, A., Sorokin, A., Azevedo, V., Ehrlich, S.D., Braun, P.G., de Jong, A., 
Venema, G., Bron, S., van Dijl, J.M., (1996). Bacillus subtilis can modulate its 
capacity and specificity for protein secretion through temporally controlled expression 
of the sipS gene for signal peptidase I. Molecular Microbiology, 22: 605–618. 
Bolhuis, A., Broekhuizen, C.P., Sorokin, A., van Roosmalen, M.L., Venema, G., 
Bron, S., Quax, W.J., and van Dijl, J.M., (1998). SecDF of Bacillus subtilis, a 
molecular Siamese twin required for the efficient secretion of proteins. Journal of 
Biological Chemistry, 273: 21217-21224. 
Bolhuis, A., Venema, G., Quax, W.J., Bron, S., van Dijl, J.M., (1999). Functional 
analysis of paralogous thiol-disulfide oxidoreductases in Bacillus subtilis. Journal of 
Biological Chemistry, 274: 24531– 24538. 
Bolotin, A., Mauger, S., Malarme, K., Ehrlich, S.D., Sorokin, A., (1999). Low-
redundancy sequencing of the entire Lactococcus lactis IL1403 genome. Antonie van 
Leeuwenhoek, 76: 27-76. 
Braunstein, M., Espinosa, B.J., Chan, J., Belisle, J.T., Jacobs, Jr. ,W.R., (2003). 
SecA2 functions in the secretion of superoxide dismutase A and in the virulence of 
Mycobacterium tuberculosis. Molecular Microbiology, 48: 453-64. 
Breitwieser, A., Egelseer, E. M., Moll, D., Ilk, N., Hotzy, C., Bohle, B., Ebner, C., 
Sleytr, U. B., Sára, M., (2002). A recombinant bacterial cell surface (S-layer)-major 
birch pollen allergenfusion protein (rSbsC/Bet v1) maintains the ability to selfassemble 
into regularly structured monomolecular lattices and the functionality of the allergen. 
Protein engineering, 15: 243–249. 
Bruch, M.D., McKnight, C.J., Gierasch, L.M., (1989). Helix formation and stability 
in a signal sequence. Biochemistry, 28: 8554–8561. 
 
154 References  
Brundage, L., Hendrick, J.P., Schiebel, E., Driessen, A.J.M., Wickner, W., (1990). 
The purified E. coli integral membrane protein SecY/E is sufficient for reconstitution of 
SecA-dependent precursor protein translocation. Cell, 62: 649–57. 
Bourgogne, A., Drysdale, M., Hilsenbeck, S.G., Peterson, S.N., Koehler, T.M., 
(2003). Global effects of virulence gene regulators in a Bacillus anthracis strain with 
both virulence plasmids. Infection & Immunity, 71: 2736-2743. 
Cao, M. and Helmann, J.D., (2004). The Bacillus subtilis extracytoplasmic-function 
sigmaX factor regulates modification of the cell envelope and resistance to cationic 
antimicrobial peptides. Journal of Bacteriology, 186: 1136–1146. 
Carnoy, C. and Roten, C.A., (2009). The dif/Xer recombination systems in 
proteobacteria. PLoS, 4: e6531. 
Cerretti, D.P., Dean, D., Davis, G.R., Bedwell, D.M., Nomura, M., (1983). The spc 
ribosomal protein operon of Escherichia coli: sequence and cotranscription of the 
ribosomal protein genes and a protein export gene, Nucleic Acids Research, 11: 2599– 
2616. 
Carucci, J.A., McGovern, T.W., Norton, S.A., Daniel, C.R., Elewski, B.E., Fallon-
Friedlander, S., Lushniak, B.D., Taylor, J.S., Warschaw, K., Wheeland, R.G., 
(2002). Cutaneous anthrax management algorithm. Journal of the American Academy of 
Dermatology, 47: 766–769. 
Chauvaux, S., Matuschek, M., Beguin, P., (1999). Distinct affinity of binding sites for 
S-layer homologous domains in Clostridium thermocellum and Bacillus anthracis cell 
envelopes. Journal of Bacteriology, 181: 2455–2458. 
Chen, Q., Wu, H., Fives-Taylor, P.M., (2004). Investigating the role of secA2 in 
secretion and glycosylation of a fimbrial adhesin in Streptococcus parasanguis FW213. 
Molecular Microbiology, 53: 843–856.  
Claessen, D., Emmins, R., Hamoen, L.W, Daniel, R.A., Errington, J., Edwards, 
D.H., (2008). Control of the cell elongation-division cycle by shuttling of PBP1 protein 
in Bacillus subtilis. Molecular Microbiology, 68: 1029-1046. 
Comer, J. E., Chopra, A. K., Peterson, J. W. and Konig, R., (2005). Direct inhibition 
of T-lymphocyte activation by anthrax toxins in vivo. Infection & Immunity, 73: 8275–
8281. 
 
155 References  
Cristóbal, S., De Gier, J.W., Nielsen, H., Von Heijne, G. (1999). Competition 
between Sec- and Tat-dependent protein translocation in Escherichia coli. EMBO 
Journal, 18: 2982–2990. 
Crowley, P.J., Svensater, G., Snoep, J.L., Bleiweis, A.S., Brady, L.J., (2004). An ffh 
mutant of Streptococcus mutans is viable and able to physiologically adapt to low pH in 
continuous culture. FEMS Microbiology Letters, 234: 315–24 
Dalbey, R.E., Lively, M.O., Bron, S., van Dijl, J.M., (1997). The chemistry and 
enzymology of the type I signal peptidases. Protein Science, 6: 1129–1138. 
Dervyn, E. and Ehrlich, S.D., (2001). Analysis of essential genes. In Functional 
analsysis of bacterial genes., 25-32. Edited by Schumann, W., Ehrlich, S. D. and 
Ogasawara, N. Chichester, U.K.: John Wiley & Sons, Ltd. 
Dixon, T. C., Meselson, M., Guillemin, J., Hanna, P. C., (1999). Anthrax. New 
England Journal of Medicine, 341: 815-826. 
Doig, P., Emödy, L., Trust, T.J. (1992). Binding of laminin and fibronectin by the 
trypsin-resistant major structural domain of the crystalline virulence surface array 
protein of Aeromonas salmonicida. Journal of Biological Chemistry, 267: 43–49. 
Dong, Y., Palmer, S. R., Hasona, A., Nagamori, S., Kaback, H. R., Dalbey R. E., 
Brady, L. J., (2008). Functional overlap but lack of complete cross-comple-mentation 
of Streptococcus mutans and Escherichia coli YidC orthologs. Journal of  Bacteriology, 
190: 2458-2469. 
Douville, K., Leonard, M., Brundage, L.A., Nishiyama, K., Tokuda, H., 
Mizushima, S., Wickner, W., (1994). Band 1 subunit of Escherichia coli preprotein 
translocase and integral membrane export factor P12 are the same protein. Journal of 
Biological Chemistry, 269: 18705-18707. 
Driessen, A.J., (1992). Precursor protein translocation by the Escherichia coli 
translocase is directed by the protonmotive force. EMBO Journal, 11: 847–853. 
Drysdale, M., Bourgogne, A., Hilsenbeck, S.G., Koehler, T.M., (2004). atxA controls 
Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB. 
Journal of Bacteriology, 186: 307–315.  
Dubrac, S., Boneca, I.G., Poupel, O., Msadek, T., (2007). New insights into the 
WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in 
 
156 References  
controlling cell wall metabolism and biofilm formation in Staphylococcus aureus. 
Journal of Bacteriology, 189: 8257–8269. 
Dubrac, S., Bisicchia, P., Devine, K.M., Msadek, T., (2008). A matter of life and 
death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction 
pathway. Molecular Microbiology, 70: 1307–1322. 
Duesbery, N.S., Webb, C.P., Leppla, S.H., Gordon, V.M., Klimpel, K.R., Copeland, 
T.D., Ahn, N.G., Oskarsson, M.K., Fukasawa, K., Paull, K.D., Vande-Woude, G. 
F., (1998). Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. 
Science, 280: 734-737. 
Dubrac, S., Bisicchia, P., Devine, K.M., Msadek, T., (2008). A matter of life and 
death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction 
pathway. Molecular Microbiology, 70: 1307–1322. 
Duong F., (2003). Binding, activation and dissociation of the dimeric SecA ATPase at 
the dimeric SecYEG translocase. EMBO Journal, 22: 4375–4384. 
During, R. L., W. Li, B. Hao, J. M. Koenig, D. S. Stephens, C. P. Quinn, 
Southwick, F. S., (2005). Anthrax lethal toxin paralyzes neutrophil actin-based 
motility. Journal of Infectious Diseases, 192: 837-845. 
Economou, A., and Wickner, W., (1994). SecA promotes preprotein translocation by 
undergoing ATP-driven cycles of membrane insertion and deinsertion. Cell, 78: 835– 
843. 
Egelseer, E.M., Schocher, I., Sára, M., Sleytr, U.B., (1995). The S-layer fom Bacillus 
stearothermophilus DSM 2358 functions as an adhesion site for a high-molecular-
weight amylase. Journal of  Bacteriology, 177:1444–1451. 
Erwin, J.L., DaSilva, LM, Bavari, S., Little, S.F., Friedlander, A.M., Chanh, T.C., 
(2001). Macrophage-derived cell lines do not express proinflammatory cytokines after 
exposure to Bacillus anthracis lethal toxin. Infection and Immunity, 69: 1175-1177. 
Fekkes, P., van der Does, C., Driessen, A.J., (1997). The molecular chaperone SecB is 
released from the carboxy-terminus of SecA during initiation of precursor protein 
translocation. EMBO Journal, 16: 6105–13. 
Fekkes, P. and Driessen, A.J., (1999). Protein targeting to the bacterial cytoplasmic 
membrane. Microbiology and Molecular Biology Reviews, 63: 161–73.  
 
157 References  
Fekkes, P., de Wit, J.G., J. van der Wolk, P., Kimsey, H.H., Kumamoto, C.A., 
Driessen, A J., (1998). Preprotein transfer to the Escherichia coli translocase requires 
the co-operative binding of SecB and the signal sequence to SecA. Molecular 
Microbiology, 29: 1179–90. 
During, R. L., W. Li, B. Hao, J. M. Koenig, D. S. Stephens, C. P. Quinn, 
Southwick, F. S., (2005). Anthrax lethal toxin paralyzes neutrophil actin-based 
motility. Journal of Infectious Diseases, 192: 837-845.  
Fischetti, V.A., Pancholi, V., Schneewind O., (1990). Conservation of a hexapeptide 
sequence in the anchor region of surface proteins from gram-positive cocci. Molecular 
Microbiology, 4: 1603–5. 
Flower, A.M., Hines, L.L., Pfennig, P.L., (2000). SecG is an auxiliary component of 
the protein export apparatus of Escherichia coli. Molecular and General Genetics, 263: 
131–136. 
Fouet, A., (2009). The surface of Bacillus anthracis. Molecular Aspects of Medicine, 
30: 374–385. 
Fouet, A., Mesnage, S., Tosi-Couture, E., Gounon, P., Mock, M., (1999). Bacillus 
anthracis surface: capsule and S-layer. Journal of Applied Microbiology, 87: 251-255. 
Fritze, D., (2004). Taxonomy of the genus Bacillus and related genera: the aerobic 
endospore-forming bacteria. Phytopahthology, 94: 2004. 
Gallagher, T., Gilliland, G., Wang, L., Bryan P., (1995). The prosegment-subtilisin 
BPN’ complex: crystal structure of a specific ‘foldase’. Structure, 3: 907–914. 
Gannon, P.M. and Kumamoto, C.A., (1993). Mutations of the molecular chaperone 
protein SecB which alter the interaction between SecB and maltose-binding protein. 
Journal of Biological Chemistry, 268: 1590–5. 
Garcia MM, Lutze-Wallace CL, Denes AS, Eaglesome MD, Hoist E, Blaser MJ., 
(1995). Protein shift and antigenic variation in the S-layer of Campylobacter fetus 
subsp. venerealis during bovine infection accompanied by genomic rearrangement of 
sapA homologs. Journal of Bacteriology, 177: 1976–1980. 
Garduño, R.A. and Kay, W.W., (1992). Interaction of the fish pathogen Aeromonas 
salmonicida with rainbow trout macrophages. Infection & Immunity, 60: 4612–4620. 
 
158 References  
Garduño, R.A., and Kay, W.W. (1993)., Capsulated cells of Aeromonas salmonicida 
grown in vitro have different functional properties than capsulated cells grown in vivo. 
Canadian Journal of Microbiology, 41: 941–945. 
Garduño, R.A., Lee, E.J.Y., Kay, W.W., (1992). S-layermediated association of 
Aeromonas salmonicida with murine macrophages. Infection & Immunity, 60: 4373–
4382. 
Gerhardt, P., (1967). Cytology of Bacillus anthracis. Federation Proceedings, 26: 
1504-1517. 
González Jr, J.M. and Carlton, B.C., (1984). A large transmissible plasmid is 
required for crystal toxin production in Bacillus thuringiensis variety israelensis. 
Plasmid, 11: 28–38. 
Gothel, S.F. and Marahiel, M.A., (1999). Peptidyl-prolyl cis-trans isomerases, a 
superfamily of ubiquitous folding catalysts. Cellular and Molecular Life Sciences, 55: 
423–436. 
Graham, S., Jeffries, A.H., Secombes, C.J. (1988). A novel assay to detect 
macrophage bactericidal activity in fish: Factors influencing the killing of Aeromonas 
salmonicida. Journal of Fish Diseases, 11: 389–396. 
Grogono-Thomas, R., Dworkin, J., Blaser, M.J., (1997). The role of S-layer proteins 
in ovine Campylobacter abortion. FEMS Microbiology Reviews, 20: 133–135.  
Grogono-Thomas, R., Dworkin, J., Blaser, M.J., Newell, D.G., (2000). Roles of the 
surface layer proteins of Campylobacter fetus subsp. fetus in bovine abortion. Infection 
& Immunity, 68: 1687–1691. 
Hanna, P.C. Kochi, S., Collier, R.J., (1992). Biochemical and physiological changes 
induced by anthrax lethal toxin in J774 macrophage-like cells. Molecular Biology of the 
Cell, 3: 1269–1277. 
Hanna, P.C., Acosta, D., Collier, R,J., (1993). On the role of macrophages in anthrax. 
Proceedings of the National Academy of Sciences of the United States of America, 90: 
10198-10201. 
Hanna, P.C., Kruskal, B.A., Ezekowitz, R.A.B., Bloom, B.R., Collier, R.J., (1994). 
Role of macrophage oxidative burst in the action of anthrax lethal toxin. Molecular 
Medicine, 1:7–18. 
 
159 References  
Hardy, S.J. and Randall, L.L., (1991). A kinetic partitioning model of  selective 
binding of nonnative proteins by the bacterial chaperone SecB. Science, 251: 439–43. 
Harris, C.R., Silhavy, T.J., (1999). Mapping an interface of SecY (PrlA) and SecE 
(PrlG) by using synthetic phenotypes and in vivo cross-linking. Journal of Bacteriology, 
181: 3438–44. 
Hartl, F.U., Lecker, S., Schiebel, E., Hendrick, J.P., Wickner, W., (1990). The 
binding cascade of SecB to SecA to SecY/E mediates preprotein targeting to the E. coli 
plasma membrane. Cell, 63: 269–79. 
Health Protection Agency. (2010) Health Protection Agency Interim Guidelines for 
Action in the Event of a Deliberate Release of Anthrax, version 6.2. 
Helgason, E., Tourasse, N.J., Meisal, R., Caugant, D.A, Kolstø, A.B., (2004). 
Multilocus sequence typing scheme for bacteria of the Bacillus cereus group. Applied 
and Environmental Microbiology, 70: 191–201. 
Helgason, E., Økstad, O.A., Caugant, D.A., Johansen, H.A., Fouet, A., Mock, M, 
Hegna, I., Kolstø, A.B., (2000). Bacillus anthracis, Bacillus cereus, and Bacillus 
thuringiensis - one species on the basis of genetic evidence. Applied and Environmental 
Microbiology, 66: 2627–30. 
Hoffmaster, A.R. and Koehler, T.M., (1997). The anthrax toxin activator gene atxA is 
associated with CO2-enhanced non-toxin gene expression in Bacillus anthracis. 
Infection & Immunity, 65: 3091–3099. 
Hoffmaster, A.R. and Koehler, T.M., (1999). Autogenous regulation of the Bacillus 
anthracis pag operon. Journal of Bacteriology, 181: 4485 – 4492. 
Holt, S., C. and Leadbetter, E., R., (1969). Comparative ultrastructure of selected 
aerobic spore-forming bacteria: a freeze-etching study. Bacteriological Reviews, 33: 
346-378. 
Hovmöller, S., Sjögren, A., Wang, D.N., (1988). The structure of crystalline bacterial 
surface layers. Progress in Biophysics and Molecular Biology, 51:131–163. 
Huber, C., Egelseer, E.M., Ilk, N., Sleytr, U.B., Sára, M. (2006a). S-layerstreptavidin 
fusion proteins and S-layer-specific heteropolysaccharides as part of a biomolecular 
construction kit for application in nanobiotechnology. Microelectronic Engineering, 83: 
1589–1593. 
 
160 References  
Huber, C., Liu, J., Egelseer, E.M., Moll, D., Knoll, W., Sleytr, U.B. & Sára, M., 
(2006b). Heterotetramers formed by an S-layer-streptavidin fusion protein and core-
streptavidin as nanoarrayed template for biochip development. Small: nano micro, 2: 
142–150. 
Hunt, J.F., Weinkauf, S., Henry, L., Fak, J.J., McNicholas, P., Olivier, D.B., 
Deisenhofer, J., (2002). Nucleotide control of interdomain interactions in the 
conformational reaction cycle of SecA. Science, 297: 2018–2026. 
Hynönen, U., Westerlund-Wikström, B., Palva, A., Korhonen, T.K. (2002).  
Identification by flagellum display of an epithelial cell- and fibronectin-binding 
function in the SlpA surface protein of  Lactobacillus brevis. Journal of Bacteriology, 
184: 3360–3367. 
Ilk, N., Völlenkle, C., Edelseer, E.M., Breitwieser, A., Uwe, B., Sleytr, U.B.,  Sára, 
M., (2002). Molecular characterization of the S-layer gene, sbpA, of Bacillus 
sphaericus CCM2177 and production of functional S-layer fusion protein with ability to 
recrystallize in a definite orientation while presented the fused allergen. Applied and 
Environmental Microbiology, 68: 3251–3260. 
Inoue H., Nojima H., Okayama H., (1990). High efficiency transformation of 
Escherichia coli with plasmids. Gene, 96: 23-28. 
Ito, K., Cerretti, D.P., Nashimoto, H., Nomura, M., (1984). Characterization of an 
amber mutation in the structural gene for ribosomal protein L15, which impairs 
expression of the protein export gene, secy, in Escherichia coli. EMBO Journal, 3: 
2319–2324.  
Jernigan, D.B., Raghunathan, P.L., Bell, B.P., Brechner, R., Bresnitz, E.A., Butler, 
J.C., Cetron, M., Cohen, M., Doyle, T., Fischer M., et al., (2002). Investigation of 
bioterrorism-related anthrax, United States, 2001: Epidemiologic findings. Emerging 
Infectious Diseases, 8: 1019–1028. 
Joly, J.C. and Wickner, W., (1993). The SecA and SecY subunits of translocase are 
the nearest neighbors of the translocating preprotein, shielding it from phospholipids. 
EMBO Journal, 12: 255–263. 
Johnsborg, O. and Havarstein, L.S., (2009). Pneumococcal LytR, a protein from the 
LytR-CpsA-Psr family, is essential for normal septum formation in Streptococcus 
pneumoniae. Journal of Bacteriology, 191: 5859-5864. 
 
161 References  
Joung, J.K., Ramm, E.R., Pabo, C.O., (2000). A bacterial two-hybrid selection 
system for studying protein−DNA and protein−protein interactions. Proceedings of the 
National Academy of Sciences of the United States of America, 97: 7382−7387. 
Karamanou, S., Vrontou, E., Sianidis, G., Baud, C., Roos, T., Kuhn, A, Politou, 
A.S., Economou, A., (1999). A molecular switch in SecA protein couples ATP 
hydrolysis to protein translocation. Molecular Microbiology, 34: 1133-1145.  
Kassam, A., Der, S.D., Mogridge, J. (2005). Differentiation of human monocytic cell 
lines confers susceptibility to Bacillus anthracis lethal toxin. Cellular Microbiology, 7: 
281-292. 
Kawaguchi, S., Müller, J., Linde, D., Kuramitsu, S., Shibata, T., Inoue, Y., 
Vassylyev, D.G., Yokoyama, S., (2001). The crystal structure of the ttCsaA protein: an 
export-related chaperone from Thermus thermophilus. EMBO Journal, 20: 562–569. 
Keenan, R.J., Freymann, D. M., Stroud, R. M., Walter, P., (2001). The signal 
recognition particle. Annual Review of Biochemistry, 70: 755–75. 
Kern, J., Ryan, C., Faull, K., Schneewind, O., (2010). Bacillus anthracis surface-
layer proteins assemble by binding to the secondary cell wall polysaccharide in a 
manner that requires csaB and tagO. Journal of Molecular Biology, 401: 757–775. 
Kihara, A., Akiyama, Y., Ito, K. (1995). FtsH is required for proteolytic elimination of 
uncomplexed forms of SecY, and essential protein translocase subunit. Proceedings of 
the National Academy of Sciences of the United States of America, 92: 4532–4536. 
Kimura, E., Akita, M., Matsuyama, S.-I., Mizushima, S., (1991). Determination of a 
region in SecA that interacts with presecretory proteins in Escherichia coli, Journal of 
Biological Chemistry, 206: 6600– 6606. 
Kist, M. and Murray, R.G.E., (1984). Components of the regular surface array of 
Aquaspirillum serpens MW5 and their assembly in vitro. Journal of Bacteriology, 157: 
599–606. 
Ko, K. S., Kim, J.-W., Kim, J.-M., Kim, W., Chung, S.-i., Kim, I. J., Kook Y.-H., 
(2004). Population Structure of the Bacillus cereus Group as Determined by Sequence 
Analysis of Six Housekeeping Genes and the plcR Gene. Infection & Immunity, 72: 
5253-5261. 
Kobayashi, K., Ehrlich, S.D., Albertini, A., Amati, G., Andersen, K.K., Arnaud, 
M., Asai, K., Ashikaga, S., Aymerich, S., Bessieres, P., et al., (2003). Essential 
 
162 References  
Bacillus subtilis genes. Proceedings of the National Academy of Sciences of the United 
States of America, 100: 4678–4683. 
Koehler, T.M., Dai, Z., Kaufman-Yarbray, M., (1994). Regulation of the Bacillus 
anthracis protective antigen gene: CO2 and a trans-acting element activate transcription 
from one of two promoters. Journal of Bacteriology, 176: 586-595. 
Kontinen, V.P., Saris, P., Sarvas, M., (1991). A gene (prsA) of Bacillus subtilis 
involved in a novel, late stage of protein export. Molecular Microbiology, 5: 1273-
1283. 
Kontinen, V.P. and Sarvas, M., (1993). The PrsA lipoprotein is essential for protein 
secretion in Bacillus subtilis and sets a limit for high-level secretion. Molecular 
Microbiology, 8: 727-737. 
Kontinen, V.P., Yamanaka, M., Nishiyama, K., Tokuda, H., (1996). Roles of the 
conserved cytoplasmic region and non-conserved carboxy-terminal region of SecE in 
Escherichia coli protein  translocase. Journal of Biochemistry, 119: 1124–1130. 
Kotiranta, A., Haapasalo, M., Kari, K., Kerosuo, E., Olsen, I., Sorsa, T., Meurman, 
J. H., Lounatmaa, K., (1998). Surface structure, hydrophobicity, phagocytosis, and 
adherence to matrix proteins of Bacillus cereus cells with and without the crystalline 
surface protein layer. Infection & Immunity, 66: 4895-4902. 
Koval, S.F. and Murray, R.G.E., (1984). The isolation of surface array proteins from 
bacteria. Canadian Journal of Biochemistry and Cell Biology, 62: 1181 - 1189. 
Koval, S. F., (1997). The effect of S-layers and cell surface hydrophobicity on prey 
selection by bacterivorous protozoa. FEMS Microbiology Reviews, 20: 138–142. 
Kronstad, J.W., Schnepf, H.E., Whiteley, H.R., (1983). Diversity of location for 
Bacillus thuringiensis crystal protein genes. Journal of Bacteriology, 154: 419–428. 
Kumamoto, C. A. and Beckwith, J., (1983). Mutations in a new gene, SecB, cause 
defective protein localization in Escherichia coli. Journal of Bacteriology, 154: 253–60. 
Küpcü, S., Mader, C., Sara, M., (1995). The crystalline cell surface layer from 
Thermoanaerobacter thermohydrosulfuricum LIII–69 as an immobilization matrix: 
Influenceof the morphological properties and the pore size of the matrix on loss of 
activity of covalently bound enzymes. Biotechnology and Applied Biochemistry, 21: 
275–286. 
 
163 References  
Laaberki, M.H., Pfeffer, J., Clarke, A.J., Dworkin, J., (2010). O-Acetylation of 
peptidoglycan is required for proper cell separation and S-layer anchoring in Bacillus. 
Journal of Biological  Chemistry, 286: 5278-88. 
Lazarevic, V., Margot, P., Soldo, B., Karamata, D., (1992). Sequencing and analysis 
of the Bacillus subtilis lytRABC divergon: a regulatory unit encompassing the structural 
genes of the N-acetylmuramoyl-L-alanine amidase and its modifier. Journal of General 
Microbiology, 138: 1949-1961. 
Le Bourgeois, P., Bugarel, M., Campo, N., Daveran-Mingot, M-L., Labonté, J., 
Lanfranchi, D., Lautier, T., Pagès, C., Ritzenthaler, P., (2007). The unconventional 
Xer recombination machinery of streptococci/lactococci. PLoS Genet, 3: e17. 
Lenz, L.L. and Portnoy, D.A., (2002). Identification of a second Listeria secA gene 
associated with protein secretion and the rough phenotype. Molecular Microbiology, 
45: 1043-56. 
Lenz, L.L., Mohammadi, S., Geissler, A., Portnoy, D.A., (2003). SecA2-dependent 
secretion of autolytic enzymes promotes Listeria monocytogenes pathogenesis. 
Proceedings of the National Academy of Sciences of the United States of America, 100: 
12432–12437. 
Leppla, S.H., (1982). Anthrax Toxin Edema Factor: A Bacterial Adenylate Cyclase 
That Increases Cyclic AMP Concentrations in Eukaryotic Cells. Proceedings of the 
National Academy of Sciences of the United States of America, 79: 3162-3166. 
Leslie, N.R. and Sherratt, D.J., (1995). Site-specific recombination in the replication 
terminus region of Escherichia coli: functional replacement of dif. EMBO Journal, 14: 
1561–1570. 
Li, P., Beckwith, J., Inouye, H., (1988). Alteration of the amino terminus of the mature 
sequence of a periplasmic protein can severely affect protein export in Escherichia coli. 
Proceedings of the National Academy of Sciences of the United States of America, 85: 
7685–7689. 
Liu, J. and Rost, B., (2001). Comparing function and structure between entire 
proteomes. Protein Science, 10: 1970–1979. 
Luirink, J., Hagen-Jongman, C.M., van der Weijden, C.C., Oudega, B., High, S., 
Dobberstein, B., Kusters, R., (1994). An alternative protein targeting pathway in 
Escherichia coli: studies on the role of FtsY. EMBO Journal, 13: 2289–2296. 
 
164 References  
Luirink, J. and Sinning, I., (2004). SRP-mediated protein targeting: structure and 
function revisited. Biochimica et Biophysica Acta, 1694:17–35. 
Machata, S., Hain, T., Rohde, M., Chakraborty, T., (2005). Simultaneous deficiency 
of both MurA and p60 proteins generates a rough phenotype in Listeria monocytogenes. 
Journal of Bacteriology, 187: 8385–8394. 
Macheboeuf, P., Contreras-Martel, C., Job, V., Dideberg, O., Dessen, A., (2006). 
Penicillin binding proteins: key players in bacterial cell cycle and drug resistance 
processes. FEMS Microbiology Reviews, 30: 673–691. 
Mader, C., Kupcu, S., Sara, M., Sleytr, U.B., (1999). Stabilizing effect of an S-layer 
on liposomes towards thermal or mechanical stress. Biochimica et Biophysica Acta, 
1418: 106–116. 
Mader, C., Küpcü, S., Sleytr, U.B., Sára M (2000). S-layer-coated liposomes as a 
versatile system for entrapping and binding target molecules. Biochimica et Biophysica 
Acta, 1463: 142–150. 
Makins, S-I., Ucluda, I., Terakado, N., Sasakawa, C., Yoshikawa, M., (1989). 
Molecular characterisation and protein analysis of the cap region, which is essential for 
encapsulation in Bacillus anthracis. Journal of Bacteriology, 171: 722–30. 
Marrero, R. and Welkos, S.L., (1995). The transformation frequency of plasmids into 
Bacillus anthracis is affected by adenine methylation. Gene, 152: 75–78. 
Matuschek, M., Sahm, K., Zibat, H., Bahl, H., (1996). Characterization of genes from 
Thermoanaerobacterium thermosulfurigenes EM1 that encode two glycosyl hydrolases 
with conserved S-layer-like domain. Molecular and General Genetics, 252: 493–496. 
Mazmanian, S.K., G. Liu, H. Ton-That, Schneewind, O., (1999). Staphylococcus 
aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science, 285: 
760-763. 
Meade, J., (2004). Images in emergency medicine. Cutaneous anthrax. Annals of 
Emergency Medicine, 43: 664-673. 
Meima, R., Eschevins, C., Fillinger, S., Bolhuis, A., Hamoen, L.W., Dorenbos, R., 
Quax, W.J., van Dijl, J.M., Provvedi, R., Chen, I., Dubnau, D., Bron, S., (2001). 
The bdbDC operon of Bacillus subtilis encodes thiol disulfide oxidoreductases required 
for competence development. Journal of Biological Chemistry, 277: 6994–7001. 
 
165 References  
Menetret, J.F., Hegde, R.S., Heinrich, S.U., Chandramouli, P., Ludtke, S.J., 
Rapoport, T.A., Akey, C.W., (2005). Architecture of the ribosome-channel complex 
derived from native membranes. Journal of Molecular Biology, 348: 445–457. 
Mescher, M.F. and Strominger, J.L. (1976). Structural (shapemaintaining) role of the 
cell surface glycoprotein of Halobacterium salinarium. Proceedings of the National 
Academy of Sciences of the United States of America, 73: 2687-2691. 
Mesnage, S., Tosi-Couture, E., Mock, M., Gounon, P., Fouet, A., (1997). Molecular 
characterization of the Bacillus anthracis main S-layer component: evidence that it is 
the major cell-associated antigen. Molecular Microbiology, 23: 1147-1155. 
Mesnage, S., Tosi-Couture, E., Gounon, P., Mock, M., Fouet, A. (1998). The capsule 
and S-layer, two independent and yet compatible macromolecular structures in Bacillus 
anthracis. Journal of Bacteriology, 180: 52 - 58. 
Mesnage, S., Tosi-Couture, E., Fouet, A., (1999). Production and cell surface 
anchoring of functional fusions between the SLH motifs of the Bacillus anthracis S-
layer proteins and the Bacillus subtilis levansucrase. Molecular Microbiology, 31: 927–
936. 
Mesnage, S., Fontaine, T., Mignot, T., Delepierre, M., Mock, M., Fouet, A., (2000). 
Bacterial SLH domain proteins are non-covalently anchored to the cell surface via a 
conserved mechanism involving wall polysaccharide pyruvylation. EMBO Journal, 19: 
4473–4484. 
Mesnage, S., Tosi-Couture, E., Gounon, P., Mock, M., Fouet, A., (1998). The 
capsule and S-layer: two independent and yet compatible macromolecular structures in 
Bacillus anthracis. Journal of Bacteriology, 180: 52–58. 
Mignot, T., Mesnage, S., Couture-Tosi, E., Mock, M., Fouet, A., (2002). 
Developmental switch of S-layer protein synthesis in Bacillus anthracis. Molecular 
Microbiology, 43: 1615– 1627. 
Mignot, T., Mock, M., Fouet, A., (2003). A plasmid-encoded regulator couples the 
synthesis of toxins and surface structures in Bacillus anthracis. Molecular 
Microbiology, 47: 917-927. 
Mignot, T., Couture-Tosi, E., Mesnage, S., Mock, M., Fouet, A., (2004). In vivo 
Bacillus anthracis gene expression requires PagR as an intermediate effector of the 
 
166 References  
AtxA signalling cascade. International Journal of Medical Microbiology, 293: 619–
624. 
Miot, M. and Betton, J.-M., (2004). Protein quality control in the bacterial periplasm. 
Microbial Cell Factories, 3: 4. 
Mitra, K., Schaffitzel, C., Saikh, T., Tama, F., Jenni, S., Brooks III, C.L., Ban, N., 
Frank, J., (2005). Structure of the E. coli protein-conducting channel bound to a 
translating ribosome. Nature, 438: 318–324. 
Moayeri, M., Haines, D., Young, H.A., Leppla, S.H., (2003). Bacillus anthracis lethal 
toxin induces TNF-α independent hypoxia-mediated toxicity in mice. Journal of 
Clinical Investigation, 112: 670-682. 
Mogk, A., Schlieker, C., Friedrich, K. L., Schonfeld, H. J., Vierling, E., Bukau, B., 
(2003). Journal of Biological Chemistry, 278: 31033-31042. 
Moll, D., Huber, C., Schlegel, B., Pum, D., Sleytr, U.B., Sleytr, U.B., (2001). S-layer 
streptavidin fusion proteins as template for nanopatterned molecular arrays. 
Proceedings of the National Academy of Sciences of the United States of America, 99: 
14646–14651. 
Müller, J.P., Bron, S., Venema, G., van Dijl, J.M., (2000). Chaperone-like activities 
of the CsaA protein of Bacillus subtilis. Microbiology, 146: 77–88.  
Munn, C. B., Ishiguro, E. E., Kay, W. W., Trust, T. J., (1982). Role of surface 
components in serum resistance of virulent Aeromonas salmonicida. Infection & 
Immunity, 36: 1069-1075. 
Muren, E.M., Suciu, D., Topping, T.B., Kumamoto, C. A., Randall, L.L., (1999). 
Mutational alterations in the homotetrameric chaperone SecB that implicate the 
structure as dimer of dimers. Journal of Biological Chemistry, 274: 19397–402. 
Murphy, C.K. and Beckwith, J., (1994). Residues essential for the function of SecE, a 
membrane component of the Escherichia coli secretion apparatus, are located in a 
conserved cytoplasmic region. Proceedings of the National Academy of Sciences of the 
United States of America, 91: 2557–2561. 
Musial-Siwek, M., Rusch, S.L., Kendall, D.A., (2007). Selective photoaffinity 
labeling identifies the signal peptide binding domain on SecA. Journal of Molecular 
Biology, 365: 637-648. 
 
167 References  
Nakamura, K., Yahagi, S., Yamazaki, R., Yamane, K., (1999). Bacillus subtilis 
histone-like protein, HBsu, is an integral component of a SRP-like particle that can bind 
the Alu domain of small cytoplasmic RNA. Journal of Biological Chemistry, 274: 
13569-13576. 
Natale, P., Bruser, T., Driessen, A.J., (2008). Sec- and Tat-mediated protein secretion 
across the bacterial cytoplasmic membrane—distinct translocases and mechanisms. 
Biochimica et Biophysica Acta, 1778: 1735-1756. 
Navarre, W.W. and Schneewind, O., (1999). Surface proteins of gram-positive 
bacteria and mechanisms of their targeting to the cell wall envelope. Microbiology and 
Molecular Biology Reviews, 63: 174–229. 
Nielsen, P., Rainey, F., Outtrup, H., Priest, F.G., (1994). Comparative 16S rDNA 
sequence analysis of some alkaliphilic bacilli and the establishment of a sixth rRNA 
group within the genus Bacillus. FEMS Microbiology Letters, 117: 61-66. 
Nishiyama, K., Mizushima, S., Tokuda, H., (1992). The carboxyl-terminal region of 
SecE interacts with SecY and is functional in the reconstitution of protein translocation 
activity in Escherichia coli. Journal of Biological Chemistry, 267: 7170– 7176. 
Nishiyama, K., Mizushima, S., Tokuda, H., (1993). A novel membrane protein 
involved in protein translocation across the cytoplasmic membrane of Escherichia coli. 
EMBO Journal, 12: 3409–3415  
O'Brien, J., Friedlander, A., Dreier, T., Ezzell, J., Leppla, S., (1985). Effects of 
anthrax toxin components on human neutrophils. Infection & Immunity, 47: 306–310. 
Okuda, K., Kigure, T., Yamada, S., Kaneko, T., Ishihara, K., Miura, T., Kato, T., 
Takazoe, I., (1997). Role for the S-layer of Campylobacter rectus ATCC33238 in 
complement mediated killing and phagocytic killing by leukocytes from guinea pig and 
human peripheral blood. Oral Diseases, 3: 113–120. 
Olivier, G., Eaton, C.A., and Campbell, N. (1986). Interaction between Aeromonas 
salmonicida and peritoneal macrophages of brook trout (Salvelinus fontinalis). 
Veterinary Immunology and Immunopathology, 12: 223–234. 
Osborne, A.R., Clemons, Jr. W.M., Rapoport, T.A., (2004). A large conformational 
change of the translocation ATPase SecA, Proceedings of the National Academy of 
Sciences of the United States of America, 101: 10937-10942. 
 
168 References  
Over, B., Heusser, R., McCallum, N., Schulthess, B., Kupferschmied, P., Gaiani, 
J.M., Sifri, C.D., Berger-Bächi, B., Stutzmann Meier, P., (2011). LytR-CpsA-Psr 
proteins in Staphylococcus aureus display partial functional redundancy and the 
deletion of all three severely impairs septum placement and cell separation. FEMS 
Microbiology Letters, 320: 142-151. 
Paccani, S. R., F. Tonello, R., Ghittoni, M., Natale, L., Muraro, M. M., D'Elios, W. 
J., Tang, C., Montecucco, Baldari, C. T., (2005). Anthrax toxins suppress T 
lymphocyte activation by disrupting antigen receptor signalling. Journal of 
Experimental Medicine, 201:325–331. 
Papanikou, E., Karamanou, S., Baud, C., Frank, M., Sianidis, G., Keramisanou, 
D., Kolodimos, C.G., Kuhn, A., Economou, A., (2005). Identification of the 
preprotein binding domain of SecA. Journal of Biological Chemistry, 280: 43209–
43217. 
Papanikolau, Y., Papadovasilaki, M., Ravelli, R.B., McCarthy, A.A., Cusack, S., 
Economou, A., Petratos, K., (2007). Structure of dimeric SecA, the Escherichia coli 
preprotein translocase motor. Journal of Molecular Biology, 366: 1545–1557. 
Pei, Z. and Blaser, M.J., (1990). Pathogenesis of Campylobacter fetus infections. Role 
of surface array proteins in virulence in a mouse model. Journal of Clinical 
Investigation, 85: 1036-1043. 
Peltier, J.B., Emanuelsson, O., Kalume, D.E., Ytterberg, J., Friso, G., Rudella, A., 
Liberles, D.A., Soderberg, L., Roepstorff, P., von Heijne, G., van Wijk, K.J., 
(2002). Central functions of the lumen and peripheral thylakoid proteome of 
Arabidopsis determined by experimentation and genome-wide prediction. Plant Cell, 
14: 211-236. 
Peters, J., Nitsch, M., Kühlmorgen, B., Golbik, R., Lupas, A., Kellermann, J., 
Engelhardt H., Pfander, J.P., Müller, S., Goldie, K., Engel, A., Stetter, K.O., 
Baumeister, W., (1995). Tetrabrachion: a filamentous archaebacterial surface protein 
assembly of unusual structure and extreme stability. Journal of Molecular Biology, 245: 
385–401. 
Pflughoeft, K.J., Sumby, P., Koehler, T.M., (2011). Bacillus anthracis sin Locus and 
Regulation of Secreted Proteases. Journal of Bacteriology, 193: 631–639. 
 
169 References  
Phillips, G.J. and Silhavy, T.J., (1992). The E. coli ffh gene is necessary for viability 
and efficient protein export. Nature, 359: 744– 746. 
Plath, K., Mothes,W., Wilkinson, B.M., Stirling, C.J., Rapoport, T.A., (1998). 
Signal sequence recognition in posttranslational protein transport across the yeast ER 
membrane. Cell, 94: 795–807.  
Pleschberger, M., Neubauer, A., Egelseer, E. M., Weigert, S., Lindner, B., Sleytr, 
U. B., Muyldermans, S., Sára, M., (2003). Generation of a functional monomolecular 
protein lattice consisting of an S-layer fusion protein comprising the variable domain of 
a camel heavy chain antibody. Bioconjugate Chemistry, 14: 440–448. 
Pleschberger, M., Saerens, D.,Weigert, S., Sleytr, U.B., Muyldermans, S., Sára, M., 
Egelseer, E.M., (2004). An S-layer heavy chain camel antibody fusion protein for 
generation of a nanopatterned sensing layer to detect the prostate-specific antigen by 
surface plasmon resonance technology. Bioconjugate Chemistry, 15: 664–671. 
Pomerantsev, A.P., Sitaraman, R., Galloway, C.R., Kivovich, V., Leppla, S.H. 
(2006). Genome engineering in Bacillus anthracis using Cre recombinase. Infection & 
Immunity, 74: 682–693. 
Pum, D. and Sleytr, U.B., (1999). The application of bacterial S-layers in molecular 
nanotechnology. Trends in Biotechnology, 17: 8–12. 
Rahfeld, J.U., Rucknagel, K.P., Schelbert, B., Ludwig, B., Hacker, J., et al., (1994). 
Confirmation of the existence of a third family among peptidyl-prolyl cistrans 
isomerases. Amino acid sequence and recombinant production of parvulin. FEBS 
Letters, 352: 180–84. 
Randall, L.L. and Hardy, S.J., (2002). SecB, one small chaperone in the complex 
milieu of the cell. Cellular and Molecular Life Sciences, 59: 1617-1623. 
Rasko, D.A., Altherr, M.R., Han, C.S., Ravel, J. (2005). Genomics of the Bacillus 
cereus group of organisms. FEMS Microbiology Reviews, 29: 303–329. 
Ray, K.C., Mesnage, S., Washburn, R., Mock, M., Fouet, A., Blaser, M., (1998). 
Complement binding to Bacillus anthracis mutants lacking surface structures. Abstracts 
Book Poster 98
th
, General Meeting. American Society for Microbiology Atlanta, 
Georgia, USA, pp. B-418. 
Read, T.D., Peterson, S.N., Tourasse, N., Baillie, L.W., Paulsen, I.T., Nelson, K.E., 
Tettelin, H., Fouts, D.E., Eisen, J.A., Gill, S.R., Holtzapple, E.K., Okstad, O.A., 
 
170 References  
Helgason, E., (2003). The genome sequence of Bacillus anthracis Ames and 
comparison to closely related bacteria. Nature, 423: 81-6. 
Rigel, N.W., Gibbons, H.S., McCann, J.R., McDonough, J. ., Kurtz, S., Braunstein, 
M., (2009). The accessory SecA2 system of mycobacteria requires ATP binding and the 
canonical SecA1. Journal of Biological Chemistry, 284: 9927–9946. 
Sabet, M., Lee, S. W., Nauman, R. K., Sims, T., Um, H. S., (2003). The surface (S-) 
layer is a virulence factor of Bacteroides forsythus. Microbiology, 149: 3617-3627. 
Saller, M.J., Fusetti F., Driessen, A. J. M., (2009). Bacillus subtilis SpoIIIJ and YqjG 
Function in Membrane Protein Biogenesis, Journal of Bacteriology, 21: 6749-6757. 
Sambrook, J., Fritsch, E.F., Maniatis, T., (1989). Molecular cloning: a laboratory 
manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 
Sanderson-Smith, M.L., Dinkla, K., Cole, J.N., Cork, A.J., Maamary P.G., 
McArthur, J.D., Chhatwal, G.S., Walker, M.J., (2008). M protein-mediated 
plasminogen binding is essential for the virulence of an invasive Streptococcus 
pyogenes isolate. Faseb Journal, 22: 2715–2722. 
Sára, M. and Sleytr, U.B., (1987). Molecular sieving through S layers of Bacillus 
stearothermophilus strains. Journal of Bacteriology, 169: 4092-4098. 
Sára, M., Pum, D., Sleytr, U.B., (1992). Permeability and chargedependent adsorption 
properties of the S-layer lattice from Bacillus coagulans E38-66. Journal of 
Bacteriology, 174: 3487-3493. 
Sára, M., Pum, D., Schuster, B., Sleytr, U.B., (2005). S-layers as patterning elements 
for application in nanobiotechnology. Journal for Nanoscience and Nanotechnology , 
5: 1939–1953. 
Schatz, P.J., Bieker, K.L., Ottemann, K.M., Silhavy, T.J., Beckwith, J., (1991). One 
of three transmembrane stretches is sufficient for the functioning of the SecE protein, a 
membrane component of the E. coli secretion machinery. EMBO Journal, 10: 1749–
1757. 
Schultze-Lam, S., Haranz, G., Beveridge, T.J., (1992). Participation of a 
cyanobacterial S-layer in fine-grain mineral formation. Journal of  Bacteriology, 74: 
7971–7981. 
Scheuring, J., Braun, N., Nothdurft, L., Stumpf, M., Veenendaal, A.K., Kol, S., van 
der Does, C., Driessen, A.J.M., Weinkauf, S., (2005). The oligomeric distribution of 
 
171 References  
SecYEG is altered by SecA and translocation ligands. Journal of Molecular Biology, 
354: 258–271. 
Schiebel E., Driessen A.J.M., Hartl F.U., Wickner W., (1991). DAH + and ATP 
function at different steps of the catalytic cycle of preprotein translocase. Cell, 64: 927– 
939. 
Schnepf, E., Crickmore, N., Van Rie, J., Lereclus, D., Baum, J., Feitelson, J., 
Zeigler, D. R., Dean, D. H., (1998). Bacillus thuringiensis and its pesticidal crystal 
proteins. Microbiology and Molecular Biology Reviews, 62: 775–806. 
Schultze-Lam, S. and Beveridge, T. J., (1994). Nucleation of Celestite and 
Strontianite on a Cyanobacterial S-Layer. Applied and Environmental Microbiology, 60: 
447 – 453. 
Sciochetti, S.A., Piggot, P.J., Blakely, G.W., (2001). Identification and 
characterisation of the dif site from Bacillus subtilis. Journal of Bacteriology, 183: 
1058–1068. 
Shan, S.O. and Walter, P., (2005). Co-translational protein targeting by the signal 
recognition particle. FEBS Letters, 579: 921–926 
Sharma, V., Arockiasamy A., Ronning, D.R., Savva, C.G., Holzenburg, A., 
Braunstein, M., Jacobs, J., Sacchettini, J.C., (2003). Crystal structure of 
Mycobacterium tuberculosis SecA, a preprotein translocating ATPase. Proceedings of 
the National Academy of Sciences of the United States of America, 100: 2243–2248.  
Shafazand, S., Doyle, R., Ruoss, S., Weinacker, A.,  Raffin, T. A., (1999). Inhalation 
anthrax: epidemiology, diagnosis and management. Chest, 116: 1369-1376. 
Shimohata, N., Nagamori, S., Akiyama, Y., Kaback, H. R., Ito, K., (2007). SecY 
alterations that impair membrane protein folding and generate a membrane stress. 
Journal of  Cell Biology, 176: 307-317. 
Shmid, F.X., (2001). Prolyl isomerases. Advances in Protein Chemistry, 59: 243-282. 
Sianidis, G., Karamanou, S., Vrontou, E., Boulias, K., Repanas, K., Kyrpides, N., 
Politou, A.S., Economou, A., (2001). Cross-talk between catalytic and regulatory 
elements in a DEAD motor domain is essential for SecA function. EMBO Journal, 20: 
961-970. 
 
172 References  
Siegel, V. and Walter, P., (1988). Each of the activities of signal recognition particle 
(SRP) is contained within a distinct domain: analysis of biochemical mutants of SRP. 
Cell, 52: 39– 49. 
Sillanpää, J., Martínez, B., Antikainen, J., Toba, T., Kalkkinen, N., Tankka, S., 
Lounatmaa, K., Keranen, J., Hook, M., Westerlund-Wikstrom, B., Pouwels, P. H., 
Korhonen, T. K., (2000). Characterization of the collagen-binding S-layer protein 
CbsA of Lactobacillus crispatus. Journal of Bacteriology, 182: 6440–6450. 
Sirisanthanta T., Brown, A.E., (2002). Anthrax of the gastrointestinal tract. Emerging 
Infectious Diseases, 8: 649-651. 
Sleytr, U. B., and Messner, P., (1983). Crystalline surface layers on bacteria. Annual 
Review of Microbiology, 37: 311–339. 
Sleytr, U.B., Sára, M., Küpcü, Z., Messner, P., (1986). Structural and chemical 
characterization of S-layers of selected strains of Bacillus stearothermophilus and 
Desulfotomaculum nigrificans. Archives in Microbiology, 146: 19–24. 
Sleytr, U.B., Messner, P., Pum, D., Sára, M. (Eds.: U.B.), (1988). Crystalline 
Bacterial Cell Surface Layers, Springer, Berlin, p. 193. 
van der Sluis, E.O., Nouwen, N., Driessen, A.J.M., (2002). SecY–SecYand SecY–
SecG contacts revealed by site-specific crosslinking. FEBS Letters, 527: 159–165. 
Smith, R.H., Messner, P., Lamontagne, L.R., Sleytr, U.B. and Unger, F.M., (1993). 
Induction of T-cell immunity to oligosaccharide antigens immobilized on crystalline 
bacterial surface layers (S-layers). Vaccine, 11: 919–924.  
Smith, H. and Stoner, H.B., (1967). Anthrax toxic complex. Federation proceedings, 
26: 1554-1557. 
Soberón, M., Pardo-López, L., López, I., Gómez, I., Tabashnik, B.E., Bravo, A., 
(2007). Engineering modified Bt toxins to counter insect resistance. Science, 318: 
1640–42. 
Song, C., Kumar, A., Saleh, M., (2009). Bioinformatic comparison of bacterial 
secretomes. Genomics Proteomics, Bioinformatics, 7: 37–46. 
Spencer, R.C., (2003). Bacillus anthracis. Journal of Clinical Pathology, 56: 182-187. 
 
173 References  
Takamatsu, D., Bensing, B. A., Sullam, P. M., (2004). Genes in the accessory sec 
locus of Streptococcus gordonii have three functionally distinct effects on the 
expression of the platelet-binding protein GspB. Molecular Microbiology, 52: 189–203. 
Takamatsu, D., Bensing, B.A., Sullam, P.M., (2005). Two additional components of 
the accessory Sec system mediating export of the Streptococcus gordonii platelet-
binding protein GspB. Journal of Bacteriology, 187: 3878–3883. 
Takami, H., Nakasone, K., Takaki, Y., Maeno, G., Sasaki, R., Masui, N., Fuji, F., 
Hirama, C., Nakamura, Y., Ogasawara, N., Kuhara, S., Horikoshi, K., (2000). 
Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and 
genomic sequence comparison with Bacillus subtilis. Nucleic Acids Research, 28: 4317-
4331. 
Takeoka, A., Takumi, K., Kawata, T., (1991). Purification and characterization of S-
layer proteins from Clostridium difficile GAI 0714. Journal of General Microbiology, 
137: 261–267. 
Tjalsma, H., Noback, M.A., Bron, S., Venema, G., Yamane, K., van Dijl, J.M., 
(1997). Bacillus subtilis contains four closely related type I signal peptidases with 
overlapping substrate specificities: Constitutive and temporally controlled expression of 
different sip genes. Journal of Biological Chemistry, 272: 25983–25992. 
Tjalsma, H., Bolhuis, A., van Roosmalen, M L., Wiegert, T., Schumann, W., 
Broekhuizen, C.P., Quax, W., Venema, G., Bron, S., van Dijl, J.M., (1998). 
Functional analysis of the secretory precursor processing machinery of Bacillus subtilis: 
identification of a eubacterial homolog of archaeal and eukaryotic signal peptidases. 
Genes & Development, 12: 2318–2331. 
Tjalsma, H., Stover, A.G., Driks, A., Venema, G., Bron, S., van Dijl, J.M., (2000). 
Conserved serine and histidine residues are critical for activity of the ER-type signal 
peptidase SipW of Bacillus subtilis. Journal of Biological Chemistry, 275: 25102-
25108. 
Tjalsma, H., Zanen, G., Bron, S., van Dijl, J.M., (2001). The eubacterial lipoprotein-
specific (type II) signal peptidase. Enzymes, 22: 3–23. 
Tjalsma, H., Bron, S., van Dijl, J. M., (2003). Complementary impact of paralogous 
OxaI-like proteins of Bacillus subtilis on post-translocational stages in protein secretion. 
Journal of Biological Chemistry, 278: 15622-15632. 
 
174 References  
Tjalsma, H., Antelmann, H., Jongbloed, J.D.H., Braun, P.G., Darmon, E., 
Dorenbos, R., Jean-Yves F. Dubois, J-Y.F, Westers, H., Zanen, G., Quax, W.J., et 
al., (2004). Proteomics of protein secretion by Bacillus subtilis: separating the 
‘‘secrets’’ of the secretome. Microbiology and Molecular Biology Reviews, 68: 207–
233. 
 Topping, T.B. and Randall L.L., (1997). Chaperone SecB from Escherichia coli 
mediates kinetic partitioning via a dynamic equilibrium with its ligand. Journal of 
Biological Chemistry, 272:19314-19318. 
Topping, T.B., Woodbury, R.L., Diamond, D.L., Hardy, S.J., Randall, L.L., 
(2001). Direct demonstration that homotetrameric chaperone SecB undergoes a 
dynamic dimer-tetramer equilibrium. Journal of Biological Chemistry, 276: 7437–41. 
Tournier, J. N., Quesnel-Hellmann, A., Mathieu, J., Montecucco, C., Tang, W. J., 
Mock, M., Vidal, D. R., Goossens, P. L., (2005). Anthrax edema toxin cooperates 
with lethal toxin to impair cytokine secretion during infection of dendritic cells. 
Journal of Immunology, 174: 4934–4941. 
Tournier, J.-N., Quesnel-Hellmann, A., Cleret, A., Vidal, D.R., (2007). Contribution 
of toxins to the pathogenesis of inhalational anthrax. Cellular Microbiology, 9: 555–
565. 
Trust, T.J., Kostrzynska, M., Emödy, L., and Wadström, T. (1993). High-affinity 
binding of the basement membrane protein collagen type IV to the crystalline virulence 
surface protein array of Aeromonas salmonicida. Molecular Microbiology, 7: 593–600. 
Turnbull, P.C., Leppla, S.H., Broster, M.G., Quinn, C.P., Melling, J., (1988). 
Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective 
immunity. Medical Microbiology and Immunology, 177: 293-303. 
Turnbull, P.C.B., Boehm, R., Cosivi, O., Doganay, M., Hugh-Jones, M.E., Joshi, D. 
D., Lalitha, M.K., de Vos, V., (1998). Guidelines for the surveillance and control of 
anthrax in humans and animals. WHO/EMC/ZDI/98.6. 
Tutrone, W.D., Scheinfeld, N.S., Weinberg, J.M., (2002). Cutaneous anthrax: a 
concise review. Cutis, 69: 27–33. 
Tziatzios, C., Schubert, D., Lotz, M., Gundogan, D., Betz, H., Schagger H., Haase, 
W., Duong, F., Collinson, I., (2004). The bacterial protein-translocation complex: 
 
175 References  
SecYEG dimers associate with one or two SecA molecules. Journal of Molecular 
Biology, 340: 513–524. 
Uchida, I., Hornung, J.M., Thorne, C.B., Klimpel, K.R., Leppla, S.H., (1993). 
Cloning and characterization of a gene whose product is a trans-activator of anthrax 
toxin synthesis. Journal of Bacteriology, 175: 5329-5338. 
Vagner, V., Dervyn, E., Ehrlich, S.D., (1998). A vector for systematic gene 
inactivation in Bacillus subtilis. Microbiology, 144: 3097-3104. 
Valent, Q.A., Scotti, P.A., High, S., De Gier, J.-W.L., Von Heijne, G., Lentzen, G., 
Wintermeyer, W., Oudega, B., Luirink, J., (1998). The Escherichia coli SRP and 
SecB targeting pathways converge at the translocon. EMBO Journal, 17: 2504–2512. 
Vassylyev, D.G., Mori, H., Vassylyeva, M.N., Tsukazaki, T., Kimura, Y., Tahirov, 
T. H., Ito, K., (2006). Crystal structure of the translocation ATPase SecA from 
Thermus thermophilus reveals a parallel, head-to-head dimer. Journal of Molecular 
Biology, 364: 248–258. 
Veenendaal, A.K., van der Does, C., Driessen, A.J.M., (2002). The core of the 
bacterial translocase harbors a tilted transmembrane segment 3 of SecE, Journal of 
Biological Chemistry, 277: 36640–36645. 
Vietri, N.J., Marrero, R., Hoover, T.A., Welkos, S.L., (1995). Identification and 
characterization of a trans-activator involved in the regulation of encapsulation by 
Bacillus anthracis. Gene, 152: 1-9. 
Vitale, G.P., Recchi, C., Napolitani, G., Mock, M., Montecucco, C., (1998). Anthrax 
lethal factor cleaves N-terminus of MAPKK's and induces tyrosine/threonine 
phosphorylation of MAPK's in cultures macrophages. Biochemical and Biophysical 
Research Communications, 248: 706-711. 
Vitikainen, M., Pummi, T., Airaksinen, U., Wahlstrom, E., Wu, H., Sarvas, M., 
Kontinen, V.P., (2001). Quantitation of the capacity of thesecretion apparatus and 
requirement for PrsA in growth and secretionof alpha-amylase in Bacillus subtilis, 
Journal of Bacteriology, 183: 1881– 1890. 
Voth, D. E., Hamm, E. E., Nguyen, L. G., Tucker, A. E., Salles, I. I., Ortiz-Leduc, 
W., Ballard, J. D., (2005). Bacillus anthracis oedema toxin as a cause of tissue 
necrosis and cell typespecific cytotoxicity. Cellular Microbiology, 7: 1139-1149. 
 
176 References  
Völlenkle, C., S. Weigert, N. Ilk, E. Egelseer, V. Weber, F. Loth, D. Falkenhagen, 
U. B. Sleytr, Sara, M., (2004). Construction of a functional S-layer fusion protein 
comprising an immunoglobulin G-binding domain for development of specific 
adsorbents for extracorporeal blood purification. Applied and Environmental 
Microbiology, 70: 1514–1521. 
Walter, P. and Blobel, G., (1981). Translocation of proteins across the endoplasmic 
reticulum III. Signal recognition protein (SRP) causes signal sequence-dependent and 
site-specific arrest of chain elongation that is released by microsomal membranes. 
Journal of Cell Biology, 91: 557–561 
Walz, A., Mujer, C.V., Connolly, J.P., Alefantis, T., Chafin, R., Dake, C., 
Whittington, J., Kumar, S.P., Khan, A.S., DelVecchio, V.G., (2007). Bacillus 
anthracissecretome time course under host-simulated conditions and identification of 
immunogenic proteins. Proteome Science, 5: 11. 
Wang, B., Kraig, E., Kolodrubetz, D., (2000). Use of defined mutants to assess the 
role of the Campylobacter rectus S-layer in bacterium-epithelial cell interactions. 
Infection & Immunity, 68:1465–1473. 
Wandersman, C., (1989). Secretion, processing and activation of bacterial extracellular 
proteases. Molecular Microbiology, 3: 1825–1831. 
Wang, L., Ruan, B., Ruvinov, S., Bryan, P.N., (1998). Engineering the independent 
folding of the subtilisin BPN’ pro-domain: correlation of pro-domain stability with the 
rate of subtilisin folding. Biochemistry, 37: 3165–3171. 
van Wely, K. H. M., Swaving, J., Broekhuizen, C. P., Rose, M., Quax, W. J., 
Driessen, A. J. M. (1999). Functional identification of the product of the Bacillus 
subtilis yvaL gene as a SecG homologue. Journal of Bacteriology, 181: 1786–1792. 
Wildhaber, I. and Baumeister, W., (1987). The cell envelope of Thermoproteus tenax: 
three-dimensional structure of the surface layer and its role in shape maintenance. 
EMBO Journal, 6: 1475-1480. 
Williams, R.C., Rees, M.L., Jacobs, M.F., Pragai, Z., Thwaite, J.E., Baillie, L.W., 
Emmerson P.T., Harwood, C.R. (2003). Production of Bacillus anthracis protective 
antigen is dependent on the extracellular chaperone. PrsA. Journal of Biological 
Chemistry, 278: 18056-18062.  
 
177 References  
van der Wolk, J.P., de Wit, J.G., Driessen, A.J., (1997). The catalytic cycle of the 
Escherichia coli SecA ATPase comprises two distinct preprotein translocation events. 
EMBO Journal, 16: 7297– 7304. 
Wong, S.L., (1995). Advances in the use of Bacillus subtilis for the expression and 
secretion of heterologous proteins. Current Opinion Biotechnology, 6: 517-522.  
Woodbury, R.L., Hardy, S.J.S., Randall, L.L., (2002). Complex behavior in solution 
of homodimeric SecA. Protein Science, 11: 875-882. 
Wu, X.C., Lee, W., Tran, L., Wong, S.L., (1991). Engineering a Bacillus subtilis 
expression–secretion system with a strain deficient in six extracellular proteases. 
Journal of Bacteriology, 173: 4952–4958. 
Yabuta, Y., Takagi, H., Inouye, M., Shinde, U., (2001). Folding pathway mediated by 
an intramolecular chaperone. Propeptide release modulates activation precision of pro-
subtilisin. Journal of Biological Chemistry, 276: 44427–44434.  
Yamada, H., Tsukagoshi, N., Udaka, S., (1981). Morphological alterations of cell wall 
concomitant with protein release in a protein-producing bacterium Bacillus brevis. 
Journal of Bacteriology, 148:322–332. 
Yang, M. J., Jung, S. H., Shin, E. S., Kim, J., Yun, H. D., Wong, S. L., Kim, H. 
(2004). Expression of a Bacillus subtilis endoglucanase in protease-deficient Bacillus 
subtilis strains. Journal of Microbiology and Biotechnology, 14: 430-434.  
Young, J.A. and Collier, R., J., (2007). Anthrax Toxin: Receptor Binding, 
Internalization, Pore Formation, and Translocation. Annual Review Biochemistry, 76: 
243–265. 
Zemansky, J., Kline, B. C., Woodward, J. J, Leber, J. H., Marquis, H., Portnoy, D. 
A., (2009). Development of a mariner-based transposon and identification of Listeria 
monocytogenes determinants, including the peptidyl- prolyl isomerase PrsA2, that 
contribute to its hemolytic phenotype. Journal of Bacteriology, 191:3950–3964. 
Zhao, G., Meier, T.I., Kahl, S.,D., Gee, K.R., Blaszczak L.,C., (1999). BOCILLIN 
FL, a sensitive and commercially available reagent for detection of penicillin-binding 
proteins. Antimicrobial Agents and Chemotherapy. 43: 1124–1128. 
Zhou, J. and Xu, Z., (2005). The structural view of bacterial translocation-specific 
chaperone SecB: implications for function. Molecular Microbiology, 58: 349–357. 
 
178 References  
Zimmer, J., Li, W., Rapoport, T., (2006). A novel dimer interface and conformational 
changes revealed by an X-ray structure of B. subtilis SecA. Journal of Molecular 
Biology, 364: 259–265. 
Zink, S.D. and Burns, D.L., (2005). Importance of srtA and srtB for growth of Bacillus 
anthracis in macrophages. Infection & Immunity, 73:5222-5228. 
Zuber, U. and Schumann, W., (1994). CIRCE, a novel heat shock element involved in 
regulation of heat shock operon dnaK of Bacillus subtilis. Journal of Bacteriology, 176: 
1359– 1363. 
 
 
 
 
179 Appendix A 
Appendix A: Growth media and solutions 
 
General growth media 
Luria-Bertani (LB) Growth Media (per litre) pH to 7.0  (Autoclave) 
Bacto Tryptone 
NaCl 
Bacto Yeast Extract 
10 g 
10 g 
5 g 
(Agar; Mast Diagnostics; Merseyside, UK) (15 g) 
 
Modified LB media  Additive stock Volume of stock added to 
1000 ml LB medium 
LB-Starch Starch 10 g prior to autoclaving 
 
E.coli transformation 
Basis of SOC and SOB broths (per litre) Autoclave 
Bacto Tryptone 
Bacto Yeast Extract 
NaCl 
KCl 
20 g 
5g 
0.58 g 
0.189 
 
2 M glucose                                                              
glucose 
Add distilled water to 100 ml and filter sterilize with 0.22 µM 
filter 
34 g 
 
 
2 M Mg
2+
 stock                                                              
MgCl2 
MgSO4 
Add distilled water to 100 ml and filter sterilize 
20.33 g 
24.65 g 
 
SOC and SOB broths   
SOB broth: add 1 ml of 2M Mg
2+ 
stock to 99 ml basis of SOB and SOC broth 
SOC broth: add 1 ml of 2M glucose and 1 ml of 2M Mg
2+ 
stock to 98 ml basis of 
SOB and SOC broth 
 
TB (Inoue) buffer (per litre)  
MnCl2 
CaCl2 
KCl 
10 mM PIPES (0.5M, pH 6.7) 
Add distilled water to 1 liter and filter sterilize with 0.45 µM 
filter 
10.9 g 
2.2 g 
18.7 g 
20 ml 
 
 
Electrophoresis buffers 
5x TBE  
Tris base 
Boric acid 
EDTA 
54 g 
27.5g 
20ml of 0.5M 
(pH 8.0) 
 
50 x TAE Running buffer (per liter)  
Tris base 
Glacial acetic acid 
0.5M EDTA (pH 8.0) 
48.4 g 
11.4 ml 
20ml  
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Bacillus subtilis transformation media 
 
Spizizen minimal medium (SMM) (per litre) (Autoclave) 
(NH4)2SO4  
K2HPO4 
KH2PO4 
C6H5O7Na3•2H2O 
MgSO4.7H2O 
2 g 
14 g 
6 g 
1 g 
0.2 g 
 
MM competence medium (per transformation)  
SMM 
40% glucose 
Tryptophan solution (2 mg/ml) 
MgSO4 (1M)  
Casamino acids (20%) 
C6H8O7 FeNH4  
10 ml 
0.125 ml 
0.1 ml 
0.06 ml 
0.01 ml 
0.005 ml 
 
MM starvation medium (per transformation)  
SMM 
40% glucose 
MgSO4 (1M)  
10 ml 
0.125ml 
0.06 ml 
 
Koehler electrotransformation media for the transformation of B. anthracis 
Growth Medium (per litre) (Autoclave) 
BHI medium (DIFCO) 37 g  
Glycerol 
(Agar; Mast Diagnostics, Merseyside, UK) 
5 g 
(10 g) 
 
Electrotransformation buffer (per litre), pH to 7.0  (Autoclave) 
HEPES-Na 1 mM  
Glycerol 10 % (w /v) 
 
Recovery Medium (per litre) (Autoclave) 
BHI medium (DIFCO) 37 g  
Glycerol 100 g 
Glucose (20 % (w/v) – filter sterilised, add to cooled sterilised 
medium 
20 ml 
MgCl2 (0.5 M) – filter sterilised, add to cooled sterilised medium 20 ml 
 
SDS-PAGE and protein purification 
Acrylamide Gels for SDS-PAGE 
 Resolving Gel (10 %) Stacking Gel (5 %) 
dH2O 5.0 ml 3.1 ml 
40 % (w/v) Bis 
Acrylamide 
2.5 ml 0.625 ml 
1.5 M Tris pH 8.8 2.5 ml - 
1 M Tris pH 6.8 - 1.25 ml 
10 % (w/v) APS 0.05 ml 0.03 ml 
TEMED 0.001 ml 0.015 ml 
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2 x SDS-PAGE Loading Buffer  
TrisHCl (pH6.8) 100 mM 
-Mercaptoethanol 100 mM 
SDS 4 % (w/v) 
Bromophenol Blue 0.2 % (w/v) 
Glycerol 20 % (w/v) 
 
10 x SDS-PAGE Running Buffer (per litre) 
Tris Base 30.2 g 
Glycine 150 g 
SDS 10g 
 
Coomassie Blue Stain (per litre)  
Coomassie Blue 0.25 g 
Ethanol 500 ml 
Glacial acetic acid 75 ml 
 
SDS-PAGE Destain   
Ethanol 30 % (v/v) 
Glacial Acetic Acid 10 % (v/v) 
 
TCA solution   
TCA 80 g 
dH2O 200 ml 
 
Urea/thiourea solution  
Urea 1.2 g 
Add 1 ml dH2O, vortex to dissolve add 0.38h thiourea and vortex 
to dissolve. Fill the volume up to 2.5ml. 
 
 
Lithium chloride solution (pH 7.5)  
LiCl 4 M 
PMSF   200 µM 
TrisCl 50 mM 
 
Phosphate buffered saline (PBS) (pH 7.4)  
NaCl 136 mM 
NaH2PO4 
KCl 
10 mM 
2.5 mM 
K2HPO4 1.8 mM 
 
1x Tris buffered saline  (TBS) (pH 7.4)  
NaCl 150mM or 
500mM* 
Tris-Cl 50 mM 
*500 mM for high stringency washes  
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Solutions for Northern blotting hybridization 
 
Hybridization solution (10ml)  
20x SSC 2.5 ml 
10% SDS 20 µl 
10% N-laurylsarcosine  100 µl 
10% blocking reagent 2 ml 
Formamide 5 ml 
 
Denaturation solution  
NaOH 0.5 M 
NaCl  1.5 M 
 
Neutralization solution   
Tris-HCl 0.5 M 
1.5 NaCl 3 M 
 
20x SSC (pH 7.0)  
NaCl 3 M 
Sodium Citrate 0.3 M 
 
10% Blocking reagent (pH 7.5)  
Blocking reagent (milk powder) 20 g  
Maleic acid buffer 200 ml  
Dissolve blocking reagent in maleic acid buffer in the microwave, stirring it from time 
to time. Adjust pH to 7.5 with NaOH, autoclave and store at 4
o
C.  
 
10% Blocking buffer (pH 7.5) (per 50 ml)  
10% Blocking reagent 5 ml 
Washing buffer I 5 ml  
Fill up to 50ml litre with dH2O  and leave for about 30 min at 37
o
C before use 
 
Maleic Acid Buffer (pH7.5)  
Maleic acid 0.1 M  
NaCl 0.15 M  
 
10x Washing Buffer I (pH 7.0)  
Maleic acid 116 g 
NaCl 87.6 g 
NaOH 
Fill up to 1 litre with dH2O 
72 g 
 
Tween Washing buffer  
10% Washing buffer I  100 ml 
Tween 80 
Fill up to 1 litre with dH2O 
3 ml 
 
Washing Solution I (per 50 ml)  
20 x SSC  10 ml 
10% SDS 
Fill up to 50ml litre with dH2O 
1 ml 
 
Washing Solution I (per 150 ml)  
20 x SSC  0.75 ml 
10% SDS 1.5 ml 
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Fill up to 150ml litre with dH2O 
 
Buffer 3 (pH 9.0)  
diethanolamine 9.63 ml 
Fill up to 1 litre with dH2O  
 
Detection buffer  (pH 9.5)  
Tris-HCl 0.1 M  
NaCl 0.1 M  
10x MOPS (pH 7.0)  
MOPS 0.2 M 
NaCl 0.05 M 
EDTA 0.02 M 
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Appendix B: Oligonucleotide primers used in the study 
Primer Sequence (restriction site inserted-red) PCR amplification 
product 
(bp)/Comment 
 
   
Complementation analysis of SecY of B. subtilis (Bsu SecY) by SecY2 
of B. anthracis (Ban SecY2) 
 
   
secY_fwd   ttttttgcggccgcTGGCGGTACAGCTGAGG  secY (370) 
secY_rev   cgcggatccACGGCGGCCAACTTC  
 
secY2_fwd ttttttggatccTGCGGAAGGAGGTTTGTG secY2 (1415) 
secY2_rev   cgacggactagtTTTTTACTTAATTCGCTTT  
 
adk_fwd   cgacggactagtTTAATAAAGAGAGGACGGG  adk-map (1468) 
Map_rev   tttgcggccgcTCGGAATTATTTTCATCA  
 
Pmut_fwd TCC TAA CAG CAC AAG AGC Amplification over 
pMUTIN4 mcs 
 
Pmut_rev CCA CAG TAG TTC ACC ACC 
Pxyl_fwd ATA AGT TAG TTT GTT TGG GC Amplification over 
pJPR1 mcs amyE_rev GGA TAT ACA GCC ATT CAG AC 
   
Creation of deletion mutants of B. anthracis  
   
prsAA_upstream_fwd ttttttcccgggGTAGTTATGTCCGATTC  prsAA upstream 
region (939) prsAA_upstream_rev ttttttcccgggTCGATAAACACTCCTAC 
prsAA_downstream_fwd ttttttcccgggGTAGTTATGTCCGATTC prsAA downstream 
region (885) prsAA_downstream_rev cgcgaattcGAACATAGAATCAATCTC 
   
prsAB_upstream_fwd tttcgtgagctcACATAACCAGCGGCGATAATA prsAB upstream 
region (906) prsAB_upstream_rev ttttttcccgggGCTAACACCTCATCCGAATATG 
prsAB_downstream_fwd ttttttcccgggCCACTTCAATCAGCGCATC prsAB downstream 
region (737) prsAB_downstream_rev tttcgcgaattcAGATGAGCATTTCCGTGCATT 
   
prsAC_upstream_fwd ttttgtgagctcAAGGGCTGGTCGATTTACCT prsAC upstream 
region (779) prsAC_upstream_rev ttttttcccgggTGAGTAAAATGACCCTTTACGT
ATTC 
prsAC_downstream_fwd ttttttcccgggAGGTTCCCTTTTCTAGTTAGTG prsAC downstream 
region (849) prsAC_downstream_rev tttcgcgaattcAAATATAAAATCCCTGCCTAA
ATTC 
   
secH_upstream_fwd ttttgtgagctcAGCTAAAAGGTCGTGCTGGT  secH upstream 
region (828) secH_upstream_rev ttttttcccgggCACCTCGTTATTGTACGTTTTC
A  
secH_downstream_fwd ttttttcccgggCAAAAAGATGGTCATCACAC  secH downstream 
region (861) secH_downstream_rev ttttgtgaattcGCTTTTTTATTGTTATATTCAGT 
   
secA2_upstream_fwd cacgagctcCTGCTACAACATCACTCTC  secA2 upstream 
region (671) secA2_upstream_rev ccacccgggCTGACAATAGCTACAT 
secA2_downstream_fwd ttttttcccgggCGAGGTGAAAGATTATG  secA2 downstream 
region (909) secA2_downstream_rev cgcgaattcGTGGTACAAGTGCTTTC  
secA2_promoter_fwd caacccgggACATCATAAAACGAGATAG promoter region of 
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secA2_promoter_rev ccactgcagACTGACAATAGCTAC secA2-secH operon 
(241) 
   
sap_upstream_fwd caagagctcCTATGGTCGGTATTTCATATG  sap upstream 
region (671) sap_upstream_rev caacccgggCTCCTTAGGAATGTAATAC 
eag_downstream_fwd caacccgggGTCGATTATAGATAAAGTG eag downstream 
region (909) eag_downstream_rev ccactgcagTAAACGACTTATCTCAG 
   
DifKmF ttttttcccgggACTGCCTATAATATATATTATG
TTAACTGGTGATTGATTGAGCAAGCTTTA
TGC 
Primers to amplify 
kanamycin 
resistance cassette 
with dif sites 
(2200) 
DifKmR ttttttcccgggAGTTAACATAATATATATTATA
GG 
CAGTGGTGATTGATTGAGCAAGCTTTAT
GC (66) 
prsAA_chromosomal_fwd GAACTGATTGCTATCTTG  
prsAB_chromosomal_fwd TACATGACGCGTATGAATCG  
prsAC_chromosomal_fwd AATGATGCTAGAATGGATACACTA  
secA2_chromosomal_fwd GCAATTGGAATCGAAACCTG  
secH_chromosomal_fwd TGAGGGTGTTCACGAACTTG  
sap_chromosomal_fwd GAACTGATTGCTATCTTG  
Km_internal_rev TAGCGAGGGCTTTACTAAGC  
   
Complementation of B.anthracis null mutants  
 
 
secA2_compl_fwd ttttttcccgggGAGGAGTGTTTACAACATGCTG secA2 (2414) 
secA2_compl_rev caactgcagTCACCTCGTTATTGTACG   
secH_compl_fwd ttttttcccgggCGAGGTGAAAGATTATGTTATC
ATTC 
secH (998 ) 
secH_compl_rev caactgcagCCAAAGAGGTGTGATGACCA  
secA2_compl_fwd ttttttcccgggGAGGAGTGTTTACAACATGCTG secA2-secH (3416) 
secH_compl_rev caactgcagCCAAAGAGGTGTGATGACCA  
sap_compl_fwd caaggatccATGGCAAAGACTAACTC sap (2534) 
sap_compl_rev ccagaattcCCTATGATACTCATAGAC  
eag_compl_fwd caaggatccATGGCAAAGACTAACTC eag (2636) 
eag_compl_rev ccagaattcCACTTTATCTATAATCGAC  
   
Bacterial-Two-Hybrid (B2H) assay  
   
B2H_secA1_fwd ttccgttctagaTAAAAAGAGGAGCGTATTTCC  secA1 (2485) 
B2H_secA1_rev ttttttggtaccCATAAATCGTTGCGGCCGACTT
GGTC 
 
B2H_secA2_fwd ttttgttctagaTATTGTCAGTAAGAGGAGTGTT
T 
secA2 (2375) 
B2H_secA2_rev ttttttggtaccGGAACACCTAAATGTCTTGC   
B2H_secY1_fwd tttttttctagaAGGTGATCTAATGTTTCGTAC secY1 (1338) 
B2H_secY1_rev ttttttggtaccTAATGGCGTTTTACCAGT  
B2H_secY2_fwd tttttttctagaTGATAAAAATATAGGAGGCGAC
A 
secY2 (1290) 
B2H_secY2_rev ttttttggtaccATAAACCCTTTATAATGACGT  
B2H_secH _fwd cgctctagaGATTATGTTATCATTCC  secH (900) 
B2H_secH_rev caaggtaccTCTTGTGGTACAAGTGC   
B2H_eag_fwd gtacgctctagaTAGCATATTCCTGAAGGAGG  5’end eag (384) 
B2H_eag_rev ttctgtggtaccACTGCTGCAATATATTTTG   
B2H_sap5’_fwd tttttttctagaTAAGGAGGAAATATATAAAATG
GCA  
5’end sap (333) 
B2H_sap5’_rev ttttttggtaccTCAGCGAAAGATGGTTTA  
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B2H_sap_fwd cacgtcgacAATGGCAAAGACTAACTC sap (2441) 
B2H_sap_rev ttttttggtaccGTTGCAGGTTTTGCTTCT  
B2H_eag/sap_sig_fwd cactctagaAATGGCAAAGACTAACTCTTAC  Signal sequence of 
sap and eag (114) B2H_eag/sap_sig_rev  ttttttggtaccCCTGCTGCTGCTACTGGA  
B2H_Bsu_ secA_fwd cgctctagaAATGCTTGGAATTTTAAAT  secA of B. subtilis 
(2541) B2H_Bsu_ secA_rev ttttttggtaccTCAGTACGGCCGCAGCA 
   
   
 
Sequencing primers for B2H 
 
   
pUT18 for GAGTTAGCTCACTCATTAGG  
pUT18 rev CCTAATGAGTGAGCTAACTC  
pUT18C for TCGACGATGGGCTGGGAGCC  
pUT18C rev AGCAGACAAGCCCGTCAGGGC  
pKT25 for GGCGGATATCGACATGT  
pKT25 rev ATCGGTGCGGGCCTCTTCGC  
pKT25N for GCTCACTCATTAGGCAC  
pKT25 rev GGCGGAACATCAATGTGGCG  
   
Protein purification   
   
pur_secA1_fwd ttttttggatccATGATCGGTATTTTAAAAAAG secA1 (2535) 
pur_secA1_rev ttttttgtcgacTGATTACTTCCCGATACCACA  
pur_secA2_fwd ttttttggatccATGCTGAATTCGGTAAAAAAG secA2 (2393) 
pur_secA2_rev ttttttgtcgacTGATTATTGTACGTTTTCAGG  
pur_secH_fwd caacatatgAAAGATTATGTTATCATTCC secH (893) 
pur_secH_rev ccaggatccTGATTAGTCTTGTGGTAC 
 
 
Northern blotting   
   
secA1_probe_fwd ATGATCGGTATTTTAAAAAAGG 5’ terminus of 
secA1 (601) secA1_probe_rev ctaatacgactcactatagggagaAAGATAGAATCGACTT
CATC 
secA2_probe_fwd atgctgaattcggtaaaaaag 5’ terminus of 
secA2 (664) secA2_probe_rev ctaatacgactcactatagggagaAAGCGGCCATATTATC
ACGT 
secY1_probe_fwd ATGTTTCGTACAATCTCCAAC 5’ terminus of 
secY1 (545) secY1_probe_rev ctaatacgactcactatagggagaCCTTTAGCTGTAATCT
GTTC 
secY2_probe_fwd ATGTTTCGTACGATTTCAAA 5’ terminus of 
secY2 (555) secY2_probe_rev ctaatacgactcactatagggagaATTACCTACTCCATTA
GCGG 
secH_probe_fwd ATGTTATCATTCCTAAAAAAAGC 5’ terminus of  
secH (530) secH_probe_rev ctaatacgactcactatagggagaTCTAGTGTATGCTTGC
TTTC 
sap_probe_fwd ATGGCAAAGACTAACTCTTA 5’ terminus of  
sap (554) sap_probe_rev ctaatacgactcactatagggagaATTCCTAATTCAACTA
AGAT 
eag_probe_fwd ATGGCAAAGACTAACTCTTAC 5’ terminus of  
eag (492) eag_probe_rev ctaatacgactcactatagggagaGATGTTTGCTTTCTCTT
CAC 
prsAA_probe_fwd ATGAAGAAAGCTATGCTTGC 5’ terminus of 
prsAA (671) prsAA_probe_rev ctaatacgactcactatagggagaATGATGTGGTAACCGA
ATTG 
prsAB_probe_fwd ATGAGAGGAAAACATATTTTC 5’ terminus of 
secAB (557) prsAB_probe_rev ctaatacgactcactatagggagaTCTTTTGATAGTAGGT
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CTTG 
prsAC_probe_fwd TTGTATAGTTATTCTTGTAT 5’ terminus of 
secAC (509) prsAC_probe_rev ctaatacgactcactatagggagaGTCTTTTCATCTTTTAC
TAA 
csaA_probe_fwd ATGTTTCGTACGATTTCAAA 5’ terminus of  
csaA (477) csaA_probe_rev ctaatacgactcactatagggagaTGCTACAACATCACTC
TC 
csaB_probe_fwd GTGCGGTTAGTTTTATCAG 5’ terminus of  
csaB (511) csaB_probe_rev ctaatacgactcactatagggagaCTGGATCTGGAACTAG
TTC 
   
qPCR 
 
  
eag_qPCR_fwd GTGCAATTACAGGTAAGCCAGAC (125) 
eag_qPCR_rev AGCATCTTTGAAAGAAGGCTGAG  
sap_qPCR_fwd CAGTTAAAGGTAACGACAAAGGAATG (140) 
sap_qPCR_rev GAGTCAGCGAAAGATGGTTTAG  
gyrB_qPCR_fwd ACCGTTCTTCATGCTGGTG (170) 
gyrB_qPCR_rev GCAACCGGAATACCTCTTTC  
   
Pull-down experiment   
   
secA2_pull_fwd caaggatccATGGATTACAAGGATGACGACGA
TAAG AACATGCTGAATTCGGTA 
secA2 (2420) 
secA2_pull_rev cgctctagaTCACCTCGTTATTGTACG  
secH_pull_fwd caaggatccATGGATTACAAGGATGACGACGA
TAAG ATTATGTTATCATTCCTA 
secH (934) 
secH_pull_rev cacctgcagCTCTATGATTAGTCTTGTG  
sap_pull_fwd caaggatccATGGATTACAAGGATGACGACGA
TAAG ATGGCAAAGACTAACTC   
sap (2487) 
sap_pull_rev caagaattcTTATTTTGTTGCAGGTTTTG  
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Appendix C: plasmids and strains used in the study 
 
Table C.1. Strains used in the study 
 
Strain  Characteristics  Source/ 
Reference 
   
E.coli   
   
   
TOP10 F
-
 mcrA (mrr-hsdRMS-mcrBC) 80lacZ M15, lacX74, deoR, 
recA1, araD139 (ara-leu)7697, galU, galK, rpsL, (Str
R
), 
endA1, nupG 
Invitrogen Ltd, 
Paisley, UK. 
   
XL1-Blue  
 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F proAB 
lacI q. ZΔM15 Tn10 (Tet r. )].  
 
Stratagene 
GM48 (JM110) dam
- 
dcm
-
 Stratagene 
   
BTH101 F-, cya-99, araD139, galE15, galK16, rpsL1 
(Strr), hsdR2, mcrA1, mcrB1 
Euromedex 
    
    
B. subtilis 168   trpC2 Anagnostopoul
-os, C and 
Spizizen, J. 
    
    
KG101 B. subtilis lacA::pMut4secY-F;
 
Em
r
 This study 
KG203 B. subtilis amyE::pJPR1-Ban- prsAB- Ban secY2-Bsu adk-map, 
Cm
r
 
This study 
KG204 B. subtilis amyE::pJPR1-Ban- secY2-Bsu adk-map, Cm
r
 This study 
KG205 B. subtilis amyE::pJPR1-Ban- prsAB- secY2-Bsu adk-map with 
pMAP65, Cm
r 
Km
r
 
This study 
KG206 B. subtilis amyE::pJPR1-Ban- prsAB- secY2-Bsu adk-map; 
lacA::pMut4secY-F with pMAP65, Cm
r 
Km
r 
Em
r
 
This study 
GQ32 secA::secA1, amyE::prsAB-eag, Cm
r 
Km
r
  Guoqing Wang 
GQ48 lacA::secA2, amyE::prsAB-eag, Cm
r 
Em
r
  Guoqing Wang 
GQ69 lacA::secA2secH, amyE::prsAB-eag, Cm
r 
Em
r
  Guoqing Wang 
GQ72 lacA::secH, amyE::prsAB-eag, Cm
r 
Em
r
  Guoqing Wang 
GQ65 secA::secA1, lacA::secA2, amyE::prsAB-eag, 
Cm
r 
Km
r 
Em
r
 
 Guoqing Wang 
GQ74 secA::secA1, lacA::secH, amyE::prsAB-eag, 
Cm
r 
Km
r 
Em
r
 
 Guoqing Wang 
GQ75 secA::secA1, lacA::secA2-secH, amyE::prsAB-
eag, Cm
r 
Km
r 
Em
r
 
 Guoqing Wang 
AB06Jeag1 amyE::prsAB-eag, Cm
r
  Pijug 
Summpunn 
AB06Jsap1 amyE::prsAB-sap, Cm
r
  Pijug 
Summpunn 
    
B. subtilis 
WB600   
trpC2, ΔnprE, ΔaprA, Δepr, Δbpf, Δ mpr, 
ΔnprB 
 Wu et al., 1991 
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B. anthracis UMCI-2      pXO1
- 
pXO2
-
 derivative of UM23 , Ura-Rif
r
 
 
Hoffmaster et  
Koehler, 1997 
    
    
ΔsecH UM23CI-2 secH:: Kmr via pKG3021 This study 
ΔsecA2H UM23CI-2 secA2-secH::Kmr via pKG302 This study 
ΔprsAA UM23CI-2 prsAA::Kmr via pKG303 This study 
ΔprsAB UM23CI-2 prsAB::Kmr via pKG304 This study 
ΔprsAC UM23CI-2 prsAC::Kmr via pKG305 This study 
Δsap-eag UM23CI-2 sap-eag:: Kmr via pKG306 This study 
secA2* UM23CI-2 secA2:: Km
r 
via pKG308 This study 
secA2 UM23C1-2 secA2:: Km
r 
via pSA102  Steven Addinal 
KG400 UM23CI-2 with pKG400, Km
r 
Em
r
  This study 
KG401 ΔsecA2H carrying pKG401, Kmr Emr   This study 
KG402 ΔsecA2H carrying pKG402, Kmr Emr  This study 
KG403 ΔsecA2H carrying pKG403, Kmr Emr  This study 
KG404-1 secA2* carrying pKG404, Kmr Emr  This study 
KG404-2 ΔsecA2H carrying pKG404, Kmr Emr  This study 
KG404-3 ΔsecH carrying pKG404, Kmr Emr  This study 
KG404-4 ΔprsAB carrying pKG404, Kmr Emr  This study 
KG404-5 Δsap-eag carrying pKG404, Kmr Emr  This study 
KG405-1 secA2* carrying pKG405, Kmr Emr  This study 
KG405-2 ΔsecA2H carrying pKG405, Kmr Emr  This study 
KG405-3 ΔsecH carrying pKG405, Kmr Emr  This study 
KG405-5 ΔprsAB carrying pKG405, Kmr Emr  This study 
KG405-6 Δsap-eag carrying pKG405, Kmr Emr  This study 
KG406 Δsap-eag carrying pKG406, Kmr Emr  This study 
KG407 Δsap-eag carrying pKG407, Kmr Emr  This study 
KG408 Δsap-eag carrying pKG408, Kmr Emr  This study 
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Table C.2. Plasmids used in the study 
 
Plasmid Characteristic Reference/Source 
 
   
Experiments in  B. subtilis  
   
pJPR1 Integration vector,  Ampr Cmr5′amyE 3′amyE, xylose-
inducible Pxylpromoter 
J. Errington 
(Newcastle 
University, 
UK) 
pMUTIN4 Integration vector ,Ap
r
 Em
r
 Lm
r 
,IPTG-inducible Pspac 
promoter 
Vagner et 
al. 1998 
pKG101 pMut4-Pspac -secY5’;
 
trpC2 Em
r
 This study 
pKG201 pJPR1-Pxyl-Ban- secY2, trpC2 Cm
r
 This study 
pKG202 pJPR1-Pxyl-Ban- adk-map, trpC2 Cm
r
 This study 
pKG203 pJPR1-Pxyl-Ban- secY2-Bsu adk-map, trpC2 Cm
r
 This study 
pKG204 pJPR1-Pxyl-Ban- secY2-Bsu adk-map trpC2 Cm
r
 This study 
pMAP65 pUB110 derivative carrying lacI under the PenP promoter. 
Phleo
R
, Km
r
 
Dervyn & 
Ehrlich, 
2001 
   
   
Construction of  B. anthracis deletion mutants 
   
pUTE583 B.anthracis gene knockout vector, Emr Cm
r
 Chen et al. 
2004 
pKG301 pUTE583 with 804bp 5’ and 837bp 3’  flanking fragments of 
B. anthracis secH separated by the ΩKm, Kmr Emr Cmr 
This study 
pKG302 pUTE583 with 826 bp 5’ secA2 flanking fragment and 837 
bp3’ secH flanking  fragment of B. anthracis separated by 
the ΩKm, Kmr Emr Cmr   
This study 
pKG303 pUTE583 with 915 bp 5’ and  861 bp 3’ flanking fragments 
of B. anthracis prsAA separated by the ΩKm, Kmr Emr Cmr 
This study 
pKG304 pUTE583 with 882 bp 5’ and 713 bp 3’flanking fragments of 
B. anthracis prsAB separated by the ΩKm, Kmr Emr Cmr 
This study 
pKG305 pUTE583 with 755 bp 5’ and 825bp 3’ flanking fragments of 
B. anthracis prsAC separated by the ΩKm, Kmr Emr Cmr 
This study 
pKG306 pUTE583 with 826 bp 5’ sap flanking fragment and 837 
bp3’ eag flanking  fragments of B. anthracis separated by 
the ΩKm, Kmr Emr Cmr 
This study 
pKG307 pUTE583 with 946 bp 5’ and  816 bp 3’flanking fragments 
of B. anthracis secA2 separated by the ΩKm, with dif sites 
between ΩKm and flanking fragments , Kmr Emr Cmr 
 
pKG308 pUTE583 with 553 bp 5’ secA2 flanking sequence and 888 
bp3’ secH flanking  fragments of B. anthracis separated by 
the ΩKm, The promoter (223bp) of secA2-secH operon was 
introduced upstream of secH Km
r
 Emr Cm
r
 
This study 
pSA102 pUTE583 with 500bp 5’ and 3’ fragments of B. anthracis 
secA2 separated by the ΩKmr, Kmr Emr Cmr 
Stephen 
Addinal 
   
Complementation in B.anthracis 
   
pLOSS bla spc Pspac-mcs PdivIVA-lacZ lacI reppLS20 Claessen et 
al., 2008 
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pHT01 Amp
r
, Cm
r
, Pgrac promoter (consisting of groEpromotor, 
the lacO operator and the gsiBSD sequence, ColE1 ori,, lacI 
repressor, E. coli/B. subtilis shuttle vector 
MoBiTec 
pKG400 Expression vector for B.anthracis. Derivative of pUTE583 
containing Pgrac, lacI, Em
r 
Cm
r
 
This study 
pKG401 pKG400-Pgrac-secA2-secH, Em
r 
Cm
r
 This study 
pKG402 pKG400-Pgrac-secA2, Em
r 
Cm
r
 This study 
pKG403 pKG400-Pgrac-secH, Em
r 
Cm
r
 This study 
pKG404 pKG400-Pgrac-sap, Em
r 
Cm
r
 This study 
pKG405 pKG400-Pgrac-eag, Em
r 
Cm
r
 This study 
   
Pull-down experiment  
   
pKG406 pKG400-Pgrac-FLAG-secA2, Em
r 
Cm
r
 This study 
pKG407 pKG400-Pgrac-FLAG-secH, Em
r 
Cm
r
 This study 
pKG408 pKG400-Pgrac-FLAG-sap, Em
r 
Cm
r
 This study 
   
Protein purification   
   
pET16b  PT7lac-10his lacI,Ampr Novagen 
pKG500 pET16b- Ptac –secH, Ampr This study 
pGEX-6P-1 Ptac-gst-lacI, Ampr GE 
Healthcare 
pLH1 pGEX-6P-1- Ptac- secA1, Ampr Lorraine 
Hewitt 
pLH2 pGEX-6P-1- Ptac- secA2, Ampr Lorraine 
Hewitt 
   
Bacterial Two Hybrid assay  
   
pUT18 Plac-cya
675-1197
, Amp
r 
(for 
 
in-frame fusions at the N-
terminal end of the T18 polypeptide) 
Euromedex 
pUT18C Plac-cya
675-1197
, Amp
r 
(for 
 
in-frame fusions at the C-
terminal end of the T18 polypeptide) 
Euromedex 
pKT25 Plac-cya1-675 (for  in-frame fusions at the C-terminal end 
of the T25 polypeptide) 
Euromedex 
pKT25N Plac-cya1-675 for  in-frame fusions at the N-terminal end of 
the T25 polypeptide) 
Euromedex 
pUT18C-zip Plac-cya1-675-zip (construct encoding leucine 
zipper from GCN4) 
Euromedex 
pKT25-zip Plac-cya675-1197-zip (construct encoding leucine 
zipper from GCN4) 
Euromedex 
pUT18-SecA1 pUT18 Plac-secA1::cyaAT18, Amp
r
 This study 
pUT18C-SecA1  pUT18C Plac- cyaAT18C ::secA1, Amp
r
 This study 
pKT25-SecA1 pKT25 Plac- cyaAT25 ::secA1, Km
r
 This study 
pKT25N-SecA1 pKT25N Plac-secA1::cyaAT25N, Km
r
 This study 
pUT18-SecA2 pUT18 Plac-secA2::cyaAT18, Amp
r
 This study 
pUT18C-SecA2  pUT18C Plac- cyaAT18C ::secA2, Amp
r
 This study 
pKT25-SecA2 pKT25 Plac- cyaAT25 ::secA2, Km
r
 This study 
pKT25N-SecA2 pKT25N Plac-secA2::cyaAT25N, Km
r
 This study 
pUT18-SecH pUT18 Plac-secH::cyaAT18, Amp
r
 This study 
pUT18C-SecH pUT18C Plac- cyaAT18C ::secH, Amp
r
 This study 
pKT25-SecH pKT25 Plac- cyaAT25 ::secH, Km
r
 This study 
pKT25N-SecH pKT25N Plac-secH::cyaAT25N, Km
r
 This study 
pUT18-SecY1 pUT18 Plac-secY1::cyaAT18, Amp
r
 This study 
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pUT18C-SecY1  pUT18C Plac- cyaAT18C ::secY1, Amp
r
 This study 
pKT25-SecY1 pKT25 Plac- cyaAT25 ::secY1Km
r
 This study 
pKT25N-SecY1 pKT25N Plac-secY1::cyaAT25N, Km
r
 This study 
pUT18-SecY2 pUT18 Plac-secY2::cyaAT18, Amp
r
 This study 
pUT18C-SecY2  pUT18C Plac- cyaAT18C ::secY2, Amp
r
 This study 
pKT25-SecY2 pKT25 Plac- cyaAT25 ::secY2, Km
r
 This study 
pKT25N-SecY2 pKT25N Plac-secY2::cyaAT25N, Km
r
 This study 
pUT18-Sap_ N-
terminus 
pUT18 Plac-sap1-290::cyaAT18, Amp
R
 This study 
pUT18C-Sap_N-
terminus  
pUT18C Plac- cyaAT18C :: sap1-290, Amp
r
 This study 
pKT25- Sap_N-
terminus 
pKT25 Plac- cyaAT25 ::sap1-290, Km
r
 This study 
pKT25N- Sap_N-
terminus 
pKT25N Plac- sap1-290::cyaAT25N, Km
r
 This study 
pUT18-EA1_ N-
terminus 
pUT18 Plac-eag1-329::cyaAT18, Amp
r
 This study 
pUT18C-EA1_N-
terminus  
pUT18C Plac- cyaAT18C ::eag1-329Amp
r
 This study 
pKT25- EA1_N-
terminus 
pKT25 Plac- cyaAT25 :: eag1-329, Km
r
 This study 
pKT25N- EA1_N-
terminus 
pKT25N Plac- eag1-329::cyaAT25N, Km
r
 This study 
pUT18-Sap pUT18 Plac-sap::cyaAT18, Amp
r
 This study 
pUT18C-Sap  pUT18C Plac- cyaAT18C ::sap, Amp
r
 This study 
pKT25-Sap pKT25 Plac- cyaAT25 :: sap, Km
r
 This study 
pKT25N-Sap pKT25N Plac- sap::cyaAT25N,Km
r
 This study 
pUT18-Bsu_SecA pUT18 Plac-Bsu_secA::cyaAT18,Amp
r
 This study 
pUT18C- Bsu_SecA pUT18C Plac- cyaAT18C ::Bsu_secA, Amp
r
 This study 
pKT25- Bsu_SecA pKT25 Plac- cyaAT25::Bsu_secA, Km
r
 This study 
pKT25N- Bsu_SecA pKT25N Plac- Bsu_secA::cyaAT25N, Km
r
 This study 
pUT18-Sap_siganl 
peptide 
pUT18 Plac-sap1-90::cyaAT18, Amp
r
 This study 
pUT18C- Sap_siganl 
peptide  
pUT18C Plac- cyaAT18C :: sap1-90, Amp
r
 This study 
pKT25- Sap_siganl 
peptide 
pKT25 Plac- cyaAT25 ::sap1-90, Km
r
 This study 
pKT25N- Sap_siganl 
peptide 
pKT25N Plac- sap1-90::cyaAT25N,Km
r
 This study 
pUT18- EA1_siganl 
peptide 
pUT18 Plac-eag1-90::cyaAT18, Amp
r
 This study 
pUT18C- EA1_siganl 
peptide  
pUT18C Plac- cyaAT18C ::eag1-90, Amp
r
 This study 
pKT25- EA1_siganl 
peptide 
pKT25 Plac- cyaAT25 :: eag1-90, Km
r
 This study 
pKT25N- EA1_siganl 
peptide 
pKT25N Plac- eag1-90::cyaAT25N, Km
r
 This study 
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